LOKIASV2_1567_ESMFold_hypothetical_protein	4n57-assembly1.cif.gz_A	4n57-assembly1.cif.gz_A Crystal structure of aminoglycoside phosphotransferase APH(2'')-IVa ADP complex	3.319E-10	1.000	319	178	487	493	19	295	296	323	0.629	0.936
LOKIASV2_1567_ESMFold_hypothetical_protein	3n4v-assembly2.cif.gz_B	3n4v-assembly2.cif.gz_B apo APH(2")-IVa form III	7.135E-10	1.000	303	178	487	493	20	296	298	329	0.629	0.930
LOKIASV2_1567_ESMFold_hypothetical_protein	3att-assembly1.cif.gz_A	3att-assembly1.cif.gz_A Crystal structure of Rv3168 with ATP	1.097E-09	1.000	295	149	482	493	2	348	352	385	0.677	0.986
LOKIASV2_1567_ESMFold_hypothetical_protein	4dfb-assembly1.cif.gz_A	4dfb-assembly1.cif.gz_A Crystal structure of aminoglycoside phosphotransferase aph(2")-id/aph(2")-iva in complex with kanamycin	1.609E-09	1.000	286	178	486	493	20	293	297	322	0.627	0.923
LOKIASV2_1567_ESMFold_hypothetical_protein	3w0p-assembly1.cif.gz_A	3w0p-assembly1.cif.gz_A Crystal structure of a thermostable mutant of aminoglycoside phosphotransferase APH(4)-Ia (D198A), ternary complex with ADP and hygromycin B	7.796E-09	1.000	285	179	491	493	13	290	295	324	0.635	0.942
LOKIASV2_1567_ESMFold_hypothetical_protein	4dta-assembly1.cif.gz_A	4dta-assembly1.cif.gz_A Crystal Structure of F95M Aminoglycoside-2''-Phosphotransferase Type IVa in Complex with Adenosine	2.996E-09	1.000	283	178	481	493	20	295	298	320	0.617	0.926
LOKIASV2_1567_ESMFold_hypothetical_protein	3dxp-assembly1.cif.gz_A-2	3dxp-assembly1.cif.gz_A-2 Crystal structure of a putative aminoglycoside phosphotransferase (reut_a1007) from ralstonia eutropha jmp134 at 2.32 A resolution	4.607E-09	1.000	269	182	492	493	23	326	329	340	0.631	0.924
LOKIASV2_1567_ESMFold_hypothetical_protein	3w0m-assembly1.cif.gz_A	3w0m-assembly1.cif.gz_A Crystal structure of a thermostable mutant of aminoglycoside phosphotransferase APH(4)-Ia, apo form	3.991E-09	1.000	268	179	492	493	11	289	293	336	0.637	0.952
LOKIASV2_1567_ESMFold_hypothetical_protein	3w0q-assembly1.cif.gz_A	3w0q-assembly1.cif.gz_A Crystal structure of a thermostable mutant of aminoglycoside phosphotransferase APH(4)-Ia (N203A), ternary complex with AMP-PNP and hygromycin B	5.318E-09	1.000	264	179	491	493	14	291	296	336	0.635	0.939
LOKIASV2_1567_ESMFold_hypothetical_protein	1nd4-assembly1.cif.gz_B	1nd4-assembly1.cif.gz_B Crystal structure of aminoglycoside-3'-phosphotransferase-IIa	1.319E-08	1.000	263	173	463	493	11	254	255	302	0.590	0.957
LOKIASV2_1567_ESMFold_hypothetical_protein	3w0r-assembly1.cif.gz_A	3w0r-assembly1.cif.gz_A Crystal structure of a thermostable mutant of aminoglycoside phosphotransferase APH(4)-Ia (N202A), ternary complex with AMP-PNP and hygromycin B	6.138E-09	1.000	260	179	482	493	13	289	295	327	0.617	0.939
LOKIASV2_1567_ESMFold_hypothetical_protein	3tyk-assembly1.cif.gz_A	3tyk-assembly1.cif.gz_A Crystal structure of aminoglycoside phosphotransferase APH(4)-Ia	2.129E-08	1.000	259	179	491	493	15	292	296	336	0.635	0.939
LOKIASV2_1567_ESMFold_hypothetical_protein	4dca-assembly1.cif.gz_A	4dca-assembly1.cif.gz_A Crystal structure of aminoglycoside phosphotransferase APH(2'')-Ib, ADP-bound	5.281E-08	1.000	253	180	485	493	15	294	296	322	0.621	0.946
LOKIASV2_1567_ESMFold_hypothetical_protein	4dtb-assembly2.cif.gz_B	4dtb-assembly2.cif.gz_B Crystal Structure of F95Y Aminoglycoside-2''-Phosphotransferase Type IVa in Complex with Guanosine	2.029E-08	1.000	253	178	481	493	20	295	297	321	0.617	0.929
LOKIASV2_1567_ESMFold_hypothetical_protein	3hav-assembly1.cif.gz_A	3hav-assembly1.cif.gz_A Structure of the streptomycin-ATP-APH(2")-IIa ternary complex	3.121E-08	1.000	248	180	486	493	18	294	296	331	0.623	0.936
LOKIASV2_1567_ESMFold_hypothetical_protein	3hav-assembly2.cif.gz_B	3hav-assembly2.cif.gz_B Structure of the streptomycin-ATP-APH(2")-IIa ternary complex	6.708E-08	1.000	245	178	475	493	16	295	297	323	0.604	0.943
LOKIASV2_1567_ESMFold_hypothetical_protein	5ih0-assembly1.cif.gz_A	5ih0-assembly1.cif.gz_A Macrolide 2'-phosphotransferase type II Y92M mutant - complex with GDP and erythromycin	7.742E-08	1.000	241	182	487	493	23	298	299	326	0.621	0.923
LOKIASV2_1567_ESMFold_hypothetical_protein	7w19-assembly2.cif.gz_B	7w19-assembly2.cif.gz_B Crystal Structure of Acinetobacter baumannii MPH-E	6.708E-08	1.000	238	179	481	493	15	290	291	322	0.615	0.948
LOKIASV2_1567_ESMFold_hypothetical_protein	2ppq-assembly1.cif.gz_A-2	2ppq-assembly1.cif.gz_A-2 Crystal structure of the homoserine kinase from Agrobacterium tumefaciens	1.310E-07	1.000	237	151	485	493	6	307	310	361	0.680	0.974
LOKIASV2_1567_ESMFold_hypothetical_protein	3i0o-assembly1.cif.gz_A	3i0o-assembly1.cif.gz_A Crystal Structure of Spectinomycin Phosphotransferase, APH(9)-Ia, in complex with ADP and Spectinomcyin	1.598E-08	1.000	235	178	489	493	18	326	329	350	0.633	0.939
LOKIASV2_1567_ESMFold_hypothetical_protein	5uxb-assembly1.cif.gz_A	5uxb-assembly1.cif.gz_A Crystal structure of macrolide 2'-phosphotransferase MphH from Brachybacterium faecium, apoenzyme	4.361E-08	1.000	234	167	478	493	12	284	290	330	0.633	0.941
LOKIASV2_1567_ESMFold_hypothetical_protein	2bkk-assembly2.cif.gz_C	2bkk-assembly2.cif.gz_C Crystal structure of Aminoglycoside Phosphotransferase APH(3')-IIIa in complex with the inhibitor AR_3a	6.096E-08	1.000	231	174	451	493	14	261	262	292	0.564	0.947
LOKIASV2_1567_ESMFold_hypothetical_protein	1l8t-assembly1.cif.gz_A	1l8t-assembly1.cif.gz_A Crystal Structure Of 3',5"-Aminoglycoside Phosphotransferase Type IIIa ADP Kanamycin A Complex	2.217E-07	1.000	231	173	445	493	14	256	263	285	0.554	0.924
LOKIASV2_1567_ESMFold_hypothetical_protein	5igw-assembly1.cif.gz_A	5igw-assembly1.cif.gz_A Macrolide 2'-phosphotransferase type II - complex with GDP and clarithromycin	1.512E-07	1.000	231	182	487	493	22	295	296	327	0.621	0.926
LOKIASV2_1567_ESMFold_hypothetical_protein	5uxb-assembly2.cif.gz_B	5uxb-assembly2.cif.gz_B Crystal structure of macrolide 2'-phosphotransferase MphH from Brachybacterium faecium, apoenzyme	8.122E-08	1.000	229	179	478	493	17	291	297	321	0.609	0.926
LOKIASV2_1567_ESMFold_hypothetical_protein	5iqc-assembly3.cif.gz_C	5iqc-assembly3.cif.gz_C Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Gentamicin C1	1.586E-07	1.000	228	178	482	493	18	294	297	321	0.619	0.933
LOKIASV2_1567_ESMFold_hypothetical_protein	2bkk-assembly1.cif.gz_A	2bkk-assembly1.cif.gz_A Crystal structure of Aminoglycoside Phosphotransferase APH(3')-IIIa in complex with the inhibitor AR_3a	4.766E-07	1.000	217	174	446	493	15	241	247	280	0.554	0.919
LOKIASV2_1567_ESMFold_hypothetical_protein	4fex-assembly3.cif.gz_C	4fex-assembly3.cif.gz_C Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor tyrphostin AG1478	3.552E-06	1.000	216	182	445	493	18	254	261	269	0.535	0.908
LOKIASV2_1567_ESMFold_hypothetical_protein	4r77-assembly3.cif.gz_A	4r77-assembly3.cif.gz_A Crystal structure of choline kinase LicA from Streptococcus pneumoniae	4.766E-07	1.000	215	176	485	493	16	281	281	324	0.629	0.947
LOKIASV2_1567_ESMFold_hypothetical_protein	4r78-assembly1.cif.gz_A	4r78-assembly1.cif.gz_A Crystal structure of LicA in complex with AMP	8.460E-07	1.000	215	149	485	493	4	286	287	351	0.684	0.986
LOKIASV2_1567_ESMFold_hypothetical_protein	3ham-assembly1.cif.gz_A	3ham-assembly1.cif.gz_A Structure of the gentamicin-APH(2")-IIa complex	6.053E-07	1.000	213	180	475	493	18	289	299	313	0.600	0.910
LOKIASV2_1567_ESMFold_hypothetical_protein	4fev-assembly1.cif.gz_A	4fev-assembly1.cif.gz_A Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP1	1.908E-06	1.000	212	165	445	493	1	256	263	297	0.570	0.973
LOKIASV2_1567_ESMFold_hypothetical_protein	4feu-assembly6.cif.gz_F	4feu-assembly6.cif.gz_F Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor anthrapyrazolone SP600125	5.731E-06	1.000	211	181	445	493	4	238	245	273	0.538	0.959
LOKIASV2_1567_ESMFold_hypothetical_protein	4few-assembly8.cif.gz_D	4few-assembly8.cif.gz_D Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP2	4.512E-06	1.000	208	182	445	493	20	259	266	276	0.535	0.902
LOKIASV2_1567_ESMFold_hypothetical_protein	4gkh-assembly2.cif.gz_B	4gkh-assembly2.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor 1-NA-PP1	5.463E-06	1.000	207	182	445	493	25	261	268	273	0.535	0.884
LOKIASV2_1567_ESMFold_hypothetical_protein	5igh-assembly1.cif.gz_A	5igh-assembly1.cif.gz_A Macrolide 2'-phosphotransferase type I	6.987E-07	1.000	207	181	482	493	25	297	301	321	0.613	0.907
LOKIASV2_1567_ESMFold_hypothetical_protein	4gkh-assembly17.cif.gz_I	4gkh-assembly17.cif.gz_I Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor 1-NA-PP1	3.077E-06	1.000	206	165	445	493	6	259	266	295	0.570	0.955
LOKIASV2_1567_ESMFold_hypothetical_protein	4ej7-assembly2.cif.gz_B	4ej7-assembly2.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, ATP-bound	2.934E-06	1.000	205	165	445	493	7	258	265	293	0.570	0.951
LOKIASV2_1567_ESMFold_hypothetical_protein	4fex-assembly2.cif.gz_B	4fex-assembly2.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor tyrphostin AG1478	9.698E-06	1.000	204	182	445	493	18	254	261	270	0.535	0.908
LOKIASV2_1567_ESMFold_hypothetical_protein	4few-assembly9.cif.gz_F	4few-assembly9.cif.gz_F Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP2	6.306E-06	1.000	201	165	445	493	10	259	266	291	0.570	0.940
LOKIASV2_1567_ESMFold_hypothetical_protein	4feu-assembly4.cif.gz_D	4feu-assembly4.cif.gz_D Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor anthrapyrazolone SP600125	7.279E-06	1.000	197	182	445	493	1	235	242	278	0.535	0.971
LOKIASV2_1567_ESMFold_hypothetical_protein	4feu-assembly3.cif.gz_C	4feu-assembly3.cif.gz_C Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor anthrapyrazolone SP600125	4.100E-06	1.000	196	181	445	493	1	255	262	284	0.538	0.973
LOKIASV2_1567_ESMFold_hypothetical_protein	4gkh-assembly10.cif.gz_J	4gkh-assembly10.cif.gz_J Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor 1-NA-PP1	8.009E-06	1.000	196	182	445	493	25	260	267	273	0.535	0.884
LOKIASV2_1567_ESMFold_hypothetical_protein	4gki-assembly6.cif.gz_F	4gki-assembly6.cif.gz_F Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor 1-NM-PP1	1.292E-05	1.000	195	182	445	493	19	254	261	274	0.535	0.904
LOKIASV2_1567_ESMFold_hypothetical_protein	4few-assembly7.cif.gz_B	4few-assembly7.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP2	1.292E-05	1.000	194	165	445	493	1	249	256	290	0.570	0.973
LOKIASV2_1567_ESMFold_hypothetical_protein	4feu-assembly2.cif.gz_B	4feu-assembly2.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor anthrapyrazolone SP600125	8.009E-06	1.000	193	165	445	493	4	256	263	289	0.570	0.962
LOKIASV2_1567_ESMFold_hypothetical_protein	4fev-assembly7.cif.gz_B	4fev-assembly7.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP1	1.232E-05	1.000	190	181	445	493	11	247	254	281	0.538	0.933
LOKIASV2_1567_ESMFold_hypothetical_protein	3i0q-assembly1.cif.gz_A	3i0q-assembly1.cif.gz_A Crystal Structure of the AMP-bound complex of Spectinomycin Phosphotransferase, APH(9)-Ia	9.310E-07	1.000	186	178	486	493	17	311	316	343	0.627	0.934
LOKIASV2_1567_ESMFold_hypothetical_protein	4gkh-assembly18.cif.gz_K	4gkh-assembly18.cif.gz_K Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor 1-NA-PP1	3.206E-05	1.000	184	165	445	493	11	262	269	293	0.570	0.937
LOKIASV2_1567_ESMFold_hypothetical_protein	4fev-assembly9.cif.gz_F	4fev-assembly9.cif.gz_F Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP1	4.700E-05	1.000	180	182	445	493	10	245	252	277	0.535	0.937
LOKIASV2_1567_ESMFold_hypothetical_protein	2ivu-assembly1.cif.gz_A-2	2ivu-assembly1.cif.gz_A-2 Crystal structure of phosphorylated RET tyrosine kinase domain complexed with the inhibitor ZD6474	1.067E-05	1.000	149	170	482	493	12	286	289	369	0.635	0.952
LOKIASV2_1567_ESMFold_hypothetical_protein	5cf4-assembly2.cif.gz_B	5cf4-assembly2.cif.gz_B CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH N,N-DICYCLOPROPYL-10-ETHYL-7-[(3-METHOXYPROPYL)AMINO] -3-METHYL-3,5,8,10-TETRAAZATRICYCLO[7.3.0.0,6] DODECA-1(9),2(6),4,7,11-PENTAENE-11-CARBOXAMIDE	2.294E-05	1.000	147	165	484	493	1	290	293	374	0.649	0.990
LOKIASV2_1567_ESMFold_hypothetical_protein	6nvl-assembly1.cif.gz_A	6nvl-assembly1.cif.gz_A FGFR1 complex with N-(2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-3-methylphenyl)acrylamide	3.528E-05	1.000	145	165	482	493	5	273	280	365	0.645	0.961
LOKIASV2_1567_ESMFold_hypothetical_protein	7du9-assembly1.cif.gz_B	7du9-assembly1.cif.gz_B Crystal structure of human Proto-oncogene tyrosine-protein kinase receptor Ret in complex with Pralsetinib	5.425E-05	1.000	141	173	482	493	12	270	273	351	0.629	0.949
LOKIASV2_1567_ESMFold_hypothetical_protein	7dhl-assembly1.cif.gz_A	7dhl-assembly1.cif.gz_A Crystal structure of FGFR3 in complex with pyrimidine derivative	5.970E-05	1.000	141	168	482	493	6	286	289	365	0.639	0.972
LOKIASV2_1567_ESMFold_hypothetical_protein	5tq3-assembly2.cif.gz_B	5tq3-assembly2.cif.gz_B Design and Synthesis of a pan-JAK kinase inhibitor clinical candidate (PF-06263276) suitable for the treatment of inflammatory diseases of the lungs and skin	7.954E-05	1.000	138	172	484	493	4	284	287	368	0.635	0.979
LOKIASV2_1567_ESMFold_hypothetical_protein	5e91-assembly1.cif.gz_A	5e91-assembly1.cif.gz_A TGF-BETA RECEPTOR TYPE 2 KINASE DOMAIN (E431A,R433A,E485A,K488A,R493A,R495A) IN COMPLEX WITH 3-AMINO-6-[4-(2- HYDROXYETHYL)PHENYL]-N-[4-(MORPHOLIN-4-YL)PYRIDIN-3-YL] PYRAZINE-2-CARBOXAMIDE	3.206E-05	1.000	138	180	492	493	5	291	297	375	0.635	0.966
LOKIASV2_1567_ESMFold_hypothetical_protein	2x2l-assembly1.cif.gz_A-2	2x2l-assembly1.cif.gz_A-2 Crystal Structure of phosphorylated RET tyrosine kinase domain with inhibitor	6.891E-05	1.000	137	156	482	493	4	287	288	384	0.663	0.986
LOKIASV2_1567_ESMFold_hypothetical_protein	2b9i-assembly1.cif.gz_A	2b9i-assembly1.cif.gz_A Crystal structure of Fus3 with a docking motif from Msg5	2.389E-04	1.000	137	170	396	493	8	159	338	235	0.460	0.450
LOKIASV2_1567_ESMFold_hypothetical_protein	8pqg-assembly1.cif.gz_A	8pqg-assembly1.cif.gz_A c-KIT T670I mutated kinase domain in complex with avapritinib	3.882E-05	1.000	136	168	480	493	17	291	292	372	0.635	0.942
LOKIASV2_1567_ESMFold_hypothetical_protein	5tq3-assembly1.cif.gz_A	5tq3-assembly1.cif.gz_A Design and Synthesis of a pan-JAK kinase inhibitor clinical candidate (PF-06263276) suitable for the treatment of inflammatory diseases of the lungs and skin	1.010E-04	1.000	135	172	484	493	4	281	284	365	0.635	0.979
LOKIASV2_1567_ESMFold_hypothetical_protein	5l3a-assembly1.cif.gz_A	5l3a-assembly1.cif.gz_A Fragment-based discovery of 6-arylindazole JAK inhibitors	1.166E-04	1.000	135	172	482	493	6	287	290	363	0.631	0.972
LOKIASV2_1567_ESMFold_hypothetical_protein	8pqg-assembly2.cif.gz_C	8pqg-assembly2.cif.gz_C c-KIT T670I mutated kinase domain in complex with avapritinib	4.700E-05	1.000	135	168	480	493	18	298	300	374	0.635	0.937
LOKIASV2_1567_ESMFold_hypothetical_protein	6qy8-assembly4.cif.gz_D	6qy8-assembly4.cif.gz_D Human CSNK2A2 bound to ERB-041	1.630E-04	1.000	135	174	402	493	32	177	323	232	0.465	0.452
LOKIASV2_1567_ESMFold_hypothetical_protein	6z1c-assembly1.cif.gz_A	6z1c-assembly1.cif.gz_A Crystal structure of Arabidopsis thaliana CK2-alpha-1 in complex with TTP-22	3.340E-04	1.000	135	180	394	493	31	169	331	218	0.436	0.420
LOKIASV2_1567_ESMFold_hypothetical_protein	4d1s-assembly1.cif.gz_A	4d1s-assembly1.cif.gz_A Pyrrole-3-carboxamides as potent and selective JAK2 inhibitors	1.166E-04	1.000	134	173	484	493	6	281	282	360	0.633	0.979
LOKIASV2_1567_ESMFold_hypothetical_protein	6in0-assembly1.cif.gz_A	6in0-assembly1.cif.gz_A Crystal structure of EphA3 in complex with 18-Crown-6	1.481E-04	1.000	133	180	486	493	9	262	272	352	0.623	0.934
LOKIASV2_1567_ESMFold_hypothetical_protein	7uyv-assembly2.cif.gz_B	7uyv-assembly2.cif.gz_B Crystal structure of JAK3 kinase domain in complex with compound 25	1.554E-04	1.000	133	172	482	493	6	279	284	368	0.631	0.965
LOKIASV2_1567_ESMFold_hypothetical_protein	3kxx-assembly4.cif.gz_D	3kxx-assembly4.cif.gz_D Structure of the mutant Fibroblast Growth Factor receptor 1	1.412E-04	1.000	133	171	493	493	18	288	288	372	0.655	0.941
LOKIASV2_1567_ESMFold_hypothetical_protein	6yzh-assembly1.cif.gz_A	6yzh-assembly1.cif.gz_A Crystal structure of P8C9 bound to CK2alpha	4.667E-04	1.000	133	171	401	493	47	197	344	235	0.469	0.439
LOKIASV2_1567_ESMFold_hypothetical_protein	6vnf-assembly1.cif.gz_B	6vnf-assembly1.cif.gz_B JAK2 JH1 in complex with MA9-086	9.181E-05	1.000	132	172	484	493	6	289	291	367	0.635	0.976
LOKIASV2_1567_ESMFold_hypothetical_protein	6tpd-assembly1.cif.gz_A	6tpd-assembly1.cif.gz_A Fragment-based discovery of pyrazolopyridones as JAK1 inhibitors with excellent subtype selectivity	1.481E-04	1.000	131	172	482	493	5	286	289	363	0.631	0.976
LOKIASV2_1567_ESMFold_hypothetical_protein	3my0-assembly13.cif.gz_M	3my0-assembly13.cif.gz_M Crystal structure of the ACVRL1 (ALK1) kinase domain bound to LDN-193189	1.215E-03	1.000	131	180	400	493	9	160	298	224	0.448	0.510
LOKIASV2_1567_ESMFold_hypothetical_protein	7uyw-assembly1.cif.gz_A	7uyw-assembly1.cif.gz_A Crystal structure of JAK2 kinase domain in complex with compound 30	8.343E-05	1.000	130	172	484	493	5	288	290	372	0.635	0.979
LOKIASV2_1567_ESMFold_hypothetical_protein	3kck-assembly1.cif.gz_A	3kck-assembly1.cif.gz_A A Novel Chemotype of Kinase Inhibitors	1.223E-04	1.000	129	173	484	493	6	286	287	365	0.633	0.979
LOKIASV2_1567_ESMFold_hypothetical_protein	3my0-assembly15.cif.gz_O	3my0-assembly15.cif.gz_O Crystal structure of the ACVRL1 (ALK1) kinase domain bound to LDN-193189	1.104E-03	1.000	129	180	400	493	9	163	297	227	0.448	0.522
LOKIASV2_1567_ESMFold_hypothetical_protein	3vud-assembly1.cif.gz_A	3vud-assembly1.cif.gz_A Crystal structure of a cysteine-deficient mutant M1 in MAP kinase JNK1	2.389E-04	1.000	129	172	396	493	1	167	355	245	0.456	0.470
LOKIASV2_1567_ESMFold_hypothetical_protein	3zfx-assembly8.cif.gz_H	3zfx-assembly8.cif.gz_H Crystal structure of EphB1	3.675E-04	1.000	128	180	486	493	9	262	266	345	0.623	0.955
LOKIASV2_1567_ESMFold_hypothetical_protein	5oxg-assembly1.cif.gz_A	5oxg-assembly1.cif.gz_A Crystal structure of the ACVR1 (ALK2) kinase in complex with LDN-212854	1.215E-03	1.000	128	173	398	493	4	155	293	229	0.458	0.519
LOKIASV2_1567_ESMFold_hypothetical_protein	6vnk-assembly4.cif.gz_A	6vnk-assembly4.cif.gz_A JAK2 JH1 in complex with PN4-073	1.112E-04	1.000	128	173	484	493	13	294	297	365	0.633	0.949
LOKIASV2_1567_ESMFold_hypothetical_protein	6xx8-assembly1.cif.gz_A	6xx8-assembly1.cif.gz_A Arabidopsis thaliana Casein Kinase 2 (CK2) alpha-1 crystal form II	7.178E-04	1.000	128	180	400	493	26	170	326	224	0.448	0.445
LOKIASV2_1567_ESMFold_hypothetical_protein	7du8-assembly1.cif.gz_B	7du8-assembly1.cif.gz_B Crystal structure of human Proto-oncogene tyrosine-protein kinase receptor Ret in complex with Selpercatinib	5.172E-05	1.000	127	174	482	493	14	276	279	338	0.627	0.943
LOKIASV2_1567_ESMFold_hypothetical_protein	4ytc-assembly1.cif.gz_A	4ytc-assembly1.cif.gz_A Discovery of VX-509 (Decernotinib): A Potent and Selective Janus kinase (JAK) 3 Inhibitor for the Treatment of Autoimmune Disease	9.181E-05	1.000	127	172	484	493	5	285	286	374	0.635	0.983
LOKIASV2_1567_ESMFold_hypothetical_protein	5e90-assembly1.cif.gz_A	5e90-assembly1.cif.gz_A TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D,I211V,Y249F, S280T,Y282F,S287N,A350C,L352F) IN COMPLEX WITH 3-AMINO-6- [4-(2-HYDROXYETHYL)PHENYL]-N-[4-(MORPHOLIN-4-YL)PYRIDIN-3-YL]PYRAZINE-2-CARBOXAMIDE	6.891E-05	1.000	127	167	493	493	1	303	303	381	0.663	1.000
LOKIASV2_1567_ESMFold_hypothetical_protein	7dv6-assembly1.cif.gz_A	7dv6-assembly1.cif.gz_A Discovery of Functionally Selective Transforming Growth Factor beta Type II Receptor (TGF-beta RII) Inhibitors as Anti-Fibrosis Agents	1.060E-04	1.000	127	180	481	493	5	302	304	365	0.613	0.980
LOKIASV2_1567_ESMFold_hypothetical_protein	3zfx-assembly4.cif.gz_D	3zfx-assembly4.cif.gz_D Crystal structure of EphB1	3.503E-04	1.000	126	180	486	493	9	260	265	346	0.623	0.951
LOKIASV2_1567_ESMFold_hypothetical_protein	7lgs-assembly2.cif.gz_B	7lgs-assembly2.cif.gz_B Structure of EGFR_D770_N771insNPG/V948R in complex with covalent inhibitor Osimertinib.	2.070E-04	1.000	126	180	487	493	11	279	286	364	0.625	0.941
LOKIASV2_1567_ESMFold_hypothetical_protein	6unr-assembly1.cif.gz_A	6unr-assembly1.cif.gz_A Kinase domain of ALK2-K492A/K493A with AMPPNP	1.471E-03	1.000	126	184	400	493	5	152	286	220	0.440	0.517
LOKIASV2_1567_ESMFold_hypothetical_protein	3rvg-assembly1.cif.gz_A	3rvg-assembly1.cif.gz_A Crystals structure of Jak2 with a 1-amino-5H-pyrido[4,3-b]indol-4-carboxamide inhibitor	2.758E-04	1.000	126	173	482	493	7	282	287	358	0.629	0.962
LOKIASV2_1567_ESMFold_hypothetical_protein	8pqf-assembly1.cif.gz_A	8pqf-assembly1.cif.gz_A c-KIT kinase domain in complex with avapritinib derivative 12	1.412E-04	1.000	126	168	480	493	17	293	294	368	0.635	0.942
LOKIASV2_1567_ESMFold_hypothetical_protein	3tzm-assembly1.cif.gz_A	3tzm-assembly1.cif.gz_A TGF-beta Receptor type 1 in complex with SB431542	9.117E-04	1.000	126	171	402	493	2	162	295	236	0.471	0.546
LOKIASV2_1567_ESMFold_hypothetical_protein	7ozy-assembly2.cif.gz_BBB	7ozy-assembly2.cif.gz_BBB FGFR2 kinase domain (residues 461-763) in complex with 38.	1.554E-04	1.000	125	171	482	493	11	277	278	352	0.633	0.960
LOKIASV2_1567_ESMFold_hypothetical_protein	8pqf-assembly2.cif.gz_C	8pqf-assembly2.cif.gz_C c-KIT kinase domain in complex with avapritinib derivative 12	1.973E-04	1.000	125	168	480	493	17	295	297	373	0.635	0.939
LOKIASV2_1567_ESMFold_hypothetical_protein	6isj-assembly1.cif.gz_A	6isj-assembly1.cif.gz_A Crystal structure of CX-4945 bound CK2 alpha from C. neoformans	2.389E-04	1.000	125	143	401	493	6	176	324	262	0.525	0.528
LOKIASV2_1567_ESMFold_hypothetical_protein	5uhn-assembly2.cif.gz_B	5uhn-assembly2.cif.gz_B Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring a N549H/E565A Double Gain-of-Function Mutation	2.506E-04	1.000	124	174	491	493	12	268	269	351	0.645	0.955
LOKIASV2_1567_ESMFold_hypothetical_protein	6i1s-assembly1.cif.gz_A	6i1s-assembly1.cif.gz_A Crystal structure of the ACVR1 (ALK2) kinase in complex with FKBP12 and the inhibitor E6201	1.868E-03	1.000	124	173	398	493	32	183	322	229	0.458	0.472
LOKIASV2_1567_ESMFold_hypothetical_protein	2pvl-assembly1.cif.gz_A	2pvl-assembly1.cif.gz_A Structure-Based Design of Pyrazolo[1,5-a][1,3,5]triazine Derivatives as Potent Inhibitors of Protein Kinase CK2	3.340E-04	1.000	124	157	400	493	11	178	328	253	0.495	0.512
LOKIASV2_1567_ESMFold_hypothetical_protein	6nvg-assembly1.cif.gz_A	6nvg-assembly1.cif.gz_A FGFR4 complex with N-(3,5-dichloro-2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)phenyl)acrylamide	1.412E-04	1.000	123	171	482	493	10	268	272	356	0.633	0.952
LOKIASV2_1567_ESMFold_hypothetical_protein	2qoc-assembly1.cif.gz_A	2qoc-assembly1.cif.gz_A Human EphA3 kinase domain, phosphorylated, AMP-PNP bound structure	2.629E-04	1.000	123	180	486	493	9	265	283	352	0.623	0.908
LOKIASV2_1567_ESMFold_hypothetical_protein	6vny-assembly1.cif.gz_A	6vny-assembly1.cif.gz_A Crystal structure of TYK2 kinase with compound 10	4.667E-04	1.000	123	173	485	493	7	285	287	364	0.635	0.972
LOKIASV2_1567_ESMFold_hypothetical_protein	6drw-assembly1.cif.gz_A	6drw-assembly1.cif.gz_A JAK2 JH1 in complex with JNJ-7706621 (Crystal Form 2)	3.035E-04	1.000	123	172	482	493	10	286	290	361	0.631	0.955
LOKIASV2_1567_ESMFold_hypothetical_protein	6uns-assembly2.cif.gz_B	6uns-assembly2.cif.gz_B Kinase domain of ALK2-K492A/K493A with LDN-193189	1.274E-03	1.000	123	171	398	493	1	154	290	231	0.462	0.531
LOKIASV2_1567_ESMFold_hypothetical_protein	7v29-assembly1.cif.gz_B	7v29-assembly1.cif.gz_B Crystal structure of FGFR4 with a dual-warhead covalent inhhibitor	2.758E-04	1.000	123	171	482	493	3	287	290	365	0.633	0.983
LOKIASV2_1567_ESMFold_hypothetical_protein	4nw6-assembly1.cif.gz_A	4nw6-assembly1.cif.gz_A Rsk2 N-terminal kinase in complex with 2-amino-7-substituted benzoxazole compound 27	1.223E-04	1.000	123	165	485	493	7	289	302	372	0.651	0.937
LOKIASV2_1567_ESMFold_hypothetical_protein	6hdr-assembly1.cif.gz_A	6hdr-assembly1.cif.gz_A Human DYRK2 bound to Curcumin	9.564E-04	1.000	123	176	398	493	94	247	407	236	0.452	0.378
LOKIASV2_1567_ESMFold_hypothetical_protein	4gk4-assembly1.cif.gz_A	4gk4-assembly1.cif.gz_A Human EphA3 Kinase domain in complex with ligand 90	4.896E-04	1.000	122	180	486	493	13	267	275	351	0.623	0.927
LOKIASV2_1567_ESMFold_hypothetical_protein	6v6q-assembly2.cif.gz_C	6v6q-assembly2.cif.gz_C Crystal Structure of Monophosphorylated FGF Receptor 2 isoform IIIb with PTR657	3.184E-04	1.000	122	174	482	493	14	274	279	352	0.627	0.935
LOKIASV2_1567_ESMFold_hypothetical_protein	7lgs-assembly1.cif.gz_A	7lgs-assembly1.cif.gz_A Structure of EGFR_D770_N771insNPG/V948R in complex with covalent inhibitor Osimertinib.	2.506E-04	1.000	122	174	487	493	10	276	283	369	0.637	0.943
LOKIASV2_1567_ESMFold_hypothetical_protein	7du9-assembly1.cif.gz_A	7du9-assembly1.cif.gz_A Crystal structure of human Proto-oncogene tyrosine-protein kinase receptor Ret in complex with Pralsetinib	4.700E-05	1.000	122	172	482	493	1	283	285	367	0.631	0.993
LOKIASV2_1567_ESMFold_hypothetical_protein	4lrm-assembly5.cif.gz_E	4lrm-assembly5.cif.gz_E EGFR D770_N771insNPG in complex with PD168393	5.651E-04	1.000	122	180	487	493	16	284	290	360	0.625	0.928
LOKIASV2_1567_ESMFold_hypothetical_protein	6xx7-assembly1.cif.gz_A	6xx7-assembly1.cif.gz_A Arabidopsis thaliana Casein Kinase 2 (CK2) alpha-1 crystal in complex with ANP	1.471E-03	1.000	122	180	398	493	34	176	329	222	0.444	0.435
LOKIASV2_1567_ESMFold_hypothetical_protein	6i5i-assembly1.cif.gz_A	6i5i-assembly1.cif.gz_A Crystal structure of CLK1 in complexed with furo[3,2-b]pyridine compound 12h	4.481E-05	1.000	122	166	491	493	7	325	335	414	0.661	0.952
LOKIASV2_1567_ESMFold_hypothetical_protein	3ugc-assembly1.cif.gz_A	3ugc-assembly1.cif.gz_A Structural basis of Jak2 inhibition by the type II inhibtor NVP-BBT594	1.346E-04	1.000	121	173	482	493	5	272	274	355	0.629	0.978
LOKIASV2_1567_ESMFold_hypothetical_protein	4agu-assembly2.cif.gz_B	4agu-assembly2.cif.gz_B CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	1.881E-04	1.000	121	180	491	493	2	267	276	369	0.633	0.964
LOKIASV2_1567_ESMFold_hypothetical_protein	7c3g-assembly2.cif.gz_B	7c3g-assembly2.cif.gz_B Crystal structure of human ALK2 kinase domain with R206H mutation in complex with a bicyclic pyrazole inhibitor RK-73134	1.471E-03	1.000	121	174	400	493	4	155	292	231	0.460	0.521
LOKIASV2_1567_ESMFold_hypothetical_protein	6v6a-assembly1.cif.gz_A	6v6a-assembly1.cif.gz_A Inhibitory scaffolding of the ancient MAPK, ERK7	4.044E-04	1.000	121	173	394	493	8	153	317	229	0.450	0.461
LOKIASV2_1567_ESMFold_hypothetical_protein	1gol-assembly1.cif.gz_A	1gol-assembly1.cif.gz_A COORDINATES OF RAT MAP KINASE ERK2 WITH AN ARGININE MUTATION AT POSITION 52	8.286E-04	1.000	120	171	403	493	18	175	357	242	0.473	0.443
LOKIASV2_1567_ESMFold_hypothetical_protein	3tt0-assembly2.cif.gz_B	3tt0-assembly2.cif.gz_B Co-structure of Fibroblast Growth Factor Receptor 1 kinase domain with 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (BGJ398)	2.389E-04	1.000	119	171	482	493	15	267	272	346	0.633	0.930
LOKIASV2_1567_ESMFold_hypothetical_protein	2ivv-assembly1.cif.gz_A-2	2ivv-assembly1.cif.gz_A-2 Crystal structure of phosphorylated RET tyrosine kinase domain complexed with the inhibitor PP1	4.072E-05	1.000	119	170	482	493	16	281	283	367	0.635	0.940
LOKIASV2_1567_ESMFold_hypothetical_protein	5s7m-assembly1.cif.gz_A	5s7m-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM000275d	1.158E-03	1.000	119	169	394	493	1	152	285	230	0.458	0.533
LOKIASV2_1567_ESMFold_hypothetical_protein	6vnx-assembly1.cif.gz_A	6vnx-assembly1.cif.gz_A Crystal structure of TYK2 kinase with compound 19	7.530E-04	1.000	119	171	487	493	5	286	290	374	0.643	0.972
LOKIASV2_1567_ESMFold_hypothetical_protein	1pkg-assembly1.cif.gz_A	1pkg-assembly1.cif.gz_A Structure of a c-Kit Kinase Product Complex	5.136E-04	1.000	119	165	480	493	13	291	292	377	0.641	0.955
LOKIASV2_1567_ESMFold_hypothetical_protein	8pqc-assembly2.cif.gz_B	8pqc-assembly2.cif.gz_B c-KIT kinase domain in complex with avapritinib derivative 9	2.278E-04	1.000	119	168	480	493	17	294	295	369	0.635	0.942
LOKIASV2_1567_ESMFold_hypothetical_protein	6l21-assembly1.cif.gz_A	6l21-assembly1.cif.gz_A Crystal structure of CK2a1 H160A with hematein	7.899E-04	1.000	119	163	401	493	25	183	331	244	0.485	0.480
LOKIASV2_1567_ESMFold_hypothetical_protein	4h3q-assembly1.cif.gz_A	4h3q-assembly1.cif.gz_A Crystal structure of human ERK2 complexed with a MAPK docking peptide	1.158E-03	1.000	119	180	396	493	17	163	352	224	0.440	0.418
LOKIASV2_1567_ESMFold_hypothetical_protein	4agu-assembly3.cif.gz_C	4agu-assembly3.cif.gz_C CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	2.629E-04	1.000	118	178	491	493	1	270	278	369	0.637	0.971
LOKIASV2_1567_ESMFold_hypothetical_protein	4j95-assembly5.cif.gz_A	4j95-assembly5.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome in Space Group C2.	2.629E-04	1.000	118	171	482	493	10	276	279	352	0.633	0.957
LOKIASV2_1567_ESMFold_hypothetical_protein	1pkg-assembly2.cif.gz_B	1pkg-assembly2.cif.gz_B Structure of a c-Kit Kinase Product Complex	3.675E-04	1.000	118	166	482	493	15	278	279	360	0.643	0.946
LOKIASV2_1567_ESMFold_hypothetical_protein	5s7u-assembly1.cif.gz_A	5s7u-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010938a	1.337E-03	1.000	118	169	394	493	1	150	280	229	0.458	0.536
LOKIASV2_1567_ESMFold_hypothetical_protein	6ylc-assembly1.cif.gz_A	6ylc-assembly1.cif.gz_A Biochemical, Cellular and Structural Characterization of Novel ERK3 Inhibitors	3.649E-03	1.000	118	180	300	493	6	116	282	123	0.245	0.394
LOKIASV2_1567_ESMFold_hypothetical_protein	7ju5-assembly1.cif.gz_A	7ju5-assembly1.cif.gz_A Structure of RET protein tyrosine kinase in complex with pralsetinib	4.072E-05	1.000	118	168	482	493	11	283	287	350	0.639	0.951
LOKIASV2_1567_ESMFold_hypothetical_protein	4v04-assembly2.cif.gz_B	4v04-assembly2.cif.gz_B FGFR1 in complex with ponatinib.	1.793E-04	1.000	118	171	482	493	16	282	289	357	0.633	0.924
LOKIASV2_1567_ESMFold_hypothetical_protein	4w9x-assembly1.cif.gz_A	4w9x-assembly1.cif.gz_A Crystal Structure of BMP-2-inducible kinase in complex with baricitinib	1.052E-03	1.000	118	176	394	493	4	158	300	229	0.444	0.517
LOKIASV2_1567_ESMFold_hypothetical_protein	3vug-assembly1.cif.gz_A	3vug-assembly1.cif.gz_A Crystal structure of a cysteine-deficient mutant M2 in MAP kinase JNK1	9.564E-04	1.000	118	172	396	493	1	167	356	246	0.456	0.469
LOKIASV2_1567_ESMFold_hypothetical_protein	3lxl-assembly1.cif.gz_A	3lxl-assembly1.cif.gz_A Structural and Thermodynamic Characterization of the TYK2 and JAK3 Kinase Domains in Complex with CP-690550 and CMP-6	6.219E-04	1.000	117	173	485	493	7	278	281	374	0.635	0.968
LOKIASV2_1567_ESMFold_hypothetical_protein	6glb-assembly2.cif.gz_B	6glb-assembly2.cif.gz_B Crystal structure of JAK3 in complex with Compound 20 (FM484)	2.893E-04	1.000	117	172	493	493	7	288	288	380	0.653	0.979
LOKIASV2_1567_ESMFold_hypothetical_protein	8pqd-assembly1.cif.gz_A	8pqd-assembly1.cif.gz_A c-KIT kinase domain in complex with avapritinib derivative 10	1.973E-04	1.000	117	168	480	493	17	296	297	371	0.635	0.943
LOKIASV2_1567_ESMFold_hypothetical_protein	5nhf-assembly1.cif.gz_A	5nhf-assembly1.cif.gz_A Human Erk2 with an Erk1/2 inhibitor	8.691E-04	1.000	117	165	394	493	2	158	340	237	0.467	0.462
LOKIASV2_1567_ESMFold_hypothetical_protein	6g97-assembly1.cif.gz_A	6g97-assembly1.cif.gz_A Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2	1.402E-03	1.000	117	180	403	493	15	168	345	232	0.454	0.446
LOKIASV2_1567_ESMFold_hypothetical_protein	6ges-assembly2.cif.gz_B	6ges-assembly2.cif.gz_B Crystal structure of ERK1 covalently bound to SM1-71	1.781E-03	1.000	117	180	394	493	18	162	350	223	0.436	0.414
LOKIASV2_1567_ESMFold_hypothetical_protein	6yg3-assembly1.cif.gz_A	6yg3-assembly1.cif.gz_A Crystal structure of MKK7 (MAP2K7) covalently bound with CPT1-70-1	3.184E-04	1.000	116	180	491	493	18	264	265	341	0.633	0.932
LOKIASV2_1567_ESMFold_hypothetical_protein	4tyi-assembly1.cif.gz_A	4tyi-assembly1.cif.gz_A Structural analysis of the human Fibroblast Growth Factor Receptor 4	5.387E-04	1.000	116	165	482	493	5	274	277	365	0.645	0.975
LOKIASV2_1567_ESMFold_hypothetical_protein	7ju6-assembly1.cif.gz_A	7ju6-assembly1.cif.gz_A Structure of RET protein tyrosine kinase in complex with selpercatinib	6.569E-05	1.000	116	165	482	493	1	285	288	369	0.645	0.990
LOKIASV2_1567_ESMFold_hypothetical_protein	5lwm-assembly1.cif.gz_A	5lwm-assembly1.cif.gz_A Crystal structure of JAK3 in complex with Compound 4 (FM381)	3.035E-04	1.000	116	173	493	493	7	290	290	380	0.651	0.979
LOKIASV2_1567_ESMFold_hypothetical_protein	4dgm-assembly1.cif.gz_A	4dgm-assembly1.cif.gz_A Crystal Structure of maize CK2 in complex with the inhibitor apigenin	1.481E-04	1.000	116	162	472	493	20	322	326	392	0.631	0.929
LOKIASV2_1567_ESMFold_hypothetical_protein	6ytg-assembly1.cif.gz_A	6ytg-assembly1.cif.gz_A CLK1 bound with beta-carboline KH-CARB13 (Cpd 3)	1.060E-04	1.000	116	166	491	493	7	321	331	406	0.661	0.952
LOKIASV2_1567_ESMFold_hypothetical_protein	6q8p-assembly1.cif.gz_A	6q8p-assembly1.cif.gz_A Structure of CLK1 with bound N-methyl-10-nitropyrido[3,4-g]quinazolin-2-amine	1.402E-03	1.000	116	166	312	493	7	145	336	157	0.298	0.414
LOKIASV2_1567_ESMFold_hypothetical_protein	3vui-assembly1.cif.gz_A	3vui-assembly1.cif.gz_A Crystal structure of a cysteine-deficient mutant M2 in MAP kinase JNK1	1.003E-03	1.000	116	172	396	493	1	167	355	246	0.456	0.470
LOKIASV2_1567_ESMFold_hypothetical_protein	8ho6-assembly1.cif.gz_A	8ho6-assembly1.cif.gz_A ScRIPK WT	6.843E-04	1.000	115	185	482	493	22	280	281	342	0.604	0.922
LOKIASV2_1567_ESMFold_hypothetical_protein	4j99-assembly2.cif.gz_B	4j99-assembly2.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659T Mutation.	3.700E-05	1.000	115	171	491	493	11	290	291	373	0.651	0.962
LOKIASV2_1567_ESMFold_hypothetical_protein	8pqi-assembly1.cif.gz_A	8pqi-assembly1.cif.gz_A PDGFRA T674I mutant kinase domain in complex with avapritinib derivative 9	3.675E-04	1.000	115	171	481	493	22	283	299	360	0.631	0.876
LOKIASV2_1567_ESMFold_hypothetical_protein	6i5h-assembly1.cif.gz_A	6i5h-assembly1.cif.gz_A Crystal structure of CLK1 in complex with furanopyrimidin VN412	8.752E-05	1.000	115	166	491	493	7	317	325	403	0.661	0.957
LOKIASV2_1567_ESMFold_hypothetical_protein	6fyo-assembly1.cif.gz_A	6fyo-assembly1.cif.gz_A X-RAY STRUCTURE OF CLK1-KD(148-484)/Cpd-2 AT 2.32A	1.412E-04	1.000	115	166	486	493	5	308	331	400	0.651	0.918
LOKIASV2_1567_ESMFold_hypothetical_protein	6rq4-assembly1.cif.gz_A	6rq4-assembly1.cif.gz_A Inhibitor of ERK2	1.003E-03	1.000	115	170	403	493	2	160	332	241	0.475	0.479
LOKIASV2_1567_ESMFold_hypothetical_protein	6qty-assembly1.cif.gz_A	6qty-assembly1.cif.gz_A Non-phosphorylated human CLK1 in complex with an indole inhibitor to 1.65 Ang	1.481E-04	1.000	115	166	486	493	4	310	333	401	0.651	0.922
LOKIASV2_1567_ESMFold_hypothetical_protein	2fys-assembly2.cif.gz_A	2fys-assembly2.cif.gz_A Crystal structure of Erk2 complex with KIM peptide derived from MKP3	9.564E-04	1.000	115	165	404	493	5	170	348	250	0.487	0.477
LOKIASV2_1567_ESMFold_hypothetical_protein	5s7u-assembly1.cif.gz_B-2	5s7u-assembly1.cif.gz_B-2 XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010938a	1.052E-03	1.000	114	172	399	493	1	150	279	234	0.462	0.538
LOKIASV2_1567_ESMFold_hypothetical_protein	3fxx-assembly1.cif.gz_A	3fxx-assembly1.cif.gz_A Human EphA3 Kinase and Juxtamembrane Region Bound to Substrate KQWDNYE[pTyr]IW	5.928E-04	1.000	114	180	486	493	16	274	288	355	0.623	0.899
LOKIASV2_1567_ESMFold_hypothetical_protein	4ian-assembly1.cif.gz_B	4ian-assembly1.cif.gz_B Crystal Structure of apo Human PRPF4B kinase domain	1.543E-03	1.000	114	168	394	493	5	161	320	239	0.460	0.491
LOKIASV2_1567_ESMFold_hypothetical_protein	6ots-assembly1.cif.gz_A	6ots-assembly1.cif.gz_A Rat ERK2 E320K	1.618E-03	1.000	114	166	396	493	7	161	324	238	0.469	0.478
LOKIASV2_1567_ESMFold_hypothetical_protein	6ise-assembly2.cif.gz_A	6ise-assembly2.cif.gz_A Crystal structure of AMPPNP bound CK2 alpha from C. neoformans	7.899E-04	1.000	114	139	401	493	4	179	327	267	0.533	0.538
LOKIASV2_1567_ESMFold_hypothetical_protein	2vag-assembly1.cif.gz_A	2vag-assembly1.cif.gz_A Crystal structure of di-phosphorylated human CLK1 in complex with a novel substituted indole inhibitor	1.793E-04	1.000	114	166	491	493	6	324	332	415	0.661	0.961
LOKIASV2_1567_ESMFold_hypothetical_protein	3vuh-assembly1.cif.gz_A	3vuh-assembly1.cif.gz_A Crystal structure of a cysteine-deficient mutant M3 in MAP kinase JNK1	8.691E-04	1.000	114	172	396	493	1	167	355	244	0.456	0.470
LOKIASV2_1567_ESMFold_hypothetical_protein	4h1m-assembly1.cif.gz_A	4h1m-assembly1.cif.gz_A Crystal structure of PYK2 with the indole 10c	5.651E-04	1.000	113	180	488	493	6	252	256	350	0.627	0.965
LOKIASV2_1567_ESMFold_hypothetical_protein	4l01-assembly3.cif.gz_B	4l01-assembly3.cif.gz_B Crystal structure of the V658F apo Jak1 pseudokinase domain	1.223E-04	1.000	113	170	481	493	14	273	274	357	0.633	0.949
LOKIASV2_1567_ESMFold_hypothetical_protein	4xuf-assembly2.cif.gz_B	4xuf-assembly2.cif.gz_B Crystal structure of the FLT3 kinase domain bound to the inhibitor quizartinib (AC220)	4.896E-04	1.000	113	167	475	493	3	271	274	358	0.627	0.982
LOKIASV2_1567_ESMFold_hypothetical_protein	7lgs-assembly3.cif.gz_C	7lgs-assembly3.cif.gz_C Structure of EGFR_D770_N771insNPG/V948R in complex with covalent inhibitor Osimertinib.	4.896E-04	1.000	113	174	487	493	11	276	283	355	0.637	0.940
LOKIASV2_1567_ESMFold_hypothetical_protein	6gla-assembly2.cif.gz_B	6gla-assembly2.cif.gz_B Crystal structure of JAK3 in complex with Compound 11 (FM481)	5.928E-04	1.000	113	173	493	493	8	286	286	377	0.651	0.976
LOKIASV2_1567_ESMFold_hypothetical_protein	4xlv-assembly1.cif.gz_A	4xlv-assembly1.cif.gz_A Crystal structure of the activated insulin receptor tyrosine kinase dimer	4.044E-04	1.000	113	156	485	493	6	293	310	386	0.669	0.929
LOKIASV2_1567_ESMFold_hypothetical_protein	4ifc-assembly1.cif.gz_A	4ifc-assembly1.cif.gz_A Crystal Structure of ADP-bound Human PRPF4B kinase domain	2.373E-03	1.000	113	164	394	493	9	169	328	244	0.469	0.491
LOKIASV2_1567_ESMFold_hypothetical_protein	6flv-assembly1.cif.gz_A	6flv-assembly1.cif.gz_A Crystal structure of ERK2 in complex with an adenosine derivative	1.618E-03	1.000	113	165	403	493	4	168	345	248	0.485	0.478
LOKIASV2_1567_ESMFold_hypothetical_protein	2y9q-assembly1.cif.gz_A	2y9q-assembly1.cif.gz_A Crystal structure of human ERK2 complexed with a MAPK docking peptide	1.868E-03	1.000	113	180	401	493	17	168	350	228	0.450	0.434
LOKIASV2_1567_ESMFold_hypothetical_protein	3kul-assembly2.cif.gz_B	3kul-assembly2.cif.gz_B Kinase domain of human ephrin type-A receptor 8 (EPHA8)	8.286E-04	1.000	112	168	484	493	2	271	272	375	0.643	0.993
LOKIASV2_1567_ESMFold_hypothetical_protein	8u2o-assembly1.cif.gz_B	8u2o-assembly1.cif.gz_B Crystal Structure of Cdk-related protein kinase 6 (PK6) from Plasmodium falciparum in complex with inhibitor TCMDC-123995	2.056E-03	1.000	112	174	396	493	5	150	276	232	0.452	0.529
LOKIASV2_1567_ESMFold_hypothetical_protein	6v6q-assembly2.cif.gz_D	6v6q-assembly2.cif.gz_D Crystal Structure of Monophosphorylated FGF Receptor 2 isoform IIIb with PTR657	2.171E-04	1.000	112	174	493	493	14	276	276	359	0.649	0.953
LOKIASV2_1567_ESMFold_hypothetical_protein	6gql-assembly2.cif.gz_B	6gql-assembly2.cif.gz_B Crystal structure of human c-KIT kinase domain in complex with AZD3229-analogue (compound 35)	2.278E-04	1.000	112	168	480	493	6	285	286	370	0.635	0.979
LOKIASV2_1567_ESMFold_hypothetical_protein	2x2k-assembly1.cif.gz_A	2x2k-assembly1.cif.gz_A Crystal Structure of phosphorylated RET tyrosine kinase domain with inhibitor	8.343E-05	1.000	112	174	482	493	21	286	290	365	0.627	0.917
LOKIASV2_1567_ESMFold_hypothetical_protein	3h9r-assembly1.cif.gz_A	3h9r-assembly1.cif.gz_A Crystal structure of the kinase domain of type I activin receptor (ACVR1) in complex with FKBP12 and dorsomorphin	3.184E-04	1.000	112	168	493	493	30	312	312	380	0.661	0.907
LOKIASV2_1567_ESMFold_hypothetical_protein	5bue-assembly1.cif.gz_A	5bue-assembly1.cif.gz_A ERK2 complexed with N-benzylpyridone tetrahydroazaindazole	2.873E-03	1.000	112	170	394	493	10	159	329	232	0.456	0.456
LOKIASV2_1567_ESMFold_hypothetical_protein	4fv8-assembly1.cif.gz_A	4fv8-assembly1.cif.gz_A Crystal Structure of the ERK2 complexed with E63	2.739E-03	1.000	112	180	394	493	18	162	334	222	0.436	0.434
LOKIASV2_1567_ESMFold_hypothetical_protein	2f49-assembly2.cif.gz_B	2f49-assembly2.cif.gz_B Crystal structure of Fus3 in complex with a Ste5 peptide	1.781E-03	1.000	112	170	394	493	8	157	337	233	0.456	0.445
LOKIASV2_1567_ESMFold_hypothetical_protein	4xp3-assembly1.cif.gz_A	4xp3-assembly1.cif.gz_A Crystal structure of ERK2 in complex with an inhibitor	1.543E-03	1.000	112	165	403	493	5	169	341	248	0.485	0.484
LOKIASV2_1567_ESMFold_hypothetical_protein	5s7q-assembly1.cif.gz_A	5s7q-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010944a	1.003E-03	1.000	111	169	491	493	1	276	282	374	0.655	0.979
LOKIASV2_1567_ESMFold_hypothetical_protein	4nus-assembly1.cif.gz_A	4nus-assembly1.cif.gz_A Rsk2 N-terminal kinase in complex with LJH685	4.667E-04	1.000	111	165	480	493	5	286	301	366	0.641	0.937
LOKIASV2_1567_ESMFold_hypothetical_protein	5j1v-assembly3.cif.gz_C	5j1v-assembly3.cif.gz_C Crystal structure of human CLK1 in complex with pyrido[3,4-g]quinazoline derivative ZW29 (compound 13)	1.052E-03	1.000	111	166	316	493	7	165	314	175	0.306	0.506
LOKIASV2_1567_ESMFold_hypothetical_protein	5j1w-assembly3.cif.gz_C	5j1w-assembly3.cif.gz_C Crystal structure of human CLK1 in complex with pyrido[3,4-g]quinazoline derivative ZW31 (compound 14)	5.928E-04	1.000	111	166	452	493	7	291	316	369	0.582	0.902
LOKIASV2_1567_ESMFold_hypothetical_protein	8bgc-assembly2.cif.gz_B	8bgc-assembly2.cif.gz_B Crystal structure of human Casein Kinase II subunit alpha (CK2a1) in complex with compound 2 (AA-CS-9-003)	1.973E-04	1.000	111	155	484	493	13	325	327	407	0.669	0.957
LOKIASV2_1567_ESMFold_hypothetical_protein	7ujs-assembly1.cif.gz_A	7ujs-assembly1.cif.gz_A Cocrystal structure of human CaMKII-alpha (CAMK2A)kinase domain and GluN2B in complex with ADP	5.136E-04	1.000	110	173	488	493	5	267	268	361	0.641	0.981
LOKIASV2_1567_ESMFold_hypothetical_protein	4j95-assembly6.cif.gz_D	4j95-assembly6.cif.gz_D Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome in Space Group C2.	1.630E-04	1.000	110	171	490	493	11	269	271	351	0.649	0.956
LOKIASV2_1567_ESMFold_hypothetical_protein	3gql-assembly3.cif.gz_C	3gql-assembly3.cif.gz_C Crystal Structure of activated receptor tyrosine kinase in complex with substrates	3.855E-04	1.000	110	171	482	493	11	267	275	346	0.633	0.935
LOKIASV2_1567_ESMFold_hypothetical_protein	7aaz-assembly1.cif.gz_A	7aaz-assembly1.cif.gz_A Crystal structure of MerTK in complex with a type 1.5 aminopyridine inhibitor	4.449E-04	1.000	110	180	482	493	14	285	290	348	0.615	0.938
LOKIASV2_1567_ESMFold_hypothetical_protein	4r7i-assembly1.cif.gz_A	4r7i-assembly1.cif.gz_A Crystal structure of FMS kinase domain with a small molecular inhibitor, GLEEVEC	4.896E-04	1.000	110	168	491	493	9	284	290	379	0.657	0.952
LOKIASV2_1567_ESMFold_hypothetical_protein	8pq9-assembly1.cif.gz_A	8pq9-assembly1.cif.gz_A c-KIT kinase domain in complex with avapritinib	1.166E-04	1.000	110	168	480	493	17	295	296	360	0.635	0.943
LOKIASV2_1567_ESMFold_hypothetical_protein	1gag-assembly1.cif.gz_A	1gag-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH A BISUBSTRATE INHIBITOR	6.523E-04	1.000	110	160	484	493	1	286	303	393	0.659	0.944
LOKIASV2_1567_ESMFold_hypothetical_protein	5bui-assembly1.cif.gz_A	5bui-assembly1.cif.gz_A ERK2 complexed with 2-pyridiyl tetrahydroazaindazole	1.543E-03	1.000	110	170	407	493	10	172	338	246	0.483	0.482
LOKIASV2_1567_ESMFold_hypothetical_protein	3v6r-assembly1.cif.gz_A	3v6r-assembly1.cif.gz_A Discovery of potent and selective covalent inhibitors of JNK	1.543E-03	1.000	110	172	300	493	1	138	350	148	0.262	0.394
LOKIASV2_1567_ESMFold_hypothetical_protein	7cil-assembly1.cif.gz_A	7cil-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with compound 7	4.667E-04	1.000	109	176	485	493	2	248	265	343	0.629	0.932
LOKIASV2_1567_ESMFold_hypothetical_protein	4gk2-assembly1.cif.gz_A	4gk2-assembly1.cif.gz_A Human EphA3 Kinase domain in complex with ligand 66	1.274E-03	1.000	109	168	482	493	5	255	265	356	0.639	0.947
LOKIASV2_1567_ESMFold_hypothetical_protein	6yky-assembly1.cif.gz_A	6yky-assembly1.cif.gz_A Biochemical, Cellular and Structural Characterization of Novel ERK3 Inhibitors	4.635E-03	1.000	109	180	307	493	3	125	281	134	0.260	0.438
LOKIASV2_1567_ESMFold_hypothetical_protein	4rwj-assembly2.cif.gz_B	4rwj-assembly2.cif.gz_B Crystal Structure of FGFR1 (C488A, C584S) in complex with AZD4547 (N-{3-[2-(3,5-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4-[(3R,5S)-3,5-DIMETHYLPIPERAZIN-1-YL]BENZAMIDE)	3.675E-04	1.000	109	171	482	493	15	277	282	353	0.633	0.933
LOKIASV2_1567_ESMFold_hypothetical_protein	8pqe-assembly2.cif.gz_B	8pqe-assembly2.cif.gz_B c-KIT kinase domain in complex with avapritinib derivative 11	1.630E-04	1.000	109	168	482	493	17	281	283	352	0.639	0.936
LOKIASV2_1567_ESMFold_hypothetical_protein	4c0t-assembly1.cif.gz_A	4c0t-assembly1.cif.gz_A Candida albicans PKh Kinase Domain	5.928E-04	1.000	109	171	490	493	3	251	291	357	0.649	0.856
LOKIASV2_1567_ESMFold_hypothetical_protein	6joi-assembly1.cif.gz_A	6joi-assembly1.cif.gz_A Crystal structure of PDGFRA T674I in complex with crenolanib by co-crystallization	4.667E-04	1.000	109	171	481	493	20	276	296	355	0.631	0.868
LOKIASV2_1567_ESMFold_hypothetical_protein	8pqh-assembly1.cif.gz_A	8pqh-assembly1.cif.gz_A PDGFRA T674I mutant kinase domain in complex with avapritinib	4.044E-04	1.000	109	180	492	493	38	314	321	360	0.635	0.863
LOKIASV2_1567_ESMFold_hypothetical_protein	2r9s-assembly2.cif.gz_B	2r9s-assembly2.cif.gz_B c-Jun N-terminal Kinase 3 with 3,5-Disubstituted Quinoline inhibitor	1.337E-03	1.000	109	171	393	493	15	160	325	231	0.452	0.449
LOKIASV2_1567_ESMFold_hypothetical_protein	5bvf-assembly1.cif.gz_A	5bvf-assembly1.cif.gz_A Tetrahydropyrrolo-diazepenones as inhibitors of ERK2 kinase	2.373E-03	1.000	109	165	394	493	6	161	327	240	0.467	0.477
LOKIASV2_1567_ESMFold_hypothetical_protein	5nhp-assembly1.cif.gz_A	5nhp-assembly1.cif.gz_A Human Erk2 with an Erk1/2 inhibitor	2.489E-03	1.000	109	165	394	493	3	159	338	238	0.467	0.464
LOKIASV2_1567_ESMFold_hypothetical_protein	4zzn-assembly1.cif.gz_A	4zzn-assembly1.cif.gz_A Human ERK2 in complex with an inhibitor	1.781E-03	1.000	109	170	403	493	10	168	339	242	0.475	0.469
LOKIASV2_1567_ESMFold_hypothetical_protein	6eq9-assembly1.cif.gz_A	6eq9-assembly1.cif.gz_A Crystal structure of JNK3 in complex with AMP-PCP	2.373E-03	1.000	109	171	300	493	15	137	350	139	0.264	0.351
LOKIASV2_1567_ESMFold_hypothetical_protein	4l7f-assembly1.cif.gz_A	4l7f-assembly1.cif.gz_A Co-crystal Structure of JNK1 and AX13587	1.471E-03	1.000	109	180	307	493	22	149	354	140	0.260	0.362
LOKIASV2_1567_ESMFold_hypothetical_protein	7aw4-assembly1.cif.gz_A	7aw4-assembly1.cif.gz_A MerTK kinase domain with type 3 inhibitor from a DNA-encoded library	7.530E-04	1.000	108	180	484	493	12	262	264	340	0.619	0.951
LOKIASV2_1567_ESMFold_hypothetical_protein	7cja-assembly1.cif.gz_A	7cja-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with compound 28	3.035E-04	1.000	108	176	485	493	2	246	265	346	0.629	0.925
LOKIASV2_1567_ESMFold_hypothetical_protein	4p4c-assembly1.cif.gz_A	4p4c-assembly1.cif.gz_A Human EphA3 Kinase domain in complex with quinoxaline derivatives	1.337E-03	1.000	108	180	486	493	9	255	266	343	0.623	0.929
LOKIASV2_1567_ESMFold_hypothetical_protein	3zfx-assembly1.cif.gz_A	3zfx-assembly1.cif.gz_A Crystal structure of EphB1	2.262E-03	1.000	108	176	486	493	2	262	267	354	0.631	0.978
LOKIASV2_1567_ESMFold_hypothetical_protein	8c09-assembly1.cif.gz_A	8c09-assembly1.cif.gz_A Crystal structure of JAK2 JH2-I559F	5.387E-04	1.000	108	172	481	493	5	271	272	356	0.629	0.982
LOKIASV2_1567_ESMFold_hypothetical_protein	5u6c-assembly1.cif.gz_A	5u6c-assembly1.cif.gz_A Crystal structure of the Mer kinase domain in complex with a macrocyclic inhibitor	5.136E-04	1.000	108	170	484	493	10	268	272	354	0.639	0.952
LOKIASV2_1567_ESMFold_hypothetical_protein	8b8n-assembly1.cif.gz_A	8b8n-assembly1.cif.gz_A Crystal structure of JAK2 JH2-V617F in complex with Cdk2 inhibitor IV	4.667E-04	1.000	108	171	481	493	6	270	274	358	0.631	0.967
LOKIASV2_1567_ESMFold_hypothetical_protein	4j95-assembly6.cif.gz_C	4j95-assembly6.cif.gz_C Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome in Space Group C2.	2.389E-04	1.000	108	171	490	493	9	279	281	368	0.649	0.964
LOKIASV2_1567_ESMFold_hypothetical_protein	3we4-assembly1.cif.gz_A	3we4-assembly1.cif.gz_A Crystal structure of S6K1 kinase domain in complex with a pyrimidine derivative PF-4708671 2-{[4-(5-ethylpyrimidin-4-yl)piperazin-1-yl]methyl}-5-(trifluoromethyl)-1H-benzimidazole	3.014E-03	1.000	108	169	300	493	1	127	287	139	0.268	0.443
LOKIASV2_1567_ESMFold_hypothetical_protein	6r6e-assembly1.cif.gz_A	6r6e-assembly1.cif.gz_A Crystal structure of di-phosphorylated human CLK1 in complex with 5-(6,7-dichloro-1-methyl-1H-indol-3-yl)pyrimidin-4-amine	4.044E-04	1.000	108	167	490	493	1	318	327	410	0.657	0.972
LOKIASV2_1567_ESMFold_hypothetical_protein	7ore-assembly1.cif.gz_A	7ore-assembly1.cif.gz_A Crystal structure of JNK3 in complex with light-activated covalent inhibitor MR-II-249 with both non-covalent and covalent binding modes (compound 4)	2.262E-03	1.000	108	171	300	493	17	139	352	138	0.264	0.349
LOKIASV2_1567_ESMFold_hypothetical_protein	4c4g-assembly1.cif.gz_A	4c4g-assembly1.cif.gz_A Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1	3.035E-04	1.000	107	176	471	493	2	247	252	330	0.600	0.976
LOKIASV2_1567_ESMFold_hypothetical_protein	5am6-assembly2.cif.gz_B	5am6-assembly2.cif.gz_B Native FGFR1 with an inhibitor	9.117E-04	1.000	107	171	482	493	16	276	280	354	0.633	0.932
LOKIASV2_1567_ESMFold_hypothetical_protein	6wxj-assembly1.cif.gz_A	6wxj-assembly1.cif.gz_A CSF1R signaling is a regulator of pathogenesis in progressive MS	4.667E-04	1.000	107	168	493	493	17	282	282	369	0.661	0.943
LOKIASV2_1567_ESMFold_hypothetical_protein	6p69-assembly2.cif.gz_B	6p69-assembly2.cif.gz_B Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to compound 11.	5.387E-04	1.000	107	171	482	493	13	282	286	358	0.633	0.944
LOKIASV2_1567_ESMFold_hypothetical_protein	6gqk-assembly2.cif.gz_B	6gqk-assembly2.cif.gz_B Crystal structure of human c-KIT kinase domain in complex with AZD3229-analogue (compound 23)	3.675E-04	1.000	107	168	480	493	11	292	293	370	0.635	0.962
LOKIASV2_1567_ESMFold_hypothetical_protein	6xvb-assembly1.cif.gz_A	6xvb-assembly1.cif.gz_A Crystal structure of the kinase domain of human c-KIT with a cyclic imidate inhibitor covalently bound to Cys788	8.286E-04	1.000	107	168	484	493	14	296	297	374	0.643	0.953
LOKIASV2_1567_ESMFold_hypothetical_protein	6agx-assembly2.cif.gz_D	6agx-assembly2.cif.gz_D The cocrystal structure of FGFR2 bound with compound 14 harboring 5H-pyrrolo[2,3-b]pyrazine scaffold	1.346E-04	1.000	107	171	482	493	10	295	298	364	0.633	0.960
LOKIASV2_1567_ESMFold_hypothetical_protein	4l44-assembly1.cif.gz_A	4l44-assembly1.cif.gz_A Crystal structures of human p70S6K1-T389A (form II)	2.611E-03	1.000	107	166	395	493	1	159	321	239	0.467	0.495
LOKIASV2_1567_ESMFold_hypothetical_protein	6khd-assembly3.cif.gz_C	6khd-assembly3.cif.gz_C Crystal structure of CLK1 in complex with CX-4945	4.242E-04	1.000	107	166	491	493	3	319	325	407	0.661	0.975
LOKIASV2_1567_ESMFold_hypothetical_protein	6k0j-assembly1.cif.gz_A	6k0j-assembly1.cif.gz_A The co-crystal structure of DYRK2 with a small molecule inhibitor	4.212E-03	1.000	107	165	398	493	1	163	327	246	0.475	0.498
LOKIASV2_1567_ESMFold_hypothetical_protein	3i5z-assembly1.cif.gz_A	3i5z-assembly1.cif.gz_A Crystal structure of ERK2 bound to (S)-N-(2-hydroxy-1-phenylethyl)-4-(5-methyl-2-(phenylamino)pyrimidin-4-yl)-1H-pyrrole-2-carboxamide	3.014E-03	1.000	107	180	394	493	18	162	331	223	0.436	0.438
LOKIASV2_1567_ESMFold_hypothetical_protein	2f9g-assembly1.cif.gz_A	2f9g-assembly1.cif.gz_A Crystal structure of Fus3 phosphorylated on Tyr182	2.893E-04	1.000	107	170	486	493	8	269	332	357	0.643	0.789
LOKIASV2_1567_ESMFold_hypothetical_protein	3w55-assembly1.cif.gz_A	3w55-assembly1.cif.gz_A The structure of ERK2 in complex with FR148083	2.373E-03	1.000	107	170	396	493	10	161	335	233	0.460	0.454
LOKIASV2_1567_ESMFold_hypothetical_protein	6fr1-assembly1.cif.gz_A	6fr1-assembly1.cif.gz_A Crystal structure of ERK2 in complex with an adenosine derivative	1.781E-03	1.000	107	165	403	493	4	168	342	247	0.485	0.482
LOKIASV2_1567_ESMFold_hypothetical_protein	4o6l-assembly2.cif.gz_B	4o6l-assembly2.cif.gz_B Crystal Structure of TTK kinase domain with an inhibitor: 401498 (N-[(1R)-1-(2-chlorophenyl)propyl]-3-{4-[(1-methylpiperidin-4-yl)oxy]phenyl}-1H-indazole-5-carboxamide)	4.896E-04	1.000	106	176	493	493	2	238	256	345	0.645	0.926
LOKIASV2_1567_ESMFold_hypothetical_protein	6xjk-assembly1.cif.gz_A	6xjk-assembly1.cif.gz_A JAK2 JH2 in complex with JAK067	5.651E-04	1.000	106	174	481	493	6	263	265	351	0.625	0.974
LOKIASV2_1567_ESMFold_hypothetical_protein	4j99-assembly6.cif.gz_D	4j99-assembly6.cif.gz_D Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659T Mutation.	2.171E-04	1.000	106	171	482	493	13	278	281	351	0.633	0.947
LOKIASV2_1567_ESMFold_hypothetical_protein	4rwk-assembly2.cif.gz_B	4rwk-assembly2.cif.gz_B Crystal structure of V561M FGFR1 gatekeeper mutation (C488A, C584S, V561M) in complex with N-{3-[2-(3,5-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4-[(3R,5S)-3,5-DIMETHYLPIPERAZIN-1-YL]BENZAMIDE (AZD4547)	6.843E-04	1.000	106	171	482	493	15	277	282	362	0.633	0.933
LOKIASV2_1567_ESMFold_hypothetical_protein	6agx-assembly2.cif.gz_C	6agx-assembly2.cif.gz_C The cocrystal structure of FGFR2 bound with compound 14 harboring 5H-pyrrolo[2,3-b]pyrazine scaffold	1.710E-04	1.000	106	171	482	493	10	281	284	356	0.633	0.958
LOKIASV2_1567_ESMFold_hypothetical_protein	6xva-assembly1.cif.gz_A	6xva-assembly1.cif.gz_A Crystal structure of the kinase domain of human c-KIT in complex with a type-II inhibitor bearing an acrylamide	2.506E-04	1.000	106	168	480	493	14	293	294	373	0.635	0.952
LOKIASV2_1567_ESMFold_hypothetical_protein	4ijp-assembly2.cif.gz_B	4ijp-assembly2.cif.gz_B Crystal Structure of Human PRPF4B kinase domain in complex with 4-{5-[(2-Chloro-pyridin-4-ylmethyl)-carbamoyl]-thiophen-2-yl}-benzo[b]thiophene-2-carboxylic acid amine	5.651E-04	1.000	106	164	394	493	9	169	334	244	0.469	0.482
LOKIASV2_1567_ESMFold_hypothetical_protein	3qyz-assembly1.cif.gz_A	3qyz-assembly1.cif.gz_A Crystal structure of ERK2 in complex with an inhibitor	1.868E-03	1.000	106	165	403	493	2	167	340	249	0.485	0.488
LOKIASV2_1567_ESMFold_hypothetical_protein	6g92-assembly1.cif.gz_A	6g92-assembly1.cif.gz_A Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2	2.156E-03	1.000	106	166	403	493	8	171	344	247	0.483	0.477
LOKIASV2_1567_ESMFold_hypothetical_protein	3vul-assembly1.cif.gz_A	3vul-assembly1.cif.gz_A Crystal structure of a cysteine-deficient mutant M1 in MAP kinase JNK1	2.389E-04	1.000	106	172	488	493	1	242	344	353	0.643	0.703
LOKIASV2_1567_ESMFold_hypothetical_protein	4xj0-assembly1.cif.gz_A	4xj0-assembly1.cif.gz_A Crystal structure of ERK2 in complex with an inhibitor 14K	1.618E-03	1.000	106	170	409	493	9	171	345	249	0.487	0.472
LOKIASV2_1567_ESMFold_hypothetical_protein	7w5c-assembly1.cif.gz_A	7w5c-assembly1.cif.gz_A Crystal structure of Mitogen Activated Protein Kinase 4 (MPK4) from Arabidopsis thaliana	3.014E-03	1.000	106	171	396	493	21	174	355	235	0.458	0.434
LOKIASV2_1567_ESMFold_hypothetical_protein	5a4e-assembly3.cif.gz_C	5a4e-assembly3.cif.gz_C DYRK1A in complex with methoxy benzothiazole fragment	2.056E-03	1.000	105	168	397	493	13	177	263	243	0.467	0.627
LOKIASV2_1567_ESMFold_hypothetical_protein	4j99-assembly5.cif.gz_A	4j99-assembly5.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659T Mutation.	1.630E-04	1.000	105	171	482	493	12	277	280	347	0.633	0.950
LOKIASV2_1567_ESMFold_hypothetical_protein	4a07-assembly1.cif.gz_A	4a07-assembly1.cif.gz_A Human PDK1 Kinase Domain in Complex with Allosteric Activator PS171 Bound to the PIF-Pocket	1.337E-03	1.000	105	169	483	493	1	279	283	371	0.639	0.986
LOKIASV2_1567_ESMFold_hypothetical_protein	7ju6-assembly1.cif.gz_B	7ju6-assembly1.cif.gz_B Structure of RET protein tyrosine kinase in complex with selpercatinib	3.035E-04	1.000	105	168	482	493	11	288	291	362	0.639	0.955
LOKIASV2_1567_ESMFold_hypothetical_protein	4j98-assembly1.cif.gz_A	4j98-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659Q Mutation.	1.710E-04	1.000	105	171	491	493	17	303	304	369	0.651	0.944
LOKIASV2_1567_ESMFold_hypothetical_protein	4hys-assembly1.cif.gz_A	4hys-assembly1.cif.gz_A Crystal structure of JNK1 in complex with JIP1 peptide and 4-(4-Indazol-1-yl-pyrimidin-2-ylamino)-cyclohexan	2.373E-03	1.000	105	180	307	493	19	146	321	137	0.260	0.399
LOKIASV2_1567_ESMFold_hypothetical_protein	7a5n-assembly2.cif.gz_B	7a5n-assembly2.cif.gz_B Structure of DYRK1A in complex with compound 34	2.262E-03	1.000	105	170	397	493	6	168	330	242	0.462	0.494
LOKIASV2_1567_ESMFold_hypothetical_protein	5bve-assembly1.cif.gz_A	5bve-assembly1.cif.gz_A Tetrahydropyrrolo-diazepenones as inhibitors of ERK2 kinase	4.635E-03	1.000	105	180	394	493	17	161	330	223	0.436	0.439
LOKIASV2_1567_ESMFold_hypothetical_protein	3i60-assembly1.cif.gz_A	3i60-assembly1.cif.gz_A Crystal structure of ERK2 bound to (S)-4-(2-(2-chlorophenylamino)-5-methylpyrimidin-4-yl)-N-(2-hydroxy-1-phenylethyl)-1H-pyrrole-2-carboxamide	3.479E-03	1.000	105	171	394	493	14	162	335	233	0.454	0.445
LOKIASV2_1567_ESMFold_hypothetical_protein	4myg-assembly2.cif.gz_B	4myg-assembly2.cif.gz_B MAPK13, active form	5.612E-03	1.000	105	176	394	493	10	156	337	228	0.444	0.436
LOKIASV2_1567_ESMFold_hypothetical_protein	4xrl-assembly1.cif.gz_A	4xrl-assembly1.cif.gz_A Crystal structure at room temperature of Erk2 in complex with an inhibitor	3.828E-03	1.000	105	170	403	493	10	168	338	243	0.475	0.470
LOKIASV2_1567_ESMFold_hypothetical_protein	8ao2-assembly1.cif.gz_A	8ao2-assembly1.cif.gz_A Specific covalent inhibitor (3) of ERK2	1.960E-03	1.000	105	166	403	493	3	166	341	245	0.483	0.481
LOKIASV2_1567_ESMFold_hypothetical_protein	6g9h-assembly1.cif.gz_A	6g9h-assembly1.cif.gz_A Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2	1.960E-03	1.000	105	165	403	493	2	168	344	250	0.485	0.485
LOKIASV2_1567_ESMFold_hypothetical_protein	4awi-assembly1.cif.gz_A	4awi-assembly1.cif.gz_A Human Jnk1alpha kinase with 4-phenyl-7-azaindole IKK2 inhibitor.	3.649E-03	1.000	105	180	300	493	19	137	352	131	0.245	0.338
LOKIASV2_1567_ESMFold_hypothetical_protein	7yl1-assembly1.cif.gz_A	7yl1-assembly1.cif.gz_A Crystal structure of JNK3 in complex with a fragment molecule	2.373E-03	1.000	105	172	300	493	1	138	352	147	0.262	0.392
LOKIASV2_1567_ESMFold_hypothetical_protein	3gql-assembly4.cif.gz_B	3gql-assembly4.cif.gz_B Crystal Structure of activated receptor tyrosine kinase in complex with substrates	2.278E-04	1.000	104	171	482	493	11	269	276	341	0.633	0.938
LOKIASV2_1567_ESMFold_hypothetical_protein	6yi8-assembly1.cif.gz_A	6yi8-assembly1.cif.gz_A HUMAN FGFR4 KINASE DOMAIN (447-753) IN COMPLEX WITH ROBLITINIB	1.166E-04	1.000	104	171	485	493	10	274	277	352	0.639	0.957
LOKIASV2_1567_ESMFold_hypothetical_protein	5grn-assembly1.cif.gz_A	5grn-assembly1.cif.gz_A Crystal structure of PDGFRA in Complex with WQ-C-159	1.158E-03	1.000	104	171	483	493	5	282	285	368	0.635	0.975
LOKIASV2_1567_ESMFold_hypothetical_protein	6v6q-assembly1.cif.gz_A	6v6q-assembly1.cif.gz_A Crystal Structure of Monophosphorylated FGF Receptor 2 isoform IIIb with PTR657	3.340E-04	1.000	104	174	493	493	15	286	286	371	0.649	0.951
LOKIASV2_1567_ESMFold_hypothetical_protein	7c3n-assembly1.cif.gz_A	7c3n-assembly1.cif.gz_A Crystal structure of JAK3 in complex with Delgocitinib	1.402E-03	1.000	104	172	491	493	6	288	289	384	0.649	0.979
LOKIASV2_1567_ESMFold_hypothetical_protein	8p04-assembly1.cif.gz_A	8p04-assembly1.cif.gz_A Crystal structure of human CLK1 in complex with Leucettinib-92	5.136E-04	1.000	104	166	491	493	6	313	321	400	0.661	0.960
LOKIASV2_1567_ESMFold_hypothetical_protein	1z57-assembly1.cif.gz_A	1z57-assembly1.cif.gz_A Crystal structure of human CLK1 in complex with 10Z-Hymenialdisine	4.667E-04	1.000	104	166	486	493	7	309	333	397	0.651	0.910
LOKIASV2_1567_ESMFold_hypothetical_protein	2b9f-assembly1.cif.gz_A	2b9f-assembly1.cif.gz_A Crystal structure of non-phosphorylated Fus3	3.503E-04	1.000	104	171	486	493	9	335	337	413	0.641	0.970
LOKIASV2_1567_ESMFold_hypothetical_protein	4h3p-assembly2.cif.gz_D	4h3p-assembly2.cif.gz_D Crystal structure of human ERK2 complexed with a MAPK docking peptide	1.274E-03	1.000	104	170	407	493	10	172	338	245	0.483	0.482
LOKIASV2_1567_ESMFold_hypothetical_protein	6pk6-assembly1.cif.gz_A	6pk6-assembly1.cif.gz_A Human PRPF4B bound to benzothiophene inhibitor 329	1.471E-03	1.000	104	164	394	493	9	169	338	243	0.469	0.476
LOKIASV2_1567_ESMFold_hypothetical_protein	6z4z-assembly2.cif.gz_B	6z4z-assembly2.cif.gz_B Crystal structure of CLK1 in complex with macrocycle ODS2004070	5.387E-04	1.000	104	166	491	493	7	328	339	415	0.661	0.950
LOKIASV2_1567_ESMFold_hypothetical_protein	6fj0-assembly1.cif.gz_A	6fj0-assembly1.cif.gz_A Crystal structure of ERK2 in complex with an adenosine derivative	3.316E-03	1.000	104	180	403	493	15	168	340	230	0.454	0.453
LOKIASV2_1567_ESMFold_hypothetical_protein	4n4s-assembly1.cif.gz_A	4n4s-assembly1.cif.gz_A A Double Mutant Rat Erk2 in Complex With a Pyrazolo[3,4-d]pyrimidine Inhibitor	3.014E-03	1.000	104	165	394	493	4	160	342	237	0.467	0.459
LOKIASV2_1567_ESMFold_hypothetical_protein	8bzp-assembly1.cif.gz_A	8bzp-assembly1.cif.gz_A JNK3 (Mitogen-activated protein kinase 10) in Complex with Compound 23 bearing a C(sp3)F2Br moiety	1.960E-03	1.000	104	180	307	493	19	144	350	137	0.260	0.360
LOKIASV2_1567_ESMFold_hypothetical_protein	4kke-assembly1.cif.gz_A	4kke-assembly1.cif.gz_A The crystal structure of AMP-bound JNK3	1.960E-03	1.000	104	172	300	493	1	138	354	149	0.262	0.390
LOKIASV2_1567_ESMFold_hypothetical_protein	5lw1-assembly3.cif.gz_H	5lw1-assembly3.cif.gz_H Crystal structure of DARPin-DARPin rigid fusion, variant DD_232_11_D12 in complex JNK1a1 and JIP1 peptide	3.828E-03	1.000	104	180	393	493	19	163	355	223	0.434	0.408
LOKIASV2_1567_ESMFold_hypothetical_protein	6x8g-assembly1.cif.gz_A	6x8g-assembly1.cif.gz_A Crystal structure of TYK2 with Compound 22	2.611E-03	1.000	103	172	487	493	6	278	282	368	0.641	0.968
LOKIASV2_1567_ESMFold_hypothetical_protein	6agx-assembly1.cif.gz_A	6agx-assembly1.cif.gz_A The cocrystal structure of FGFR2 bound with compound 14 harboring 5H-pyrrolo[2,3-b]pyrazine scaffold	3.855E-04	1.000	103	171	482	493	10	282	285	357	0.633	0.958
LOKIASV2_1567_ESMFold_hypothetical_protein	5amn-assembly1.cif.gz_A-2	5amn-assembly1.cif.gz_A-2 The Discovery of 2-Substituted Phenol Quinazolines as Potent and Selective RET Kinase Inhibitors	4.242E-04	1.000	103	171	482	493	12	288	289	369	0.633	0.958
LOKIASV2_1567_ESMFold_hypothetical_protein	5ew8-assembly2.cif.gz_B	5ew8-assembly2.cif.gz_B FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH JNJ-4275693	4.896E-04	1.000	103	174	482	493	17	283	290	348	0.627	0.921
LOKIASV2_1567_ESMFold_hypothetical_protein	5flf-assembly4.cif.gz_D	5flf-assembly4.cif.gz_D DISEASE LINKED MUTATION IN FGFR	1.412E-04	1.000	103	171	489	493	9	285	290	367	0.647	0.955
LOKIASV2_1567_ESMFold_hypothetical_protein	6q8p-assembly2.cif.gz_B	6q8p-assembly2.cif.gz_B Structure of CLK1 with bound N-methyl-10-nitropyrido[3,4-g]quinazolin-2-amine	5.928E-04	1.000	103	166	490	493	7	322	333	405	0.659	0.949
LOKIASV2_1567_ESMFold_hypothetical_protein	6q2a-assembly13.cif.gz_M	6q2a-assembly13.cif.gz_M Trypanosoma brucei CLK1 kinase domain in complex with a covalent aminobenzimidazole inhibitor AB1	8.228E-03	1.000	103	174	299	493	2	120	339	133	0.256	0.351
LOKIASV2_1567_ESMFold_hypothetical_protein	3o71-assembly1.cif.gz_A	3o71-assembly1.cif.gz_A Crystal structure of ERK2/DCC peptide complex	2.262E-03	1.000	103	169	396	493	7	161	340	236	0.462	0.456
LOKIASV2_1567_ESMFold_hypothetical_protein	6ot6-assembly1.cif.gz_A	6ot6-assembly1.cif.gz_A Rat ERK2 D319N	4.862E-03	1.000	103	165	403	493	4	168	346	248	0.485	0.477
LOKIASV2_1567_ESMFold_hypothetical_protein	5jrs-assembly2.cif.gz_A	5jrs-assembly2.cif.gz_A CRYSTAL STRUCTURE OF BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE COMPLEXED WITH 4-[2-FLUORO-3-(4-OXO -3,4-DIHYDROQUINAZOLIN-3-YL)PHENYL]-7-(2-HYDROXYPROPAN-2-Y L)-9H-CARBAZOLE-1-CARBOXAMIDE	1.158E-03	1.000	102	174	482	493	7	257	258	344	0.627	0.973
LOKIASV2_1567_ESMFold_hypothetical_protein	6bss-assembly1.cif.gz_A	6bss-assembly1.cif.gz_A JAK2 JH2 in complex with NU6102	1.052E-03	1.000	102	172	481	493	6	268	271	355	0.629	0.970
LOKIASV2_1567_ESMFold_hypothetical_protein	7t1t-assembly1.cif.gz_A	7t1t-assembly1.cif.gz_A JAK2 JH2 IN COMPLEX WITH JAK292	1.052E-03	1.000	102	172	481	493	7	273	274	361	0.629	0.974
LOKIASV2_1567_ESMFold_hypothetical_protein	6v9c-assembly1.cif.gz_A	6v9c-assembly1.cif.gz_A Crystal structure of FGFR4 kinase domain in complex with covalent inhibitor	3.675E-04	1.000	102	171	482	493	10	275	279	357	0.633	0.953
LOKIASV2_1567_ESMFold_hypothetical_protein	3krl-assembly1.cif.gz_A	3krl-assembly1.cif.gz_A cFMS Tyrosine kinase in complex with 5-Cyano-furan-2-carboxylic acid [4-(4-methyl-piperazin-1-yl)-2-piperidin-1-yl-phenyl]-amide	1.215E-03	1.000	102	168	487	493	15	280	281	357	0.649	0.947
LOKIASV2_1567_ESMFold_hypothetical_protein	8wsw-assembly4.cif.gz_D	8wsw-assembly4.cif.gz_D The Crystal Structure of LIMK2a from Biortus	1.698E-03	1.000	102	180	492	493	2	274	281	365	0.635	0.972
LOKIASV2_1567_ESMFold_hypothetical_protein	8u2o-assembly1.cif.gz_A	8u2o-assembly1.cif.gz_A Crystal Structure of Cdk-related protein kinase 6 (PK6) from Plasmodium falciparum in complex with inhibitor TCMDC-123995	1.104E-03	1.000	102	166	485	493	1	271	289	376	0.649	0.938
LOKIASV2_1567_ESMFold_hypothetical_protein	4j96-assembly3.cif.gz_B	4j96-assembly3.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659M Mutation Identified in Cervical Cancer.	4.667E-04	1.000	102	157	492	493	2	303	305	388	0.682	0.990
LOKIASV2_1567_ESMFold_hypothetical_protein	1pme-assembly1.cif.gz_A	1pme-assembly1.cif.gz_A STRUCTURE OF PENTA MUTANT HUMAN ERK2 MAP KINASE COMPLEXED WITH A SPECIFIC INHIBITOR OF HUMAN P38 MAP KINASE	2.611E-03	1.000	102	170	403	493	5	160	334	241	0.475	0.467
LOKIASV2_1567_ESMFold_hypothetical_protein	4x21-assembly1.cif.gz_A	4x21-assembly1.cif.gz_A The MAP kinase JNK3 as target for halogen bonding	3.014E-03	1.000	102	180	300	493	19	137	336	130	0.245	0.354
LOKIASV2_1567_ESMFold_hypothetical_protein	8aof-assembly1.cif.gz_A	8aof-assembly1.cif.gz_A Specific covalent inhibitor(16) of ERK2	1.698E-03	1.000	102	170	403	493	10	163	341	238	0.475	0.452
LOKIASV2_1567_ESMFold_hypothetical_protein	3nr9-assembly1.cif.gz_A-2	3nr9-assembly1.cif.gz_A-2 Structure of human CDC2-like kinase 2 (CLK2)	4.667E-04	1.000	102	165	491	493	17	332	341	408	0.663	0.927
LOKIASV2_1567_ESMFold_hypothetical_protein	4kkg-assembly1.cif.gz_A	4kkg-assembly1.cif.gz_A Crystal structure of apo and AMP-bound JNK3	3.316E-03	1.000	102	172	301	493	1	139	353	148	0.264	0.394
LOKIASV2_1567_ESMFold_hypothetical_protein	4cv9-assembly1.cif.gz_A	4cv9-assembly1.cif.gz_A MPS1 kinase with 3-aminopyridin-2-one inhibitors	8.691E-04	1.000	101	176	476	493	2	253	255	344	0.611	0.988
LOKIASV2_1567_ESMFold_hypothetical_protein	5ap4-assembly1.cif.gz_A	5ap4-assembly1.cif.gz_A Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.	8.691E-04	1.000	101	177	471	493	3	253	258	333	0.598	0.973
LOKIASV2_1567_ESMFold_hypothetical_protein	4nks-assembly2.cif.gz_B	4nks-assembly2.cif.gz_B Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazolaminopyrimidine 3	1.402E-03	1.000	101	171	482	493	13	268	271	358	0.633	0.945
LOKIASV2_1567_ESMFold_hypothetical_protein	8ex2-assembly1.cif.gz_A	8ex2-assembly1.cif.gz_A Crystal structure of JAK2 JH2 (pseudokinase domain) in complex with HTSA3	1.402E-03	1.000	101	172	481	493	7	270	273	356	0.629	0.967
LOKIASV2_1567_ESMFold_hypothetical_protein	3ky2-assembly2.cif.gz_B	3ky2-assembly2.cif.gz_B Crystal structure of Fibroblast Growth Factor Receptor 1 kinase domain	2.611E-03	1.000	101	171	482	493	14	275	280	348	0.633	0.936
LOKIASV2_1567_ESMFold_hypothetical_protein	2pwl-assembly1.cif.gz_A	2pwl-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic N549H Mutation Responsible for Crouzon Syndrome.	7.178E-04	1.000	101	171	491	493	10	283	284	365	0.651	0.965
LOKIASV2_1567_ESMFold_hypothetical_protein	3ri1-assembly1.cif.gz_A	3ri1-assembly1.cif.gz_A Crystal structure of the catalytic domain of FGFR2 kinase in complex with ARQ 069	7.899E-04	1.000	101	171	493	493	3	285	285	373	0.655	0.993
LOKIASV2_1567_ESMFold_hypothetical_protein	7v29-assembly2.cif.gz_A	7v29-assembly2.cif.gz_A Crystal structure of FGFR4 with a dual-warhead covalent inhhibitor	3.184E-04	1.000	101	171	482	493	3	290	293	354	0.633	0.983
LOKIASV2_1567_ESMFold_hypothetical_protein	6ra5-assembly1.cif.gz_A	6ra5-assembly1.cif.gz_A Human tnik in complex with compound 9	1.274E-03	1.000	101	174	486	493	13	292	295	375	0.635	0.949
LOKIASV2_1567_ESMFold_hypothetical_protein	6ig8-assembly1.cif.gz_A	6ig8-assembly1.cif.gz_A Crystal structure of CSF-1R kinase domain with a small molecular inhibitor, JTE-952	1.274E-03	1.000	101	168	487	493	19	300	301	372	0.649	0.937
LOKIASV2_1567_ESMFold_hypothetical_protein	5ywm-assembly1.cif.gz_X	5ywm-assembly1.cif.gz_X Crystal structure of CK2a2 form-1	4.862E-03	1.000	101	180	402	493	34	176	313	228	0.452	0.457
LOKIASV2_1567_ESMFold_hypothetical_protein	4ijp-assembly1.cif.gz_A	4ijp-assembly1.cif.gz_A Crystal Structure of Human PRPF4B kinase domain in complex with 4-{5-[(2-Chloro-pyridin-4-ylmethyl)-carbamoyl]-thiophen-2-yl}-benzo[b]thiophene-2-carboxylic acid amine	2.373E-03	1.000	101	165	394	493	8	167	331	241	0.467	0.483
LOKIASV2_1567_ESMFold_hypothetical_protein	6fi6-assembly1.cif.gz_A	6fi6-assembly1.cif.gz_A Crystal structure of ERK2 in complex with an adenosine derivative	3.479E-03	1.000	101	165	403	493	4	168	338	248	0.485	0.488
LOKIASV2_1567_ESMFold_hypothetical_protein	4xp2-assembly1.cif.gz_A	4xp2-assembly1.cif.gz_A Crystal structure of ERK2 in complex with an inhibitor	5.612E-03	1.000	101	180	403	493	16	169	339	232	0.454	0.454
LOKIASV2_1567_ESMFold_hypothetical_protein	6ytd-assembly1.cif.gz_A	6ytd-assembly1.cif.gz_A CLK1 V324A mutant bound with benzothiazole Tg003 (Cpd 2)	5.136E-04	1.000	101	166	491	493	7	328	339	415	0.661	0.950
LOKIASV2_1567_ESMFold_hypothetical_protein	4iz7-assembly1.cif.gz_C	4iz7-assembly1.cif.gz_C Structure of Non-Phosphorylated ERK2 bound to the PEA-15 Death Effector Domain	3.161E-03	1.000	101	165	401	493	3	166	340	245	0.481	0.482
LOKIASV2_1567_ESMFold_hypothetical_protein	6b4w-assembly1.cif.gz_A	6b4w-assembly1.cif.gz_A TTK in Complex with Inhibitor	7.178E-04	1.000	100	176	493	493	2	241	259	346	0.645	0.927
LOKIASV2_1567_ESMFold_hypothetical_protein	6tu9-assembly2.cif.gz_B	6tu9-assembly2.cif.gz_B The ROR1 Pseudokinase Domain Bound To Ponatinib	2.373E-03	1.000	100	167	481	493	1	258	259	353	0.639	0.996
LOKIASV2_1567_ESMFold_hypothetical_protein	7chn-assembly1.cif.gz_A	7chn-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with compound 9	8.691E-04	1.000	100	176	476	493	2	262	266	348	0.611	0.981
LOKIASV2_1567_ESMFold_hypothetical_protein	6cn9-assembly1.cif.gz_A	6cn9-assembly1.cif.gz_A Crystal structure of the Kinase domain of WNK1	5.887E-03	1.000	100	185	394	493	17	161	271	222	0.426	0.535
LOKIASV2_1567_ESMFold_hypothetical_protein	5ugl-assembly2.cif.gz_B	5ugl-assembly2.cif.gz_B Crystal Structure of FGF Receptor 2 Tyrosine Kinase Domain Harboring the D650V Activating Mutation	6.219E-04	1.000	100	171	491	493	11	270	271	359	0.651	0.959
LOKIASV2_1567_ESMFold_hypothetical_protein	5lpv-assembly1.cif.gz_A	5lpv-assembly1.cif.gz_A Crystal structure of the BRI1 kinase domain (865-1160) in complex with AMPPNP and Mn from Arabidopsis thaliana	2.739E-03	1.000	100	185	489	493	22	283	285	358	0.619	0.919
LOKIASV2_1567_ESMFold_hypothetical_protein	5ugl-assembly1.cif.gz_A	5ugl-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 Tyrosine Kinase Domain Harboring the D650V Activating Mutation	4.896E-04	1.000	100	174	491	493	13	284	285	366	0.645	0.954
LOKIASV2_1567_ESMFold_hypothetical_protein	7kia-assembly1.cif.gz_A	7kia-assembly1.cif.gz_A Crystal structure of FGFR2 kinase domain gatekeeper mutant V564F in complex with covalent compound 19	5.136E-04	1.000	100	171	491	493	11	286	287	367	0.651	0.962
LOKIASV2_1567_ESMFold_hypothetical_protein	7mfc-assembly1.cif.gz_A	7mfc-assembly1.cif.gz_A Crystal structure of CSF1R in complex with vimseltinib	1.274E-03	1.000	100	168	484	493	9	286	287	366	0.643	0.969
LOKIASV2_1567_ESMFold_hypothetical_protein	6xv9-assembly2.cif.gz_B	6xv9-assembly2.cif.gz_B Crystal structure of the kinase domain of human c-KIT in complex with a type-II inhibitor	3.675E-04	1.000	100	168	480	493	11	291	292	365	0.635	0.962
LOKIASV2_1567_ESMFold_hypothetical_protein	5ui0-assembly1.cif.gz_A	5ui0-assembly1.cif.gz_A Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring an E565A/K659M Double Gain-of-Function Mutation	3.184E-04	1.000	100	171	492	493	17	299	301	363	0.653	0.940
LOKIASV2_1567_ESMFold_hypothetical_protein	6t2w-assembly1.cif.gz_A	6t2w-assembly1.cif.gz_A Crystal structure of the CSF1R kinase domain with a dihydropurinone inhibitor (compound 4)	7.178E-04	1.000	100	168	491	493	27	303	304	368	0.657	0.911
LOKIASV2_1567_ESMFold_hypothetical_protein	6khd-assembly2.cif.gz_B	6khd-assembly2.cif.gz_B Crystal structure of CLK1 in complex with CX-4945	5.136E-04	1.000	100	165	491	493	3	323	332	412	0.663	0.967
LOKIASV2_1567_ESMFold_hypothetical_protein	2ghl-assembly1.cif.gz_A	2ghl-assembly1.cif.gz_A Mutant Mus Musculus P38 Kinase Domain in Complex with Inhibitor PG-874743	4.212E-03	1.000	100	180	392	493	20	160	334	220	0.432	0.422
LOKIASV2_1567_ESMFold_hypothetical_protein	6fyk-assembly2.cif.gz_B	6fyk-assembly2.cif.gz_B X-Ray structure of CLK2-KD(136-496)/Indazole1 at 2.39A	3.479E-03	1.000	100	165	314	493	17	175	349	176	0.304	0.456
LOKIASV2_1567_ESMFold_hypothetical_protein	7orf-assembly1.cif.gz_A	7orf-assembly1.cif.gz_A Crystal structure of JNK3 in complex with FMU-001-367 (compound 1)	2.056E-03	1.000	100	172	300	493	1	138	351	147	0.262	0.393
LOKIASV2_1567_ESMFold_hypothetical_protein	5c03-assembly1.cif.gz_A	5c03-assembly1.cif.gz_A Crystal Structure of kinase	2.156E-03	0.999	99	180	481	493	11	260	260	345	0.613	0.962
LOKIASV2_1567_ESMFold_hypothetical_protein	7vjl-assembly2.cif.gz_B	7vjl-assembly2.cif.gz_B The crystal structure of FGFR4 kinase domain in complex with N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-(2,2,2-trifluoroacetyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide	4.044E-04	0.999	99	174	482	493	14	260	266	335	0.627	0.929
LOKIASV2_1567_ESMFold_hypothetical_protein	6yi8-assembly2.cif.gz_B	6yi8-assembly2.cif.gz_B HUMAN FGFR4 KINASE DOMAIN (447-753) IN COMPLEX WITH ROBLITINIB	2.389E-04	0.999	99	171	482	493	12	265	270	338	0.633	0.941
LOKIASV2_1567_ESMFold_hypothetical_protein	4twn-assembly1.cif.gz_A	4twn-assembly1.cif.gz_A Human EphA3 Kinase domain in complex with Birb796	2.262E-03	0.999	99	180	486	493	14	266	276	355	0.623	0.917
LOKIASV2_1567_ESMFold_hypothetical_protein	4hw7-assembly1.cif.gz_A	4hw7-assembly1.cif.gz_A Crystal structure of FMS kinase domain with a small molecular inhibitor, PLX647-OME	1.337E-03	0.999	99	168	484	493	10	287	289	369	0.643	0.962
LOKIASV2_1567_ESMFold_hypothetical_protein	1t46-assembly1.cif.gz_A	1t46-assembly1.cif.gz_A STRUCTURAL BASIS FOR THE AUTOINHIBITION AND STI-571 INHIBITION OF C-KIT TYROSINE KINASE	1.003E-03	0.999	99	168	484	493	18	294	297	369	0.643	0.933
LOKIASV2_1567_ESMFold_hypothetical_protein	3krj-assembly1.cif.gz_A	3krj-assembly1.cif.gz_A cFMS tyrosine kinase in complex with 4-Cyano-1H-imidazole-2-carboxylic acid (2-cyclohex-1-enyl-4-piperidin-4-yl-phenyl)-amide	9.564E-04	0.999	99	168	476	493	32	301	304	357	0.627	0.888
LOKIASV2_1567_ESMFold_hypothetical_protein	6opi-assembly1.cif.gz_A	6opi-assembly1.cif.gz_A phosphorylated ERK2 with SCH-CPD336	5.651E-04	0.999	99	165	489	493	5	324	326	404	0.659	0.982
LOKIASV2_1567_ESMFold_hypothetical_protein	4o6e-assembly1.cif.gz_A	4o6e-assembly1.cif.gz_A Discovery of 5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine Inhibitors of Erk2	4.044E-04	0.999	99	166	492	493	3	324	328	403	0.663	0.982
LOKIASV2_1567_ESMFold_hypothetical_protein	6q8p-assembly3.cif.gz_C	6q8p-assembly3.cif.gz_C Structure of CLK1 with bound N-methyl-10-nitropyrido[3,4-g]quinazolin-2-amine	1.158E-03	0.999	99	166	486	493	6	309	334	400	0.651	0.910
LOKIASV2_1567_ESMFold_hypothetical_protein	4qp2-assembly1.cif.gz_A	4qp2-assembly1.cif.gz_A Crystal Structure of ERKs in complex with 5-chlorobenzo[d]oxazol-2-amine	5.350E-03	0.999	99	170	401	493	9	164	336	239	0.471	0.464
LOKIASV2_1567_ESMFold_hypothetical_protein	5nho-assembly1.cif.gz_A	5nho-assembly1.cif.gz_A Human Erk2 with an Erk1/2 inhibitor	3.479E-03	0.999	99	165	394	493	4	159	343	237	0.467	0.455
LOKIASV2_1567_ESMFold_hypothetical_protein	2eu9-assembly1.cif.gz_A	2eu9-assembly1.cif.gz_A Crystal Structure of CLK3	4.862E-03	0.999	99	165	312	493	11	167	345	171	0.300	0.455
LOKIASV2_1567_ESMFold_hypothetical_protein	5lcj-assembly1.cif.gz_A	5lcj-assembly1.cif.gz_A In-Gel Activity-Based Protein Profiling of a Clickable Covalent Erk 1/2 Inhibitor	6.176E-03	0.999	99	166	403	493	5	168	346	247	0.483	0.474
LOKIASV2_1567_ESMFold_hypothetical_protein	6z55-assembly2.cif.gz_B	6z55-assembly2.cif.gz_B Crystal structure of CLK3 in complex with macrocycle ODS2004070	2.873E-03	0.999	99	165	314	493	19	177	357	175	0.304	0.445
LOKIASV2_1567_ESMFold_hypothetical_protein	4c4j-assembly1.cif.gz_A	4c4j-assembly1.cif.gz_A Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1	1.337E-03	0.999	98	176	485	493	1	246	262	344	0.629	0.939
LOKIASV2_1567_ESMFold_hypothetical_protein	8c08-assembly1.cif.gz_A	8c08-assembly1.cif.gz_A Crystal structure of JAK2 JH2-K539L	1.337E-03	0.999	98	170	481	493	4	265	270	359	0.633	0.970
LOKIASV2_1567_ESMFold_hypothetical_protein	7k0v-assembly1.cif.gz_D	7k0v-assembly1.cif.gz_D Crystal structure of bRaf in complex with inhibitor GNE-0749	1.698E-03	0.999	98	170	481	493	4	270	271	364	0.633	0.985
LOKIASV2_1567_ESMFold_hypothetical_protein	7olx-assembly1.cif.gz_A	7olx-assembly1.cif.gz_A MerTK kinase domain with type 1.5 inhibitor containing a tri-methyl pyrazole group	1.215E-03	0.999	98	174	482	493	20	271	275	344	0.627	0.916
LOKIASV2_1567_ESMFold_hypothetical_protein	3dpk-assembly1.cif.gz_A	3dpk-assembly1.cif.gz_A cFMS tyrosine kinase in complex with a pyridopyrimidinone inhibitor	2.611E-03	0.999	98	168	452	493	20	260	279	324	0.578	0.864
LOKIASV2_1567_ESMFold_hypothetical_protein	4qqj-assembly1.cif.gz_A	4qqj-assembly1.cif.gz_A Crystal Structure of FGF Receptor (FGFR) 4 Kinase Domain Harboring the V550L Gate-Keeper Mutation	7.899E-04	0.999	98	171	482	493	3	277	282	358	0.633	0.975
LOKIASV2_1567_ESMFold_hypothetical_protein	5ugx-assembly1.cif.gz_B	5ugx-assembly1.cif.gz_B Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 Harboring a E565A/D650V double Gain-of-Function Mutation	5.651E-04	0.999	98	171	491	493	10	281	282	354	0.651	0.965
LOKIASV2_1567_ESMFold_hypothetical_protein	3qqu-assembly2.cif.gz_B	3qqu-assembly2.cif.gz_B Cocrystal structure of unphosphorylated igf with pyrimidine 8	2.156E-03	0.999	98	166	484	493	3	229	288	341	0.647	0.788
LOKIASV2_1567_ESMFold_hypothetical_protein	3wf8-assembly1.cif.gz_A	3wf8-assembly1.cif.gz_A Crystal structure of S6K1 kinase domain in complex with a quinoline derivative 2-oxo-2-[(4-sulfamoylphenyl)amino]ethyl 7,8,9,10-tetrahydro-6H-cyclohepta[b]quinoline-11-carboxylate	1.698E-03	0.999	98	169	483	493	1	283	288	367	0.639	0.983
LOKIASV2_1567_ESMFold_hypothetical_protein	6yti-assembly1.cif.gz_A	6yti-assembly1.cif.gz_A CLK1 bound with ETH1610 (Cpd 17)	7.899E-04	0.999	98	166	491	493	3	320	329	415	0.661	0.967
LOKIASV2_1567_ESMFold_hypothetical_protein	3tei-assembly1.cif.gz_A	3tei-assembly1.cif.gz_A Crystal structure of human ERK2 complexed with a MAPK docking peptide	4.212E-03	0.999	98	171	394	493	12	160	339	231	0.454	0.440
LOKIASV2_1567_ESMFold_hypothetical_protein	4y46-assembly1.cif.gz_A	4y46-assembly1.cif.gz_A Pyridopyrimidinone Derivatives as Potent and Selective c-Jun N-Terminal Kinase (JNK) inhibitors	5.100E-03	0.999	98	172	300	493	1	138	340	148	0.262	0.406
LOKIASV2_1567_ESMFold_hypothetical_protein	4yno-assembly1.cif.gz_A	4yno-assembly1.cif.gz_A Crystal structure of MAPK13 at INACTIVE FORM	3.014E-03	0.999	98	172	399	493	5	169	342	247	0.462	0.482
LOKIASV2_1567_ESMFold_hypothetical_protein	4ux9-assembly1.cif.gz_A	4ux9-assembly1.cif.gz_A Crystal structure of JNK1 bound to a MKK7 docking motif	6.219E-04	0.999	98	180	487	493	19	341	343	407	0.625	0.942
LOKIASV2_1567_ESMFold_hypothetical_protein	2gph-assembly1.cif.gz_A	2gph-assembly1.cif.gz_A Docking motif interactions in the MAP kinase ERK2	4.419E-03	0.999	98	165	396	493	3	160	345	238	0.471	0.458
LOKIASV2_1567_ESMFold_hypothetical_protein	4s2z-assembly1.cif.gz_A	4s2z-assembly1.cif.gz_A ERK2 Intrinsically active mutant R65S	4.212E-03	0.999	98	166	403	493	4	168	346	246	0.483	0.477
LOKIASV2_1567_ESMFold_hypothetical_protein	3v6r-assembly2.cif.gz_B	3v6r-assembly2.cif.gz_B Discovery of potent and selective covalent inhibitors of JNK	4.016E-03	0.999	98	172	300	493	1	138	347	148	0.262	0.398
LOKIASV2_1567_ESMFold_hypothetical_protein	7e75-assembly1.cif.gz_A	7e75-assembly1.cif.gz_A Crystal structure of human ERK2 mutant (G37C)	4.212E-03	0.999	98	165	394	493	5	160	349	238	0.467	0.447
LOKIASV2_1567_ESMFold_hypothetical_protein	6tn9-assembly1.cif.gz_A	6tn9-assembly1.cif.gz_A X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 16	8.691E-04	0.999	97	176	471	493	4	254	259	339	0.600	0.969
LOKIASV2_1567_ESMFold_hypothetical_protein	7cht-assembly1.cif.gz_A	7cht-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with compound 30	7.530E-04	0.999	97	176	471	493	2	256	261	339	0.600	0.977
LOKIASV2_1567_ESMFold_hypothetical_protein	1gjo-assembly1.cif.gz_A	1gjo-assembly1.cif.gz_A The FGFr2 tyrosine kinase domain	4.242E-04	0.999	97	171	491	493	10	279	280	365	0.651	0.964
LOKIASV2_1567_ESMFold_hypothetical_protein	5uhn-assembly1.cif.gz_A	5uhn-assembly1.cif.gz_A Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring a N549H/E565A Double Gain-of-Function Mutation	6.843E-04	0.999	97	174	491	493	12	281	282	362	0.645	0.957
LOKIASV2_1567_ESMFold_hypothetical_protein	7ozd-assembly2.cif.gz_BBB	7ozd-assembly2.cif.gz_BBB FGFR1 kinase domain (residues 458-765) with mutations C488A, C584S in complex with 34.	4.667E-04	0.999	97	171	482	493	14	280	285	356	0.633	0.937
LOKIASV2_1567_ESMFold_hypothetical_protein	5ui0-assembly2.cif.gz_B	5ui0-assembly2.cif.gz_B Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring an E565A/K659M Double Gain-of-Function Mutation	4.667E-04	0.999	97	171	493	493	16	304	304	377	0.655	0.951
LOKIASV2_1567_ESMFold_hypothetical_protein	3bea-assembly1.cif.gz_A	3bea-assembly1.cif.gz_A cFMS tyrosine kinase (tie2 KID) in complex with a pyrimidinopyridone inhibitor	1.158E-03	0.999	97	168	493	493	29	306	310	372	0.661	0.897
LOKIASV2_1567_ESMFold_hypothetical_protein	4eyj-assembly1.cif.gz_A	4eyj-assembly1.cif.gz_A MAPK13 Complex with inhibitor	4.212E-03	0.999	97	172	393	493	5	168	338	240	0.450	0.485
LOKIASV2_1567_ESMFold_hypothetical_protein	1pmn-assembly1.cif.gz_A	1pmn-assembly1.cif.gz_A Crystal structure of JNK3 in complex with an imidazole-pyrimidine inhibitor	2.489E-03	0.999	97	172	308	493	1	146	344	158	0.278	0.424
LOKIASV2_1567_ESMFold_hypothetical_protein	6ge0-assembly1.cif.gz_A	6ge0-assembly1.cif.gz_A Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2	7.477E-03	0.999	97	170	403	493	10	168	345	242	0.475	0.461
LOKIASV2_1567_ESMFold_hypothetical_protein	4d2s-assembly1.cif.gz_A	4d2s-assembly1.cif.gz_A Human TTK in complex with a Dyrk1B inhibitor	1.003E-03	0.999	96	176	485	493	4	234	249	336	0.629	0.928
LOKIASV2_1567_ESMFold_hypothetical_protein	4c4e-assembly1.cif.gz_A	4c4e-assembly1.cif.gz_A Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1	1.337E-03	0.999	96	176	471	493	1	252	257	333	0.600	0.981
LOKIASV2_1567_ESMFold_hypothetical_protein	6occ-assembly1.cif.gz_A	6occ-assembly1.cif.gz_A JAK2 JH2 in complex with JAK190	1.104E-03	0.999	96	172	485	493	6	265	268	362	0.637	0.970
LOKIASV2_1567_ESMFold_hypothetical_protein	4rix-assembly1.cif.gz_A	4rix-assembly1.cif.gz_A Crystal structure of an EGFR/HER3 kinase domain heterodimer containing the cancer-associated HER3-Q790R mutation	7.178E-04	0.999	96	180	487	493	11	264	269	340	0.625	0.944
LOKIASV2_1567_ESMFold_hypothetical_protein	8c0a-assembly2.cif.gz_B	8c0a-assembly2.cif.gz_B Crystal structure of JAK2 JH2-R683S	1.781E-03	0.999	96	172	481	493	7	270	273	354	0.629	0.967
LOKIASV2_1567_ESMFold_hypothetical_protein	6qhr-assembly1.cif.gz_A	6qhr-assembly1.cif.gz_A Structure of the mitogen activated kinase kinase 7 in complex with pyrazolopyrimidine 1m	9.117E-04	0.999	96	180	489	493	20	282	286	357	0.629	0.920
LOKIASV2_1567_ESMFold_hypothetical_protein	3hng-assembly1.cif.gz_A	3hng-assembly1.cif.gz_A Crystal structure of VEGFR1 in complex with N-(4-Chlorophenyl)-2-((pyridin-4-ylmethyl)amino)benzamide	2.489E-03	0.999	96	171	481	493	19	287	288	352	0.631	0.934
LOKIASV2_1567_ESMFold_hypothetical_protein	6xvb-assembly2.cif.gz_B	6xvb-assembly2.cif.gz_B Crystal structure of the kinase domain of human c-KIT with a cyclic imidate inhibitor covalently bound to Cys788	5.387E-04	0.999	96	168	484	493	6	287	288	362	0.643	0.979
LOKIASV2_1567_ESMFold_hypothetical_protein	7ozb-assembly2.cif.gz_BBB	7ozb-assembly2.cif.gz_BBB FGFR1 kinase domain (residues 458-765) with mutations C488A, C584S in complex with 38.	4.449E-04	0.999	96	171	482	493	14	285	291	348	0.633	0.935
LOKIASV2_1567_ESMFold_hypothetical_protein	6pnx-assembly1.cif.gz_B	6pnx-assembly1.cif.gz_B Crystal Structure of an Asymmetric Dimer of FGF Receptor 3 Kinases Trapped in A-loop Tyrosine Transphosphorylation Reaction	5.651E-04	0.999	96	171	482	493	13	290	294	353	0.633	0.946
LOKIASV2_1567_ESMFold_hypothetical_protein	7ybp-assembly1.cif.gz_A	7ybp-assembly1.cif.gz_A Crystal structure of FGFR4(V550L) kinase domain with 10z	3.675E-04	0.999	96	171	482	493	4	295	300	363	0.633	0.973
LOKIASV2_1567_ESMFold_hypothetical_protein	4xoy-assembly1.cif.gz_A	4xoy-assembly1.cif.gz_A Crystal structure of ERK2 in complex with an inhibitor	4.635E-03	0.999	96	165	403	493	3	163	330	242	0.485	0.488
LOKIASV2_1567_ESMFold_hypothetical_protein	3ttj-assembly1.cif.gz_A	3ttj-assembly1.cif.gz_A Crystal Structure of JNK3 complexed with CC-359, a JNK inhibitor for the prevention of ischemia-reperfusion injury	5.887E-03	0.999	96	174	300	493	2	135	333	144	0.258	0.402
LOKIASV2_1567_ESMFold_hypothetical_protein	7ugb-assembly1.cif.gz_A	7ugb-assembly1.cif.gz_A Crystal structure of rat ERK2 complexed with docking peptide from ISG20	8.691E-04	0.999	96	165	492	493	3	330	333	409	0.665	0.985
LOKIASV2_1567_ESMFold_hypothetical_protein	4qta-assembly1.cif.gz_A	4qta-assembly1.cif.gz_A Structure of human ERK2 in complex with SCH772984 revealing a novel inhibitor-induced binding pocket	7.477E-03	0.999	96	165	396	493	5	162	335	239	0.471	0.472
LOKIASV2_1567_ESMFold_hypothetical_protein	6fjb-assembly1.cif.gz_A	6fjb-assembly1.cif.gz_A Crystal structure of ERK2 in complex with an adenosine derivative	6.478E-03	0.999	96	170	403	493	9	167	337	242	0.475	0.472
LOKIASV2_1567_ESMFold_hypothetical_protein	7nr3-assembly1.cif.gz_A	7nr3-assembly1.cif.gz_A Discovery of ASTX029, a clinical candidate which modulates the phosphorylation and catalytic activity of ERK1/2	1.003E-03	0.999	96	166	492	493	5	334	337	416	0.663	0.979
LOKIASV2_1567_ESMFold_hypothetical_protein	6ytw-assembly2.cif.gz_B	6ytw-assembly2.cif.gz_B CLK3 bound with benzothiazole Tg003 (Cpd 2)	3.649E-03	0.999	96	165	417	493	13	228	339	300	0.513	0.637
LOKIASV2_1567_ESMFold_hypothetical_protein	3e7o-assembly2.cif.gz_A	3e7o-assembly2.cif.gz_A Crystal Structure of JNK2	3.649E-03	0.999	96	171	393	493	14	162	342	234	0.452	0.436
LOKIASV2_1567_ESMFold_hypothetical_protein	4iz7-assembly2.cif.gz_A	4iz7-assembly2.cif.gz_A Structure of Non-Phosphorylated ERK2 bound to the PEA-15 Death Effector Domain	9.963E-03	0.999	96	165	396	493	4	161	344	240	0.471	0.459
LOKIASV2_1567_ESMFold_hypothetical_protein	3vuk-assembly1.cif.gz_A	3vuk-assembly1.cif.gz_A Crystal structure of a cysteine-deficient mutant M5 in MAP kinase JNK1	5.651E-04	0.999	96	172	486	493	1	293	355	389	0.639	0.825
LOKIASV2_1567_ESMFold_hypothetical_protein	4zeg-assembly1.cif.gz_A	4zeg-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with a pyrazolopyrimidine inhibitor	2.056E-03	0.998	95	176	471	493	1	254	260	335	0.600	0.977
LOKIASV2_1567_ESMFold_hypothetical_protein	5ur1-assembly2.cif.gz_B	5ur1-assembly2.cif.gz_B FGFR1 kinase domain complex with SN37333 in reversible binding mode	1.104E-03	0.998	95	171	482	493	10	260	265	349	0.633	0.947
LOKIASV2_1567_ESMFold_hypothetical_protein	2w5b-assembly1.cif.gz_A	2w5b-assembly1.cif.gz_A Human Nek2 kinase ATPgammaS-bound	5.612E-03	0.998	95	180	393	493	6	152	271	224	0.434	0.542
LOKIASV2_1567_ESMFold_hypothetical_protein	7lvh-assembly2.cif.gz_B	7lvh-assembly2.cif.gz_B CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 ISOFORM 1 COMPLEXED WITH LIGAND N-[3-METHOXY-4-(1,3-OXAZOL-5-YL)PHENYL]-3-(PROPAN-2-YL)PIPERIDINE-2-CARBOXAMIDE	1.868E-03	0.998	95	176	479	493	3	268	281	352	0.617	0.947
LOKIASV2_1567_ESMFold_hypothetical_protein	4qqt-assembly1.cif.gz_A	4qqt-assembly1.cif.gz_A Crystal Structure of FGF Receptor (FGFR) 4 Tyrosine Kinase Domain	5.928E-04	0.998	95	176	482	493	13	280	283	346	0.623	0.947
LOKIASV2_1567_ESMFold_hypothetical_protein	7lvh-assembly1.cif.gz_A	7lvh-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 ISOFORM 1 COMPLEXED WITH LIGAND N-[3-METHOXY-4-(1,3-OXAZOL-5-YL)PHENYL]-3-(PROPAN-2-YL)PIPERIDINE-2-CARBOXAMIDE	2.156E-03	0.998	95	176	479	493	4	272	284	366	0.617	0.947
LOKIASV2_1567_ESMFold_hypothetical_protein	7kia-assembly2.cif.gz_B	7kia-assembly2.cif.gz_B Crystal structure of FGFR2 kinase domain gatekeeper mutant V564F in complex with covalent compound 19	7.178E-04	0.998	95	171	492	493	11	285	288	368	0.653	0.955
LOKIASV2_1567_ESMFold_hypothetical_protein	3b8q-assembly1.cif.gz_A	3b8q-assembly1.cif.gz_A Crystal structure of the VEGFR2 kinase domain in complex with a naphthamide inhibitor	6.523E-04	0.998	95	171	492	493	12	288	292	355	0.653	0.949
LOKIASV2_1567_ESMFold_hypothetical_protein	6nsp-assembly1.cif.gz_A	6nsp-assembly1.cif.gz_A TRK-A IN COMPLEX WITH LIGAND 9	2.739E-03	0.998	95	180	487	493	11	291	293	368	0.625	0.959
LOKIASV2_1567_ESMFold_hypothetical_protein	7ybx-assembly1.cif.gz_A	7ybx-assembly1.cif.gz_A Crystal structure of FGFR4(V550M) kinase domain with 10z	6.523E-04	0.998	95	171	482	493	4	295	300	359	0.633	0.973
LOKIASV2_1567_ESMFold_hypothetical_protein	5vnd-assembly3.cif.gz_A	5vnd-assembly3.cif.gz_A Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to H3B-6527	5.651E-04	0.998	95	171	482	493	11	295	302	358	0.633	0.944
LOKIASV2_1567_ESMFold_hypothetical_protein	4r7h-assembly1.cif.gz_A	4r7h-assembly1.cif.gz_A Crystal structure of FMS KINASE domain with a small molecular inhibitor, PLX3397	1.337E-03	0.998	95	171	486	493	29	307	308	369	0.641	0.906
LOKIASV2_1567_ESMFold_hypothetical_protein	8ao5-assembly1.cif.gz_A	8ao5-assembly1.cif.gz_A Specific covalent inhibitor (6) of ERK2	4.635E-03	0.998	95	166	403	493	1	161	330	245	0.483	0.488
LOKIASV2_1567_ESMFold_hypothetical_protein	4ifc-assembly2.cif.gz_B	4ifc-assembly2.cif.gz_B Crystal Structure of ADP-bound Human PRPF4B kinase domain	3.828E-03	0.998	95	164	394	493	7	166	330	244	0.469	0.485
LOKIASV2_1567_ESMFold_hypothetical_protein	4fv5-assembly1.cif.gz_A	4fv5-assembly1.cif.gz_A Crystal Structure of the ERK2 complexed with EK9	9.564E-04	0.998	95	165	491	493	6	273	331	380	0.663	0.810
LOKIASV2_1567_ESMFold_hypothetical_protein	4fv9-assembly1.cif.gz_A	4fv9-assembly1.cif.gz_A Crystal Structure of the ERK2 complexed with E71	8.286E-04	0.998	95	165	488	493	7	290	332	376	0.657	0.855
LOKIASV2_1567_ESMFold_hypothetical_protein	4qp9-assembly1.cif.gz_A	4qp9-assembly1.cif.gz_A Crystal Structure of ERK2 in complex with 7-(1-propyl-1H-pyrazol-4-yl)-2-(pyridin-4-yl)-5H-pyrrolo[2,3-b]pyrazine	9.497E-03	0.998	95	166	394	493	3	157	335	235	0.465	0.463
LOKIASV2_1567_ESMFold_hypothetical_protein	2ghm-assembly1.cif.gz_A	2ghm-assembly1.cif.gz_A Mutated MAP kinase P38 (Mus Musculus) in complex with Inhbitor PG-895449	5.612E-03	0.998	95	180	407	493	20	171	336	233	0.462	0.452
LOKIASV2_1567_ESMFold_hypothetical_protein	8ao4-assembly1.cif.gz_A	8ao4-assembly1.cif.gz_A Specific covalent inhibitor (5) of ERK2	6.523E-04	0.998	95	165	492	493	4	335	339	418	0.665	0.979
LOKIASV2_1567_ESMFold_hypothetical_protein	8x23-assembly1.cif.gz_A	8x23-assembly1.cif.gz_A The Crystal Structure of MAPK13 from Biortus.	2.739E-03	0.998	95	170	399	493	4	170	345	250	0.467	0.484
LOKIASV2_1567_ESMFold_hypothetical_protein	3elj-assembly1.cif.gz_A	3elj-assembly1.cif.gz_A Jnk1 complexed with a bis-anilino-pyrrolopyrimidine inhibitor.	6.795E-03	0.998	95	172	300	493	1	138	347	148	0.262	0.398
LOKIASV2_1567_ESMFold_hypothetical_protein	1pmv-assembly1.cif.gz_A	1pmv-assembly1.cif.gz_A The structure of JNK3 in complex with a dihydroanthrapyrazole inhibitor	4.862E-03	0.998	95	172	395	493	1	166	347	247	0.454	0.478
LOKIASV2_1567_ESMFold_hypothetical_protein	6yvs-assembly3.cif.gz_C	6yvs-assembly3.cif.gz_C FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH 5-{4-[(Pyridin-3-ylmethyl)-amino]-5-trifluoromethyl-pyrimidin-2-ylamino}-1,3-dihydro-indol-2-one	1.698E-03	0.998	94	180	358	493	9	205	254	214	0.363	0.776
LOKIASV2_1567_ESMFold_hypothetical_protein	6qho-assembly1.cif.gz_A	6qho-assembly1.cif.gz_A Dual specificity mitogen-activated protein kinase kinase 7 in complex with pyrazolopyrimidine 1a	2.489E-03	0.998	94	180	493	493	19	275	275	351	0.637	0.935
LOKIASV2_1567_ESMFold_hypothetical_protein	6ib0-assembly1.cif.gz_A	6ib0-assembly1.cif.gz_A The structure of MKK7 in complex with the covalent 4-amino-pyrazolopyrimidine 3a	1.003E-03	0.998	94	180	491	493	20	289	290	353	0.633	0.931
LOKIASV2_1567_ESMFold_hypothetical_protein	4j96-assembly3.cif.gz_A	4j96-assembly3.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659M Mutation Identified in Cervical Cancer.	7.530E-04	0.998	94	174	492	493	20	300	302	366	0.647	0.930
LOKIASV2_1567_ESMFold_hypothetical_protein	3tt0-assembly1.cif.gz_A	3tt0-assembly1.cif.gz_A Co-structure of Fibroblast Growth Factor Receptor 1 kinase domain with 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (BGJ398)	5.928E-04	0.998	94	168	482	493	11	298	305	352	0.639	0.944
LOKIASV2_1567_ESMFold_hypothetical_protein	6il3-assembly1.cif.gz_A	6il3-assembly1.cif.gz_A Crystal structure of the FLT3 kinase bound to a small molecule inhibitor	1.868E-03	0.998	94	162	482	493	26	306	310	373	0.651	0.906
LOKIASV2_1567_ESMFold_hypothetical_protein	3fe3-assembly1.cif.gz_B	3fe3-assembly1.cif.gz_B Crystal structure of the kinase MARK3/Par-1: T211A-S215A double mutant	9.963E-03	0.998	94	171	394	493	3	149	317	233	0.454	0.464
LOKIASV2_1567_ESMFold_hypothetical_protein	4n4s-assembly2.cif.gz_B	4n4s-assembly2.cif.gz_B A Double Mutant Rat Erk2 in Complex With a Pyrazolo[3,4-d]pyrimidine Inhibitor	1.471E-03	0.998	94	165	488	493	4	294	337	380	0.657	0.864
LOKIASV2_1567_ESMFold_hypothetical_protein	5tf9-assembly1.cif.gz_A	5tf9-assembly1.cif.gz_A Crystal structure of WNK1 in complex with Mn2+AMPPNP and WNK476	5.100E-03	0.998	93	185	476	493	17	259	262	326	0.592	0.927
LOKIASV2_1567_ESMFold_hypothetical_protein	5ei6-assembly1.cif.gz_A	5ei6-assembly1.cif.gz_A Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a Structure-Based Hydridization Approach	2.262E-03	0.998	93	176	487	493	1	262	264	354	0.633	0.992
LOKIASV2_1567_ESMFold_hypothetical_protein	6c1c-assembly2.cif.gz_B	6c1c-assembly2.cif.gz_B FGFR1 kinase complex with inhibitor SN37116	1.543E-03	0.998	93	171	489	493	11	262	267	356	0.647	0.944
LOKIASV2_1567_ESMFold_hypothetical_protein	4ymj-assembly2.cif.gz_B	4ymj-assembly2.cif.gz_B (R)-2-Phenylpyrrolidine Substitute Imidazopyridazines: a New Class of Potent and Selective Pan-TRK Inhibitors	2.873E-03	0.998	93	173	482	493	10	270	276	354	0.629	0.946
LOKIASV2_1567_ESMFold_hypothetical_protein	4c8b-assembly1.cif.gz_A	4c8b-assembly1.cif.gz_A Structure of the kinase domain of human RIPK2 in complex with ponatinib	1.781E-03	0.998	93	180	491	493	11	274	279	361	0.633	0.946
LOKIASV2_1567_ESMFold_hypothetical_protein	6p68-assembly2.cif.gz_B	6p68-assembly2.cif.gz_B Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to compound 22.	1.104E-03	0.998	93	174	482	493	16	281	286	347	0.627	0.930
LOKIASV2_1567_ESMFold_hypothetical_protein	2pwl-assembly1.cif.gz_B	2pwl-assembly1.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic N549H Mutation Responsible for Crouzon Syndrome.	7.899E-04	0.998	93	171	493	493	10	286	286	366	0.655	0.969
LOKIASV2_1567_ESMFold_hypothetical_protein	5o4a-assembly1.cif.gz_A	5o4a-assembly1.cif.gz_A Human FGF in complex with a covalent inhibitor	4.242E-04	0.998	93	171	482	493	10	284	290	351	0.633	0.948
LOKIASV2_1567_ESMFold_hypothetical_protein	7kie-assembly1.cif.gz_A	7kie-assembly1.cif.gz_A Crystal structure of FGFR2 kinase domain gatekeeper mutant V564F in complex with covalent compound 3	1.337E-03	0.998	93	171	482	493	5	286	291	354	0.633	0.969
LOKIASV2_1567_ESMFold_hypothetical_protein	2i0v-assembly1.cif.gz_A	2i0v-assembly1.cif.gz_A c-FMS tyrosine kinase in complex with a quinolone inhibitor	2.056E-03	0.998	93	167	487	493	31	302	303	361	0.651	0.898
LOKIASV2_1567_ESMFold_hypothetical_protein	6mob-assembly1.cif.gz_A	6mob-assembly1.cif.gz_A Crystal structure of KIT1 in complex with DP2976 via co-crystallization	5.136E-04	0.998	93	168	482	493	16	304	306	359	0.639	0.944
LOKIASV2_1567_ESMFold_hypothetical_protein	3gqi-assembly1.cif.gz_A	3gqi-assembly1.cif.gz_A Crystal Structure of activated receptor tyrosine kinase in complex with substrates	7.530E-04	0.998	93	171	489	493	10	295	307	371	0.647	0.932
LOKIASV2_1567_ESMFold_hypothetical_protein	8cgc-assembly1.cif.gz_A	8cgc-assembly1.cif.gz_A Structure of CSF1R in complex with a pyrollopyrimidine (compound 23)	1.698E-03	0.998	93	168	493	493	29	309	311	374	0.661	0.904
LOKIASV2_1567_ESMFold_hypothetical_protein	6fyv-assembly1.cif.gz_A	6fyv-assembly1.cif.gz_A X-RAY STRUCTURE OF CLK4-KD(146-480)/CX-4945 AT 2.46A	2.056E-03	0.998	93	165	486	493	2	306	329	397	0.653	0.927
LOKIASV2_1567_ESMFold_hypothetical_protein	4iza-assembly2.cif.gz_C	4iza-assembly2.cif.gz_C Structure of Dually Phosphorylated ERK2 bound to the PEA-15 Death Effector Domain	6.478E-03	0.998	93	165	396	493	3	161	335	240	0.471	0.475
LOKIASV2_1567_ESMFold_hypothetical_protein	8x5m-assembly1.cif.gz_A	8x5m-assembly1.cif.gz_A The Crystal Structure of JNK1 from Biortus.	9.054E-03	0.998	93	171	300	493	16	134	341	138	0.264	0.349
LOKIASV2_1567_ESMFold_hypothetical_protein	2xrw-assembly1.cif.gz_A	2xrw-assembly1.cif.gz_A Linear binding motifs for JNK and for calcineurin antagonistically control the nuclear shuttling of NFAT4	9.117E-04	0.998	93	180	486	493	26	286	349	348	0.623	0.748
LOKIASV2_1567_ESMFold_hypothetical_protein	4y5h-assembly1.cif.gz_A	4y5h-assembly1.cif.gz_A Pyridopyrimidinone Derivatives as Potent and Selective c-Jun N-Terminal Kinase (JNK) inhibitors	5.887E-03	0.998	93	172	307	493	1	147	349	157	0.276	0.421
LOKIASV2_1567_ESMFold_hypothetical_protein	5jrs-assembly3.cif.gz_B	5jrs-assembly3.cif.gz_B CRYSTAL STRUCTURE OF BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE COMPLEXED WITH 4-[2-FLUORO-3-(4-OXO -3,4-DIHYDROQUINAZOLIN-3-YL)PHENYL]-7-(2-HYDROXYPROPAN-2-Y L)-9H-CARBAZOLE-1-CARBOXAMIDE	3.479E-03	0.997	92	174	489	493	7	239	240	342	0.641	0.971
LOKIASV2_1567_ESMFold_hypothetical_protein	4c4i-assembly1.cif.gz_A	4c4i-assembly1.cif.gz_A Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1	2.739E-03	0.997	92	176	476	493	1	251	253	344	0.611	0.992
LOKIASV2_1567_ESMFold_hypothetical_protein	8edh-assembly1.cif.gz_A	8edh-assembly1.cif.gz_A Identification of a class of WNK isoform-specific inhibitors through high-throughput screening	5.100E-03	0.997	92	174	452	493	9	235	255	311	0.566	0.890
LOKIASV2_1567_ESMFold_hypothetical_protein	4js8-assembly1.cif.gz_A	4js8-assembly1.cif.gz_A Crystal structure of TTK kinase domain with an inhibitor: 401348	3.649E-03	0.997	92	176	485	493	2	246	261	344	0.629	0.939
LOKIASV2_1567_ESMFold_hypothetical_protein	8pm3-assembly3.cif.gz_C	8pm3-assembly3.cif.gz_C Crystal structure of MAP2K6 with a covalent compound GCL94	1.960E-03	0.997	92	169	489	493	1	271	273	363	0.651	0.993
LOKIASV2_1567_ESMFold_hypothetical_protein	3cjf-assembly1.cif.gz_A	3cjf-assembly1.cif.gz_A Crystal structure of VEGFR2 in complex with a 3,4,5-trimethoxy aniline containing pyrimidine	2.873E-03	0.997	92	171	485	493	13	280	281	360	0.639	0.954
LOKIASV2_1567_ESMFold_hypothetical_protein	5o4a-assembly2.cif.gz_B	5o4a-assembly2.cif.gz_B Human FGF in complex with a covalent inhibitor	3.675E-04	0.997	92	171	482	493	14	286	291	350	0.633	0.938
LOKIASV2_1567_ESMFold_hypothetical_protein	3lco-assembly1.cif.gz_A	3lco-assembly1.cif.gz_A Inhibitor Bound to A DFG-Out structure of the Kinase Domain of CSF-1R	3.828E-03	0.997	92	168	486	493	17	292	293	365	0.647	0.942
LOKIASV2_1567_ESMFold_hypothetical_protein	4tyg-assembly1.cif.gz_A	4tyg-assembly1.cif.gz_A Structural analysis of the human Fibroblast Growth Factor Receptor 4 Kinase	3.855E-04	0.997	92	171	485	493	20	292	293	351	0.639	0.932
LOKIASV2_1567_ESMFold_hypothetical_protein	7zy6-assembly1.cif.gz_A	7zy6-assembly1.cif.gz_A Identification of M4205 a highly selective inhibitor of cKIT mutations for unresectable metastatic or recurrent GIST	4.419E-03	0.997	92	168	484	493	16	291	293	359	0.643	0.942
LOKIASV2_1567_ESMFold_hypothetical_protein	5vnd-assembly3.cif.gz_B	5vnd-assembly3.cif.gz_B Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to H3B-6527	9.564E-04	0.997	92	171	482	493	14	288	295	360	0.633	0.932
LOKIASV2_1567_ESMFold_hypothetical_protein	4ynz-assembly1.cif.gz_A	4ynz-assembly1.cif.gz_A Structure of the N-terminal domain of SAD	1.104E-03	0.997	92	177	486	493	12	253	313	351	0.629	0.773
LOKIASV2_1567_ESMFold_hypothetical_protein	2ogv-assembly1.cif.gz_A	2ogv-assembly1.cif.gz_A Crystal Structure of the Autoinhibited Human c-Fms Kinase Domain	1.052E-03	0.997	92	104	493	493	4	316	317	443	0.791	0.987
LOKIASV2_1567_ESMFold_hypothetical_protein	7nr9-assembly1.cif.gz_A	7nr9-assembly1.cif.gz_A Discovery of ASTX029, a clinical candidate which modulates the phosphorylation and catalytic activity of ERK1/2	1.104E-03	0.997	92	172	492	493	12	333	335	412	0.651	0.961
LOKIASV2_1567_ESMFold_hypothetical_protein	3c9w-assembly2.cif.gz_B	3c9w-assembly2.cif.gz_B Crystal Structure of ERK-2 with hypothemycin covalently bound	1.402E-03	0.997	92	165	488	493	7	295	336	379	0.657	0.860
LOKIASV2_1567_ESMFold_hypothetical_protein	5ekn-assembly1.cif.gz_A	5ekn-assembly1.cif.gz_A Crystal structure of MAPK13 complex with inhibitor	5.100E-03	0.997	92	172	392	493	5	167	336	240	0.448	0.485
LOKIASV2_1567_ESMFold_hypothetical_protein	4x21-assembly2.cif.gz_B	4x21-assembly2.cif.gz_B The MAP kinase JNK3 as target for halogen bonding	4.635E-03	0.997	92	171	393	493	14	162	336	231	0.452	0.443
LOKIASV2_1567_ESMFold_hypothetical_protein	4qp8-assembly2.cif.gz_B	4qp8-assembly2.cif.gz_B Crystal Structure of ERK2 in complex with 2-(1H-pyrazol-4-yl)-7-(pyridin-3-yl)-5H-pyrrolo[2,3-b]pyrazine	9.497E-03	0.997	92	166	394	493	3	157	337	239	0.465	0.460
LOKIASV2_1567_ESMFold_hypothetical_protein	6qa1-assembly1.cif.gz_A	6qa1-assembly1.cif.gz_A ERK2 mini-fragment binding	7.844E-03	0.997	92	165	403	493	3	168	342	245	0.485	0.485
LOKIASV2_1567_ESMFold_hypothetical_protein	6q7k-assembly1.cif.gz_A	6q7k-assembly1.cif.gz_A ERK2 mini-fragment binding	1.265E-02	0.997	92	180	403	493	18	171	346	231	0.454	0.445
LOKIASV2_1567_ESMFold_hypothetical_protein	4nif-assembly1.cif.gz_E	4nif-assembly1.cif.gz_E Heterodimeric structure of ERK2 and RSK1	1.337E-03	0.997	92	180	488	493	16	303	348	376	0.627	0.828
LOKIASV2_1567_ESMFold_hypothetical_protein	4qtd-assembly1.cif.gz_A	4qtd-assembly1.cif.gz_A Structure of human JNK1 in complex with SCH772984 and the AMPPNP-hydrolysed triphosphate revealing the second type-I binding mode	8.631E-03	0.997	92	171	300	493	17	139	355	136	0.264	0.346
LOKIASV2_1567_ESMFold_hypothetical_protein	4bi0-assembly1.cif.gz_A	4bi0-assembly1.cif.gz_A Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitor	2.489E-03	0.997	91	176	471	493	1	249	254	332	0.600	0.980
LOKIASV2_1567_ESMFold_hypothetical_protein	5ap2-assembly1.cif.gz_A	5ap2-assembly1.cif.gz_A Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.	7.477E-03	0.997	91	176	476	493	1	254	256	350	0.611	0.992
LOKIASV2_1567_ESMFold_hypothetical_protein	5n87-assembly1.cif.gz_A	5n87-assembly1.cif.gz_A TTK kinase domain in complex with NTRC 0066-0	2.373E-03	0.997	91	176	471	493	1	251	256	337	0.600	0.980
LOKIASV2_1567_ESMFold_hypothetical_protein	6h3k-assembly1.cif.gz_A	6h3k-assembly1.cif.gz_A Introduction of a methyl group curbs metabolism of pyrido[3,4-d]pyrimidine MPS1 inhibitors and enables the discovery of the Phase 1 clinical candidate BOS172722.	3.161E-03	0.997	91	176	487	493	1	255	257	342	0.633	0.992
LOKIASV2_1567_ESMFold_hypothetical_protein	5ehl-assembly1.cif.gz_A	5ehl-assembly1.cif.gz_A Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a Structure-Based Hydridization Approach	1.960E-03	0.997	91	176	487	493	2	254	258	346	0.633	0.981
LOKIASV2_1567_ESMFold_hypothetical_protein	7aay-assembly1.cif.gz_A	7aay-assembly1.cif.gz_A Crystal structure of MerTK kinase domain in complex with Merestinib	1.471E-03	0.997	91	171	482	493	15	269	273	347	0.633	0.934
LOKIASV2_1567_ESMFold_hypothetical_protein	7olv-assembly1.cif.gz_A	7olv-assembly1.cif.gz_A MerTK kinase domain with type 1.5 inhibitor containing a di-methyl, cyano pyrazole group	1.868E-03	0.997	91	171	482	493	16	269	273	345	0.633	0.930
LOKIASV2_1567_ESMFold_hypothetical_protein	4uwy-assembly2.cif.gz_B	4uwy-assembly2.cif.gz_B FGFR1 Apo structure	1.960E-03	0.997	91	171	482	493	15	269	273	351	0.633	0.934
LOKIASV2_1567_ESMFold_hypothetical_protein	2psq-assembly1.cif.gz_A	2psq-assembly1.cif.gz_A Crystal Structure of Unphosphorylated Unactivated Wild Type FGF Receptor 2 (FGFR2) Kinase Domain	1.618E-03	0.997	91	171	493	493	9	287	287	364	0.655	0.972
LOKIASV2_1567_ESMFold_hypothetical_protein	6iup-assembly1.cif.gz_A	6iup-assembly1.cif.gz_A Crystal structure of FGFR4 kinase domain in complex with compound 5	9.117E-04	0.997	91	180	482	493	16	285	288	346	0.615	0.938
LOKIASV2_1567_ESMFold_hypothetical_protein	5flf-assembly2.cif.gz_B	5flf-assembly2.cif.gz_B DISEASE LINKED MUTATION IN FGFR	6.843E-04	0.997	91	171	482	493	14	286	292	364	0.633	0.935
LOKIASV2_1567_ESMFold_hypothetical_protein	3g0f-assembly1.cif.gz_B	3g0f-assembly1.cif.gz_B KIT kinase domain mutant D816H in complex with sunitinib	3.828E-03	0.997	91	168	482	493	19	291	293	364	0.639	0.932
LOKIASV2_1567_ESMFold_hypothetical_protein	8gmc-assembly2.cif.gz_B	8gmc-assembly2.cif.gz_B CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH 5-[(4-aminopiperidin-1-yl)methyl]-N-{3-[5-(propan-2-yl)-1,3,4-thiadiazol-2-yl]phenyl}pyrrolo[2,1-f][1,2,4]triazin-4-amine	3.649E-03	0.997	91	176	479	493	7	280	294	351	0.617	0.932
LOKIASV2_1567_ESMFold_hypothetical_protein	7yc3-assembly1.cif.gz_A	7yc3-assembly1.cif.gz_A Crystal structure of FGFR4 kinase domain with 10t	7.899E-04	0.997	91	171	482	493	4	295	300	358	0.633	0.973
LOKIASV2_1567_ESMFold_hypothetical_protein	5eg3-assembly1.cif.gz_A	5eg3-assembly1.cif.gz_A Crystal Structure of the Activated FGF Receptor 2 (FGFR2) Kinase Domain in complex with the cSH2 domain of Phospholipase C gamma (PLCgamma)	1.215E-03	0.997	91	168	492	493	9	292	302	366	0.659	0.940
LOKIASV2_1567_ESMFold_hypothetical_protein	2wel-assembly1.cif.gz_A	2wel-assembly1.cif.gz_A Crystal structure of SU6656-bound calcium/calmodulin-dependent protein kinase II delta in complex with calmodulin	1.471E-03	0.997	91	174	471	493	5	262	304	348	0.604	0.849
LOKIASV2_1567_ESMFold_hypothetical_protein	4xj0-assembly2.cif.gz_B	4xj0-assembly2.cif.gz_B Crystal structure of ERK2 in complex with an inhibitor 14K	1.698E-03	0.997	91	165	492	493	3	334	338	419	0.665	0.982
LOKIASV2_1567_ESMFold_hypothetical_protein	4qny-assembly3.cif.gz_B	4qny-assembly3.cif.gz_B Crystal structure of MapK from Leishmania donovani, LDBPK_331470	1.158E-03	0.997	91	176	493	493	17	339	339	411	0.645	0.953
LOKIASV2_1567_ESMFold_hypothetical_protein	4oav-assembly1.cif.gz_D	4oav-assembly1.cif.gz_D Complete human RNase L in complex with 2-5A (5'-ppp heptamer), AMPPCP and RNA substrate.	1.698E-03	0.997	91	198	482	493	346	541	674	297	0.578	0.291
LOKIASV2_1567_ESMFold_hypothetical_protein	3cek-assembly1.cif.gz_A	3cek-assembly1.cif.gz_A Crystal structure of human dual specificity protein kinase (TTK)	2.873E-03	0.996	90	176	485	493	2	240	256	340	0.629	0.934
LOKIASV2_1567_ESMFold_hypothetical_protein	5nad-assembly1.cif.gz_A	5nad-assembly1.cif.gz_A TTK kinase domain in complex with BAY 1217389	2.739E-03	0.996	90	176	493	493	1	238	257	347	0.645	0.926
LOKIASV2_1567_ESMFold_hypothetical_protein	6jol-assembly1.cif.gz_A	6jol-assembly1.cif.gz_A Crystal structure of PDGFRA in complex with imatinib by co-crystallization	5.100E-03	0.996	90	171	483	493	6	277	279	360	0.635	0.975
LOKIASV2_1567_ESMFold_hypothetical_protein	2i0y-assembly1.cif.gz_A	2i0y-assembly1.cif.gz_A cFMS tyrosine kinase (FGF KID) in complex with an arylamide inhibitor	3.649E-03	0.996	90	165	473	493	15	287	289	360	0.627	0.945
LOKIASV2_1567_ESMFold_hypothetical_protein	8gmd-assembly1.cif.gz_A	8gmd-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH (5P)-3-({(8R)-5-[(4-aminopiperidin-1-yl)methyl]pyrrolo[2,1-f][1,2,4]triazin-4-yl}amino)-5-[2-(propan-2-yl)-2H-tetrazol-5-yl]phenol	2.739E-03	0.996	90	176	479	493	4	281	294	354	0.617	0.946
LOKIASV2_1567_ESMFold_hypothetical_protein	6itt-assembly1.cif.gz_B	6itt-assembly1.cif.gz_B Crystal structure of unactivated c-KIT in complex with compound	1.402E-03	0.996	90	168	484	493	17	295	297	359	0.643	0.939
LOKIASV2_1567_ESMFold_hypothetical_protein	7zw8-assembly1.cif.gz_A	7zw8-assembly1.cif.gz_A Identification of M4205 a highly selective inhibitor of cKIT mutations for unresectable metastatic or recurrent GIST	1.402E-03	0.996	90	168	484	493	23	299	301	369	0.643	0.920
LOKIASV2_1567_ESMFold_hypothetical_protein	4i5h-assembly1.cif.gz_A	4i5h-assembly1.cif.gz_A Crystal Structure of a Double Mutant Rat Erk2 Complexed With a Type II Quinazoline Inhibitor	9.054E-03	0.996	90	170	300	493	10	132	335	140	0.266	0.367
LOKIASV2_1567_ESMFold_hypothetical_protein	4h39-assembly1.cif.gz_A	4h39-assembly1.cif.gz_A Crystal Structure of JNK3 in Complex with JIP1 Peptide	7.899E-04	0.996	90	172	488	493	1	296	340	385	0.643	0.871
LOKIASV2_1567_ESMFold_hypothetical_protein	4s30-assembly1.cif.gz_A	4s30-assembly1.cif.gz_A ERK2 intrinsically active mutant (I84A)	1.686E-02	0.996	90	171	403	493	10	166	342	239	0.473	0.459
LOKIASV2_1567_ESMFold_hypothetical_protein	3coi-assembly1.cif.gz_A	3coi-assembly1.cif.gz_A Crystal structure of p38delta kinase	2.739E-03	0.996	90	180	399	493	26	171	344	229	0.446	0.424
LOKIASV2_1567_ESMFold_hypothetical_protein	4h36-assembly1.cif.gz_A	4h36-assembly1.cif.gz_A Crystal Structure of JNK3 in Complex with ATF2 Peptide	3.184E-04	0.996	90	172	492	493	1	349	353	435	0.651	0.989
LOKIASV2_1567_ESMFold_hypothetical_protein	5n93-assembly1.cif.gz_A	5n93-assembly1.cif.gz_A TTK kinase domain in complex with TC-Mps1-12	4.635E-03	0.996	89	176	471	493	1	255	260	338	0.600	0.981
LOKIASV2_1567_ESMFold_hypothetical_protein	6g3c-assembly2.cif.gz_B	6g3c-assembly2.cif.gz_B Crystal Structure of JAK2-V617F pseudokinase domain in complex with Compound 2	4.016E-03	0.996	89	171	481	493	5	265	268	349	0.631	0.974
LOKIASV2_1567_ESMFold_hypothetical_protein	5nud-assembly2.cif.gz_B	5nud-assembly2.cif.gz_B FIBROBLAST GROWTH FACTOR RECEPTOR 4 KINASE DOMAIN (449-753) IN COMPLEX WITH IRREVERSIBLE LIGAND CGA159527	7.899E-04	0.996	89	174	482	493	19	268	271	335	0.627	0.923
LOKIASV2_1567_ESMFold_hypothetical_protein	4fv6-assembly1.cif.gz_A	4fv6-assembly1.cif.gz_A Crystal Structure of the ERK2 complexed with E57	2.373E-03	0.996	89	180	488	493	17	290	332	359	0.627	0.825
LOKIASV2_1567_ESMFold_hypothetical_protein	4qny-assembly3.cif.gz_A-2	4qny-assembly3.cif.gz_A-2 Crystal structure of MapK from Leishmania donovani, LDBPK_331470	2.873E-03	0.996	89	176	493	493	17	333	333	409	0.645	0.952
LOKIASV2_1567_ESMFold_hypothetical_protein	4aa5-assembly1.cif.gz_A	4aa5-assembly1.cif.gz_A P38ALPHA MAP KINASE BOUND TO CMPD 33	5.350E-03	0.996	89	171	392	493	9	159	340	229	0.450	0.444
LOKIASV2_1567_ESMFold_hypothetical_protein	5ke0-assembly1.cif.gz_A	5ke0-assembly1.cif.gz_A Discovery of 1-1H-Pyrazolo 4,3-c pyridine-6-yl urea Inhibitors of Extracellular Signal Regulated Kinase ERK for the Treatment of Cancers	9.117E-04	0.996	89	170	492	493	3	336	340	418	0.655	0.982
LOKIASV2_1567_ESMFold_hypothetical_protein	6yu1-assembly1.cif.gz_a	6yu1-assembly1.cif.gz_a CLK3 bound with beta-carboline KH-CARB13 (Cpd 3)	6.795E-03	0.996	89	165	417	493	12	229	340	304	0.513	0.641
LOKIASV2_1567_ESMFold_hypothetical_protein	6g9n-assembly1.cif.gz_A	6g9n-assembly1.cif.gz_A Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2	1.052E-03	0.996	89	170	492	493	10	341	345	420	0.655	0.962
LOKIASV2_1567_ESMFold_hypothetical_protein	6dtl-assembly1.cif.gz_A	6dtl-assembly1.cif.gz_A Mitogen-activated protein kinase 6	2.489E-03	0.996	89	181	396	493	3	180	356	252	0.438	0.500
LOKIASV2_1567_ESMFold_hypothetical_protein	4c4h-assembly1.cif.gz_A	4c4h-assembly1.cif.gz_A Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1	4.212E-03	0.995	88	176	471	493	1	243	248	330	0.600	0.980
LOKIASV2_1567_ESMFold_hypothetical_protein	4riw-assembly1.cif.gz_A	4riw-assembly1.cif.gz_A Crystal structure of an EGFR/HER3 kinase domain heterodimer	1.698E-03	0.995	88	180	487	493	11	264	269	345	0.625	0.944
LOKIASV2_1567_ESMFold_hypothetical_protein	5ew3-assembly1.cif.gz_A	5ew3-assembly1.cif.gz_A Human Vascular Endothelial Growth Factor Receptor 2 (KDR) Kinase Domain in complex with AAL993	5.100E-03	0.995	88	171	485	493	9	273	274	361	0.639	0.967
LOKIASV2_1567_ESMFold_hypothetical_protein	8h75-assembly1.cif.gz_D	8h75-assembly1.cif.gz_D FGFR2 in complex with YJ001	8.228E-03	0.995	88	171	491	493	10	276	277	370	0.651	0.964
LOKIASV2_1567_ESMFold_hypothetical_protein	2hak-assembly8.cif.gz_H	2hak-assembly8.cif.gz_H Catalytic and ubiqutin-associated domains of MARK1/PAR-1	8.631E-03	0.995	88	171	422	493	3	181	277	265	0.511	0.646
LOKIASV2_1567_ESMFold_hypothetical_protein	8p7j-assembly2.cif.gz_B	8p7j-assembly2.cif.gz_B Crystal structure of MAP2K6 with a covalent compound GCL96	2.262E-03	0.995	88	180	489	493	9	277	279	352	0.629	0.964
LOKIASV2_1567_ESMFold_hypothetical_protein	4uxq-assembly1.cif.gz_A	4uxq-assembly1.cif.gz_A FGFR4 in complex with Ponatinib	9.117E-04	0.995	88	174	482	493	15	283	286	346	0.627	0.941
LOKIASV2_1567_ESMFold_hypothetical_protein	3js2-assembly2.cif.gz_B	3js2-assembly2.cif.gz_B Crystal structure of minimal kinase domain of fibroblast growth factor receptor 1 in complex with 5-(2-thienyl)nicotinic acid	1.052E-03	0.995	88	171	482	493	15	287	291	360	0.633	0.938
LOKIASV2_1567_ESMFold_hypothetical_protein	5a46-assembly2.cif.gz_B	5a46-assembly2.cif.gz_B FGFR1 in complex with dovitinib	5.928E-04	0.995	88	171	482	493	16	290	297	358	0.633	0.926
LOKIASV2_1567_ESMFold_hypothetical_protein	4e73-assembly1.cif.gz_A	4e73-assembly1.cif.gz_A Crystal structure of JNK1beta-JIP in complex with an azaquinolone inhbitor	1.274E-03	0.995	88	171	486	493	15	317	318	401	0.641	0.953
LOKIASV2_1567_ESMFold_hypothetical_protein	6pjj-assembly1.cif.gz_B	6pjj-assembly1.cif.gz_B Human PRPF4B bound to benzothiophene inhibitor 224	7.128E-03	0.995	88	164	394	493	3	161	326	241	0.469	0.488
LOKIASV2_1567_ESMFold_hypothetical_protein	4qp2-assembly2.cif.gz_B	4qp2-assembly2.cif.gz_B Crystal Structure of ERKs in complex with 5-chlorobenzo[d]oxazol-2-amine	6.795E-03	0.995	88	165	394	493	3	157	329	240	0.467	0.471
LOKIASV2_1567_ESMFold_hypothetical_protein	4ux9-assembly3.cif.gz_C	4ux9-assembly3.cif.gz_C Crystal structure of JNK1 bound to a MKK7 docking motif	3.161E-03	0.995	88	180	487	493	19	331	333	400	0.625	0.940
LOKIASV2_1567_ESMFold_hypothetical_protein	6z2v-assembly1.cif.gz_A	6z2v-assembly1.cif.gz_A CLK3 A319V mutant bound with beta-carboline KH-CARB13 (Cpd 3)	2.873E-03	0.995	88	165	489	493	13	311	339	391	0.659	0.882
LOKIASV2_1567_ESMFold_hypothetical_protein	7w5o-assembly2.cif.gz_B	7w5o-assembly2.cif.gz_B Crystal structure of ERK2 with an allosteric inhibitor	1.532E-02	0.995	88	169	396	493	6	159	345	235	0.462	0.446
LOKIASV2_1567_ESMFold_hypothetical_protein	3pze-assembly1.cif.gz_A	3pze-assembly1.cif.gz_A JNK1 in complex with inhibitor	1.003E-03	0.995	88	171	491	493	16	302	347	376	0.651	0.827
LOKIASV2_1567_ESMFold_hypothetical_protein	4z7h-assembly1.cif.gz_A	4z7h-assembly1.cif.gz_A Crystal structure of human IRE1 cytoplasmic kinase-RNase region - complex with imidazopyridine compound 3	1.392E-02	0.995	88	184	304	493	14	125	385	128	0.245	0.291
LOKIASV2_1567_ESMFold_hypothetical_protein	6n6o-assembly1.cif.gz_A	6n6o-assembly1.cif.gz_A Crystal structure of the human TTK in complex with an inhibitor	3.649E-03	0.994	87	176	493	493	2	235	254	344	0.645	0.921
LOKIASV2_1567_ESMFold_hypothetical_protein	8b9e-assembly1.cif.gz_A	8b9e-assembly1.cif.gz_A Crystal structure of JAK2 JH2-V617F in complex with Z902-A3	6.795E-03	0.994	87	172	481	493	7	270	274	351	0.629	0.964
LOKIASV2_1567_ESMFold_hypothetical_protein	6qft-assembly1.cif.gz_A	6qft-assembly1.cif.gz_A Structure of the mitogen activated kinase kinase 7 in complex with pyrazolopyrimidin 1b	6.843E-04	0.994	87	180	491	493	18	275	276	350	0.633	0.935
LOKIASV2_1567_ESMFold_hypothetical_protein	4nk9-assembly1.cif.gz_B	4nk9-assembly1.cif.gz_B Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazolaminopyrimidine 1	3.479E-03	0.994	87	171	482	493	14	275	282	358	0.633	0.929
LOKIASV2_1567_ESMFold_hypothetical_protein	4k33-assembly1.cif.gz_A	4k33-assembly1.cif.gz_A Crystal Structure of FGF Receptor 3 (FGFR3) Kinase Domain Harboring the K650E Mutation, a Gain-of-Function Mutation Responsible for Thanatophoric Dysplasia Type II and Spermatocytic Seminoma	1.274E-03	0.994	87	171	482	493	9	290	293	349	0.633	0.962
LOKIASV2_1567_ESMFold_hypothetical_protein	8gmd-assembly2.cif.gz_B	8gmd-assembly2.cif.gz_B CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH (5P)-3-({(8R)-5-[(4-aminopiperidin-1-yl)methyl]pyrrolo[2,1-f][1,2,4]triazin-4-yl}amino)-5-[2-(propan-2-yl)-2H-tetrazol-5-yl]phenol	5.612E-03	0.994	87	176	479	493	9	285	299	352	0.617	0.926
LOKIASV2_1567_ESMFold_hypothetical_protein	4uwc-assembly2.cif.gz_B	4uwc-assembly2.cif.gz_B Fibroblast growth factor receptor 1 kinase in complex with JK-P3	7.178E-04	0.994	87	171	482	493	15	295	301	360	0.633	0.934
LOKIASV2_1567_ESMFold_hypothetical_protein	4ogr-assembly3.cif.gz_I	4ogr-assembly3.cif.gz_I crystal structure of P-TEFb complex with AFF4 and Tat	2.041E-02	0.994	87	180	304	493	12	136	319	136	0.254	0.392
LOKIASV2_1567_ESMFold_hypothetical_protein	1ukh-assembly1.cif.gz_A	1ukh-assembly1.cif.gz_A Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125	1.402E-03	0.994	87	175	484	493	2	320	321	410	0.629	0.994
LOKIASV2_1567_ESMFold_hypothetical_protein	3k3i-assembly1.cif.gz_A	3k3i-assembly1.cif.gz_A p38alpha bound to novel DGF-out compound PF-00215955	9.054E-03	0.994	87	180	392	493	20	160	332	219	0.432	0.425
LOKIASV2_1567_ESMFold_hypothetical_protein	6fn5-assembly1.cif.gz_A	6fn5-assembly1.cif.gz_A Crystal structure of ERK2 in complex with an adenosine derivative	1.150E-02	0.994	87	165	403	493	4	166	336	249	0.485	0.485
LOKIASV2_1567_ESMFold_hypothetical_protein	3nnx-assembly1.cif.gz_A	3nnx-assembly1.cif.gz_A Crystal structure of phosphorylated P38 alpha in complex with DP802	5.612E-03	0.994	87	165	407	493	7	180	337	257	0.493	0.516
LOKIASV2_1567_ESMFold_hypothetical_protein	4g6o-assembly1.cif.gz_A	4g6o-assembly1.cif.gz_A Crystal Structure of the ERK2	1.769E-02	0.994	87	170	403	493	10	166	341	242	0.475	0.460
LOKIASV2_1567_ESMFold_hypothetical_protein	5ci6-assembly2.cif.gz_B	5ci6-assembly2.cif.gz_B Crystal structure of Arabidopsis thaliana MPK6	4.862E-03	0.994	87	181	395	493	3	179	350	251	0.436	0.506
LOKIASV2_1567_ESMFold_hypothetical_protein	6yty-assembly1.cif.gz_A	6yty-assembly1.cif.gz_A CLK3 A319V mutant bound with benzothiazole Tg003 (Cpd 2)	2.873E-03	0.994	87	165	485	493	20	306	353	380	0.651	0.813
LOKIASV2_1567_ESMFold_hypothetical_protein	7lv3-assembly1.cif.gz_A	7lv3-assembly1.cif.gz_A Crystal structure of human protein kinase G (PKG) R-C complex in inhibited state	1.274E-03	0.994	87	120	483	493	254	564	601	424	0.738	0.517
LOKIASV2_1567_ESMFold_hypothetical_protein	5ei2-assembly1.cif.gz_A	5ei2-assembly1.cif.gz_A Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a Structure-Based Hydridization Approach	4.635E-03	0.993	86	176	473	493	1	253	256	336	0.604	0.988
LOKIASV2_1567_ESMFold_hypothetical_protein	3wzj-assembly1.cif.gz_A	3wzj-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH 4-(6-(cyclohexylamino)-8-(((tetrahydro-2H-pyran-4-yl)methyl)amino)imidazo[1,2-b]pyridazin-3-yl)-N-cyclopropylbenzamide	2.262E-03	0.993	86	177	471	493	10	252	257	328	0.598	0.946
LOKIASV2_1567_ESMFold_hypothetical_protein	5n9s-assembly1.cif.gz_A	5n9s-assembly1.cif.gz_A TTK kinase domain in complex with BAY 1161909	4.635E-03	0.993	86	176	493	493	1	241	260	350	0.645	0.927
LOKIASV2_1567_ESMFold_hypothetical_protein	2fgi-assembly1.cif.gz_B	2fgi-assembly1.cif.gz_B CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FGF RECEPTOR 1 IN COMPLEX WITH INHIBITOR PD173074	1.003E-03	0.993	86	171	482	493	13	269	272	349	0.633	0.945
LOKIASV2_1567_ESMFold_hypothetical_protein	3rhx-assembly1.cif.gz_B	3rhx-assembly1.cif.gz_B Crystal structure of the catalytic domain of FGFR1 kinase in complex with ARQ 069	4.862E-03	0.993	86	171	482	493	13	272	275	362	0.633	0.945
LOKIASV2_1567_ESMFold_hypothetical_protein	4ux9-assembly2.cif.gz_B	4ux9-assembly2.cif.gz_B Crystal structure of JNK1 bound to a MKK7 docking motif	4.016E-03	0.993	86	180	482	493	19	325	327	390	0.615	0.939
LOKIASV2_1567_ESMFold_hypothetical_protein	3heg-assembly1.cif.gz_A	3heg-assembly1.cif.gz_A P38 in complex with Sorafenib	1.265E-02	0.993	86	180	393	493	20	161	333	225	0.434	0.426
LOKIASV2_1567_ESMFold_hypothetical_protein	4mq2-assembly2.cif.gz_B	4mq2-assembly2.cif.gz_B The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitor	4.419E-03	0.993	86	169	397	493	13	176	339	238	0.465	0.484
LOKIASV2_1567_ESMFold_hypothetical_protein	5u6i-assembly1.cif.gz_A	5u6i-assembly1.cif.gz_A Discovery of MLi-2, an Orally Available and Selective LRRK2 Inhibitor that Reduces Brain Kinase Activity	1.265E-02	0.993	86	180	403	493	8	160	339	230	0.454	0.451
LOKIASV2_1567_ESMFold_hypothetical_protein	4eym-assembly1.cif.gz_A	4eym-assembly1.cif.gz_A MAPK13 complex with inhibitor	7.128E-03	0.993	86	172	392	493	5	167	340	238	0.448	0.479
LOKIASV2_1567_ESMFold_hypothetical_protein	4zzo-assembly1.cif.gz_A	4zzo-assembly1.cif.gz_A Human ERK2 in complex with an irreversible inhibitor	1.960E-03	0.993	86	170	492	493	10	338	340	422	0.655	0.968
LOKIASV2_1567_ESMFold_hypothetical_protein	4qp1-assembly2.cif.gz_B	4qp1-assembly2.cif.gz_B Crystal structure of ERK2 in complex with N-cyclohexyl-9H-purin-6-amine	2.141E-02	0.993	86	166	394	493	4	157	343	236	0.465	0.449
LOKIASV2_1567_ESMFold_hypothetical_protein	5hbe-assembly1.cif.gz_A	5hbe-assembly1.cif.gz_A CDK8-CYCC IN COMPLEX WITH 8-[3-Chloro-5-(1-methyl-2,2-dioxo-2, 3-dihydro-1H-2l6-benzo[c]isothiazol-5-yl)-pyridin- 4-yl]-1-oxa-3,8-diaza-spiro[4.5]decan-2-one	4.388E-02	0.993	86	185	300	493	27	141	344	123	0.235	0.334
LOKIASV2_1567_ESMFold_hypothetical_protein	5r9d-assembly1.cif.gz_A	5r9d-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment S00888c in complex with MAP kinase p38-alpha	1.265E-02	0.993	86	180	393	493	20	161	344	222	0.434	0.413
LOKIASV2_1567_ESMFold_hypothetical_protein	4h3b-assembly2.cif.gz_C	4h3b-assembly2.cif.gz_C Crystal Structure of JNK3 in Complex with SAB Peptide	5.928E-04	0.993	86	172	492	493	1	347	351	429	0.651	0.989
LOKIASV2_1567_ESMFold_hypothetical_protein	3zzw-assembly1.cif.gz_A	3zzw-assembly1.cif.gz_A Crystal structure of the kinase domain of ROR2	5.100E-03	0.992	85	174	481	493	7	268	269	359	0.625	0.974
LOKIASV2_1567_ESMFold_hypothetical_protein	4ymj-assembly1.cif.gz_A	4ymj-assembly1.cif.gz_A (R)-2-Phenylpyrrolidine Substitute Imidazopyridazines: a New Class of Potent and Selective Pan-TRK Inhibitors	5.100E-03	0.992	85	172	482	493	9	268	271	353	0.631	0.959
LOKIASV2_1567_ESMFold_hypothetical_protein	5a46-assembly1.cif.gz_A	5a46-assembly1.cif.gz_A FGFR1 in complex with dovitinib	1.158E-03	0.992	85	171	482	493	10	282	289	357	0.633	0.945
LOKIASV2_1567_ESMFold_hypothetical_protein	4uwb-assembly2.cif.gz_B	4uwb-assembly2.cif.gz_B Fibroblast growth factor receptor 1 kinase in complex with JK-P5	9.564E-04	0.992	85	171	493	493	15	296	299	362	0.655	0.943
LOKIASV2_1567_ESMFold_hypothetical_protein	6gqk-assembly1.cif.gz_A	6gqk-assembly1.cif.gz_A Crystal structure of human c-KIT kinase domain in complex with AZD3229-analogue (compound 23)	9.117E-04	0.992	85	168	480	493	16	304	305	362	0.635	0.948
LOKIASV2_1567_ESMFold_hypothetical_protein	7ake-assembly1.cif.gz_A	7ake-assembly1.cif.gz_A Structure of DYRK1A in complex with compound 58	9.963E-03	0.992	85	165	397	493	3	170	333	247	0.473	0.505
LOKIASV2_1567_ESMFold_hypothetical_protein	5eko-assembly1.cif.gz_A	5eko-assembly1.cif.gz_A Crystal structure of MAPK13 complex with inhibitor	7.844E-03	0.992	85	172	400	493	5	170	341	250	0.465	0.487
LOKIASV2_1567_ESMFold_hypothetical_protein	4fv1-assembly1.cif.gz_A	4fv1-assembly1.cif.gz_A Crystal Structure of the ERK2 complexed with EK4	4.016E-03	0.992	85	165	492	493	3	340	343	424	0.665	0.985
LOKIASV2_1567_ESMFold_hypothetical_protein	4fv7-assembly1.cif.gz_A	4fv7-assembly1.cif.gz_A Crystal Structure of the ERK2 complexed with E94	2.156E-03	0.992	85	166	492	493	5	339	344	420	0.663	0.974
LOKIASV2_1567_ESMFold_hypothetical_protein	4ux9-assembly4.cif.gz_D	4ux9-assembly4.cif.gz_D Crystal structure of JNK1 bound to a MKK7 docking motif	1.327E-02	0.992	85	182	396	493	1	159	344	236	0.436	0.462
LOKIASV2_1567_ESMFold_hypothetical_protein	3g90-assembly1.cif.gz_X	3g90-assembly1.cif.gz_X JNK-3 bound to (Z)-5-fluoro-1-((6-fluoro-4H-benzo[d][1,3]dioxin-8-yl)methyl)-3-(hydroxyimino)indolin-2-one	1.532E-02	0.992	85	174	300	493	2	135	345	148	0.258	0.388
LOKIASV2_1567_ESMFold_hypothetical_protein	3r63-assembly1.cif.gz_A	3r63-assembly1.cif.gz_A Structure of ERK2 (SPE) mutant (S246E)	3.014E-03	0.992	85	166	492	493	4	340	347	422	0.663	0.971
LOKIASV2_1567_ESMFold_hypothetical_protein	5ap1-assembly1.cif.gz_A	5ap1-assembly1.cif.gz_A Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.	4.419E-03	0.991	84	176	471	493	2	266	272	346	0.600	0.974
LOKIASV2_1567_ESMFold_hypothetical_protein	8e1x-assembly1.cif.gz_A	8e1x-assembly1.cif.gz_A FGFR2 kinase domain in complex with a Pyrazolo[1,5-a]pyrimidine analog (Compound 29)	1.471E-03	0.991	84	174	482	493	13	289	290	343	0.627	0.955
LOKIASV2_1567_ESMFold_hypothetical_protein	5xgn-assembly1.cif.gz_B	5xgn-assembly1.cif.gz_B Crystal structure of EGFR 696-1022 T790M/C797S in complex with Go6976	5.100E-03	0.991	84	165	487	493	1	276	308	367	0.655	0.896
LOKIASV2_1567_ESMFold_hypothetical_protein	6khd-assembly1.cif.gz_A	6khd-assembly1.cif.gz_A Crystal structure of CLK1 in complex with CX-4945	2.156E-03	0.991	84	165	486	493	3	299	322	379	0.653	0.922
LOKIASV2_1567_ESMFold_hypothetical_protein	6qx9-assembly1.cif.gz_K	6qx9-assembly1.cif.gz_K Structure of a human fully-assembled precatalytic spliceosome (pre-B complex).	1.045E-02	0.991	84	165	394	493	2	161	322	241	0.467	0.497
LOKIASV2_1567_ESMFold_hypothetical_protein	4f7j-assembly1.cif.gz_A	4f7j-assembly1.cif.gz_A Crystal structure of human CDK8/CYCC in complex with compound 3 (1-[3-tert-butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]-3-(2-hydroxyethyl)urea)	5.846E-02	0.991	84	183	300	493	20	135	326	124	0.239	0.356
LOKIASV2_1567_ESMFold_hypothetical_protein	4iir-assembly1.cif.gz_A	4iir-assembly1.cif.gz_A Crystal Structure of AMPPNP-bound Human PRPF4B kinase domain	1.769E-02	0.991	84	187	394	493	15	167	326	227	0.422	0.469
LOKIASV2_1567_ESMFold_hypothetical_protein	3da6-assembly1.cif.gz_A	3da6-assembly1.cif.gz_A Crystal Structure of human JNK3 complexed with N-(3-methyl-4-(3-(2-(methylamino)pyrimidin-4-yl)pyridin-2-yloxy)naphthalen-1-yl)-1H-benzo[d]imidazol-2-amine	1.265E-02	0.991	84	174	300	493	2	135	328	146	0.258	0.409
LOKIASV2_1567_ESMFold_hypothetical_protein	1uki-assembly1.cif.gz_A	1uki-assembly1.cif.gz_A Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125	2.156E-03	0.991	84	173	487	493	16	326	328	401	0.639	0.948
LOKIASV2_1567_ESMFold_hypothetical_protein	8aoe-assembly1.cif.gz_A	8aoe-assembly1.cif.gz_A Specific covalent inhibitor(15) of ERK2	9.497E-03	0.991	84	165	403	493	4	159	337	244	0.485	0.463
LOKIASV2_1567_ESMFold_hypothetical_protein	6g9a-assembly1.cif.gz_A	6g9a-assembly1.cif.gz_A Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2	2.611E-03	0.991	84	166	492	493	8	338	342	418	0.663	0.968
LOKIASV2_1567_ESMFold_hypothetical_protein	2zdt-assembly1.cif.gz_A	2zdt-assembly1.cif.gz_A Crystal Structure of human JNK3 complexed with an isoquinolone inhibitor	5.100E-03	0.991	84	172	300	493	1	138	342	150	0.262	0.404
LOKIASV2_1567_ESMFold_hypothetical_protein	4s34-assembly1.cif.gz_A	4s34-assembly1.cif.gz_A ERK2 (I84A) in complex with AMP-PNP	2.489E-03	0.991	84	167	491	493	5	289	343	365	0.659	0.831
LOKIASV2_1567_ESMFold_hypothetical_protein	6yu1-assembly2.cif.gz_c	6yu1-assembly2.cif.gz_c CLK3 bound with beta-carboline KH-CARB13 (Cpd 3)	1.045E-02	0.991	84	165	417	493	22	239	350	304	0.513	0.623
LOKIASV2_1567_ESMFold_hypothetical_protein	6zr5-assembly2.cif.gz_B	6zr5-assembly2.cif.gz_B Crystal structure of JNK1 in complex with ATF2(19-58)	2.356E-02	0.991	84	180	307	493	23	148	359	138	0.260	0.351
LOKIASV2_1567_ESMFold_hypothetical_protein	6c18-assembly2.cif.gz_B	6c18-assembly2.cif.gz_B FGFR1 kinase complex with inhibitor SN37115	5.887E-03	0.990	83	171	493	493	8	255	255	354	0.655	0.973
LOKIASV2_1567_ESMFold_hypothetical_protein	5eh0-assembly1.cif.gz_A-2	5eh0-assembly1.cif.gz_A-2 Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a Structure-Based Hydridization Approach	5.350E-03	0.990	83	176	487	493	1	256	258	344	0.633	0.992
LOKIASV2_1567_ESMFold_hypothetical_protein	3wyx-assembly1.cif.gz_A	3wyx-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH 6-((3-(cyanomethoxy)-4-(1-methyl-1H-pyrazol-4-yl)phenyl)amino)-2-(cyclohexylamino)nicotinonitrile	7.477E-03	0.990	83	176	471	493	1	252	258	340	0.600	0.977
LOKIASV2_1567_ESMFold_hypothetical_protein	8edh-assembly2.cif.gz_C	8edh-assembly2.cif.gz_C Identification of a class of WNK isoform-specific inhibitors through high-throughput screening	7.844E-03	0.990	83	185	487	493	17	237	261	334	0.615	0.847
LOKIASV2_1567_ESMFold_hypothetical_protein	6yg5-assembly1.cif.gz_A	6yg5-assembly1.cif.gz_A Crystal structure of MKK7 (MAP2K7) in complex with ASC69	3.014E-03	0.990	83	183	492	493	20	259	262	337	0.629	0.916
LOKIASV2_1567_ESMFold_hypothetical_protein	3brb-assembly2.cif.gz_B	3brb-assembly2.cif.gz_B Crystal structure of catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with ADP	1.052E-03	0.990	83	171	484	493	8	268	271	353	0.637	0.963
LOKIASV2_1567_ESMFold_hypothetical_protein	8xfl-assembly2.cif.gz_B	8xfl-assembly2.cif.gz_B The Crystal Structure of MARK4 from Biortus.	1.461E-02	0.990	83	174	417	493	5	167	278	257	0.495	0.586
LOKIASV2_1567_ESMFold_hypothetical_protein	3cjg-assembly1.cif.gz_A	3cjg-assembly1.cif.gz_A Crystal structure of VEGFR2 in complex with a 3,4,5-trimethoxy aniline containing pyrimidine	3.828E-03	0.990	83	174	485	493	18	281	282	339	0.633	0.936
LOKIASV2_1567_ESMFold_hypothetical_protein	5d7a-assembly2.cif.gz_B	5d7a-assembly2.cif.gz_B Crystal structure of the kinase domain of TRAF2 and NCK-interacting protein kinase with NCB-0846	9.497E-03	0.990	83	180	493	493	15	286	286	364	0.637	0.951
LOKIASV2_1567_ESMFold_hypothetical_protein	6xvj-assembly1.cif.gz_A	6xvj-assembly1.cif.gz_A Crystal structure of the KDR (VEGFR2) kinase domain in complex with a type-II inhibitor	1.618E-03	0.990	83	174	482	493	21	302	305	349	0.627	0.925
LOKIASV2_1567_ESMFold_hypothetical_protein	6ekd-assembly1.cif.gz_A	6ekd-assembly1.cif.gz_A Crystal structure of JNK3 in complex with a pyridinylimidazole inhibitor	1.215E-03	0.990	83	174	486	493	2	281	325	362	0.635	0.862
LOKIASV2_1567_ESMFold_hypothetical_protein	8ao9-assembly1.cif.gz_A	8ao9-assembly1.cif.gz_A Specific covalent inhibitor(10) of ERK2	2.873E-03	0.990	83	170	492	493	10	335	338	411	0.655	0.964
LOKIASV2_1567_ESMFold_hypothetical_protein	4qp1-assembly1.cif.gz_A	4qp1-assembly1.cif.gz_A Crystal structure of ERK2 in complex with N-cyclohexyl-9H-purin-6-amine	3.479E-03	0.990	83	166	492	493	4	335	342	419	0.663	0.971
LOKIASV2_1567_ESMFold_hypothetical_protein	8wgf-assembly1.cif.gz_A	8wgf-assembly1.cif.gz_A The Crystal Structure of JNK3 from Biortus.	2.156E-03	0.990	83	171	487	493	1	344	345	429	0.643	0.997
LOKIASV2_1567_ESMFold_hypothetical_protein	3cgf-assembly1.cif.gz_A	3cgf-assembly1.cif.gz_A IRAK-4 Inhibitors (Part II)- A structure based assessment of imidazo[1,2 a]pyridine binding	2.262E-03	0.990	83	172	487	493	1	345	346	434	0.641	0.997
LOKIASV2_1567_ESMFold_hypothetical_protein	5u6y-assembly1.cif.gz_B	5u6y-assembly1.cif.gz_B Pseudo-atomic model of the CaMKIIa holoenzyme.	3.161E-03	0.990	83	175	481	493	2	282	459	369	0.623	0.612
LOKIASV2_1567_ESMFold_hypothetical_protein	3wzk-assembly1.cif.gz_A	3wzk-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH N-cyclopropyl-4-(8-((thiophen-2-ylmethyl)amino)imidazo[1,2-a]pyrazin-3-yl)benzamide	8.631E-03	0.988	82	176	487	493	1	256	258	349	0.633	0.992
LOKIASV2_1567_ESMFold_hypothetical_protein	6tnc-assembly1.cif.gz_A	6tnc-assembly1.cif.gz_A X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 46	5.350E-03	0.988	82	177	471	493	10	254	259	329	0.598	0.946
LOKIASV2_1567_ESMFold_hypothetical_protein	4nka-assembly1.cif.gz_B	4nka-assembly1.cif.gz_B Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazolaminopyrimidine 2	2.873E-03	0.988	82	171	482	493	16	280	287	360	0.633	0.923
LOKIASV2_1567_ESMFold_hypothetical_protein	2qu5-assembly1.cif.gz_A	2qu5-assembly1.cif.gz_A Crystal structure of the VEGFR2 kinase domain in complex with a benzimidazole inhibitor	3.828E-03	0.988	82	171	487	493	14	291	292	354	0.643	0.952
LOKIASV2_1567_ESMFold_hypothetical_protein	8gmc-assembly1.cif.gz_A	8gmc-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH 5-[(4-aminopiperidin-1-yl)methyl]-N-{3-[5-(propan-2-yl)-1,3,4-thiadiazol-2-yl]phenyl}pyrrolo[2,1-f][1,2,4]triazin-4-amine	7.128E-03	0.988	82	176	479	493	4	279	293	365	0.617	0.942
LOKIASV2_1567_ESMFold_hypothetical_protein	5x02-assembly1.cif.gz_A	5x02-assembly1.cif.gz_A Crystal structure of the FLT3 kinase domain bound to the inhibitor FF-10101	4.862E-03	0.988	82	154	482	493	21	301	305	376	0.667	0.921
LOKIASV2_1567_ESMFold_hypothetical_protein	6khf-assembly1.cif.gz_A	6khf-assembly1.cif.gz_A Crystal structure of CLK3 in complex with CX-4945	7.477E-03	0.988	82	165	482	493	5	274	327	362	0.645	0.826
LOKIASV2_1567_ESMFold_hypothetical_protein	4crl-assembly1.cif.gz_A	4crl-assembly1.cif.gz_A Crystal structure of human CDK8-Cyclin C in complex with cortistatin A	8.571E-02	0.988	82	185	300	493	29	141	339	121	0.235	0.333
LOKIASV2_1567_ESMFold_hypothetical_protein	5r90-assembly1.cif.gz_A	5r90-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N11145a in complex with MAP kinase p38-alpha	2.246E-02	0.988	82	180	393	493	21	161	342	220	0.434	0.412
LOKIASV2_1567_ESMFold_hypothetical_protein	3v6s-assembly1.cif.gz_A	3v6s-assembly1.cif.gz_A Discovery of potent and selective covalent inhibitors of JNK	2.993E-02	0.988	82	172	393	493	1	164	349	241	0.450	0.470
LOKIASV2_1567_ESMFold_hypothetical_protein	4jt3-assembly1.cif.gz_A	4jt3-assembly1.cif.gz_A Crystal Structure of TTK kinase domain with an inhibitor: 400740	6.795E-03	0.986	81	180	471	493	11	249	254	329	0.592	0.941
LOKIASV2_1567_ESMFold_hypothetical_protein	3zzw-assembly1.cif.gz_B	3zzw-assembly1.cif.gz_B Crystal structure of the kinase domain of ROR2	4.862E-03	0.986	81	174	481	493	7	264	265	360	0.625	0.974
LOKIASV2_1567_ESMFold_hypothetical_protein	5tf9-assembly2.cif.gz_B	5tf9-assembly2.cif.gz_B Crystal structure of WNK1 in complex with Mn2+AMPPNP and WNK476	1.265E-02	0.986	81	185	475	493	21	265	266	329	0.590	0.921
LOKIASV2_1567_ESMFold_hypothetical_protein	5d7a-assembly3.cif.gz_C	5d7a-assembly3.cif.gz_C Crystal structure of the kinase domain of TRAF2 and NCK-interacting protein kinase with NCB-0846	1.265E-02	0.986	81	180	488	493	13	284	286	365	0.627	0.951
LOKIASV2_1567_ESMFold_hypothetical_protein	5eak-assembly2.cif.gz_B	5eak-assembly2.cif.gz_B Optimization of Microtubule Affinity Regulating Kinase (MARK) Inhibitors with Improved Physical Properties	7.477E-03	0.986	81	174	478	493	2	199	300	317	0.619	0.660
LOKIASV2_1567_ESMFold_hypothetical_protein	7clh-assembly1.cif.gz_A	7clh-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with compound 19	9.497E-03	0.984	80	176	485	493	1	243	260	350	0.629	0.935
LOKIASV2_1567_ESMFold_hypothetical_protein	7aw2-assembly1.cif.gz_A	7aw2-assembly1.cif.gz_A MerTK kinase domain with type 1.5 inhibitor from a DNA-encoded library	5.887E-03	0.984	80	171	482	493	15	266	270	348	0.633	0.933
LOKIASV2_1567_ESMFold_hypothetical_protein	4rix-assembly2.cif.gz_C	4rix-assembly2.cif.gz_C Crystal structure of an EGFR/HER3 kinase domain heterodimer containing the cancer-associated HER3-Q790R mutation	5.100E-03	0.984	80	180	487	493	11	270	275	359	0.625	0.945
LOKIASV2_1567_ESMFold_hypothetical_protein	5ax9-assembly3.cif.gz_C	5ax9-assembly3.cif.gz_C Crystal structure of the kinase domain of human TRAF2 and NCK-interacting protein kinase in complex with compund 9	8.631E-03	0.984	80	180	488	493	14	281	282	353	0.627	0.950
LOKIASV2_1567_ESMFold_hypothetical_protein	8h75-assembly1.cif.gz_B	8h75-assembly1.cif.gz_B FGFR2 in complex with YJ001	5.350E-03	0.984	80	171	482	493	4	280	283	354	0.633	0.979
LOKIASV2_1567_ESMFold_hypothetical_protein	5cwz-assembly2.cif.gz_B	5cwz-assembly2.cif.gz_B Crystal structure of the kinase domain of human TRAF2 and NCK-interacting protein kinase	9.963E-03	0.984	80	180	486	493	15	283	284	363	0.623	0.947
LOKIASV2_1567_ESMFold_hypothetical_protein	1xo2-assembly1.cif.gz_B	1xo2-assembly1.cif.gz_B Crystal structure of a human cyclin-dependent kinase 6 complex with a flavonol inhibitor, fisetin	5.313E-02	0.984	80	181	394	493	1	152	289	230	0.434	0.526
LOKIASV2_1567_ESMFold_hypothetical_protein	7rj8-assembly1.cif.gz_A	7rj8-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 ISOFORM 1 COMPLEXED WITH LIGAND (2R)-2-AMINO-N-[3-(DIFLUOROM ETHOXY)-4-(1,3-OXAZOL-5-YL)PHENYL]-4-METHYLPENTANAMIDE	8.631E-03	0.984	80	177	479	493	6	284	297	363	0.615	0.939
LOKIASV2_1567_ESMFold_hypothetical_protein	3vid-assembly1.cif.gz_A	3vid-assembly1.cif.gz_A Crystal structure of human VEGFR2 kinase domain with Compound A.	1.868E-03	0.984	80	174	485	493	21	298	299	353	0.633	0.930
LOKIASV2_1567_ESMFold_hypothetical_protein	6hh1-assembly1.cif.gz_A	6hh1-assembly1.cif.gz_A Structure of c-Kit with allosteric inhibitor 3G8	1.618E-03	0.984	80	168	482	493	18	302	303	362	0.639	0.941
LOKIASV2_1567_ESMFold_hypothetical_protein	4fuy-assembly1.cif.gz_A	4fuy-assembly1.cif.gz_A Crystal Structure of the ERK2 complexed with EK2	3.828E-03	0.984	80	171	492	493	8	327	332	412	0.653	0.964
LOKIASV2_1567_ESMFold_hypothetical_protein	5r99-assembly1.cif.gz_A	5r99-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13619a in complex with MAP kinase p38-alpha	2.141E-02	0.984	80	180	392	493	20	160	344	221	0.432	0.410
LOKIASV2_1567_ESMFold_hypothetical_protein	5awm-assembly1.cif.gz_A	5awm-assembly1.cif.gz_A The Crystal Structure of JNK from Drosophila melanogaster Reveals an Evolutionarily Conserved Topology with that of Mammalian JNK Proteins.	2.356E-02	0.984	80	171	300	493	14	132	345	135	0.264	0.345
LOKIASV2_1567_ESMFold_hypothetical_protein	4iz5-assembly2.cif.gz_B	4iz5-assembly2.cif.gz_B Structure of the complex between ERK2 phosphomimetic mutant and PEA-15	2.373E-03	0.984	80	165	492	493	4	343	347	431	0.665	0.980
LOKIASV2_1567_ESMFold_hypothetical_protein	2wqo-assembly1.cif.gz_A	2wqo-assembly1.cif.gz_A STRUCTURE OF NEK2 BOUND TO THE AMINOPYRIDINE CCT241950	3.624E-02	0.981	79	180	300	493	6	124	242	130	0.245	0.492
LOKIASV2_1567_ESMFold_hypothetical_protein	6tnd-assembly1.cif.gz_A	6tnd-assembly1.cif.gz_A X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 79	9.497E-03	0.981	79	176	469	493	1	248	254	333	0.596	0.976
LOKIASV2_1567_ESMFold_hypothetical_protein	1vr2-assembly1.cif.gz_A	1vr2-assembly1.cif.gz_A HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (KDR) KINASE DOMAIN	2.873E-03	0.981	79	171	485	493	10	274	275	344	0.639	0.964
LOKIASV2_1567_ESMFold_hypothetical_protein	4tye-assembly1.cif.gz_A	4tye-assembly1.cif.gz_A Structural analysis of the human Fibroblast Growth Factor Receptor 4 Kinase	4.016E-03	0.981	79	171	482	493	12	286	292	349	0.633	0.942
LOKIASV2_1567_ESMFold_hypothetical_protein	3vhk-assembly1.cif.gz_A	3vhk-assembly1.cif.gz_A Crystal structure of the VEGFR2 kinase domain in complex with a back pocket binder	9.117E-04	0.981	79	174	485	493	20	296	297	352	0.633	0.933
LOKIASV2_1567_ESMFold_hypothetical_protein	8enj-assembly1.cif.gz_A	8enj-assembly1.cif.gz_A Design, synthesis, biological evaluation, and X-ray crystallography of diarylpyrazole derivatives possessing terminal arylsulfonamide moieties as anti-proliferative agents targeting c-Jun N-terminal kinase (JNK)	1.003E-03	0.981	79	172	486	493	1	331	333	423	0.639	0.994
LOKIASV2_1567_ESMFold_hypothetical_protein	6qag-assembly1.cif.gz_A	6qag-assembly1.cif.gz_A ERK2 mini-fragment binding	4.016E-03	0.981	79	165	489	493	4	337	340	422	0.659	0.982
LOKIASV2_1567_ESMFold_hypothetical_protein	6ytw-assembly1.cif.gz_A	6ytw-assembly1.cif.gz_A CLK3 bound with benzothiazole Tg003 (Cpd 2)	7.128E-03	0.981	79	176	493	493	31	324	349	387	0.645	0.842
LOKIASV2_1567_ESMFold_hypothetical_protein	4qrc-assembly1.cif.gz_A	4qrc-assembly1.cif.gz_A Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 4 in Complex with Ponatinib	4.419E-03	0.978	78	171	482	493	3	294	297	357	0.633	0.983
LOKIASV2_1567_ESMFold_hypothetical_protein	3vnt-assembly1.cif.gz_A	3vnt-assembly1.cif.gz_A Crystal Structure of the Kinase domain of Human VEGFR2 with a [1,3]thiazolo[5,4-b]pyridine derivative	1.618E-03	0.978	78	171	485	493	19	300	301	370	0.639	0.937
LOKIASV2_1567_ESMFold_hypothetical_protein	5kz8-assembly1.cif.gz_A	5kz8-assembly1.cif.gz_A Mark2 complex with 7-[(1S)-1-(4-fluorophenyl)ethyl]-5,5-dimethyl-2-(3-pyridylamino)pyrrolo[2,3-d]pyrimidin-6-one	8.228E-03	0.978	78	171	486	493	2	224	302	345	0.641	0.738
LOKIASV2_1567_ESMFold_hypothetical_protein	6pjj-assembly1.cif.gz_C	6pjj-assembly1.cif.gz_C Human PRPF4B bound to benzothiophene inhibitor 224	1.946E-02	0.978	78	187	394	493	10	162	326	227	0.422	0.469
LOKIASV2_1567_ESMFold_hypothetical_protein	4iir-assembly2.cif.gz_B	4iir-assembly2.cif.gz_B Crystal Structure of AMPPNP-bound Human PRPF4B kinase domain	8.631E-03	0.978	78	164	394	493	7	164	328	242	0.469	0.482
LOKIASV2_1567_ESMFold_hypothetical_protein	2b1p-assembly1.cif.gz_A	2b1p-assembly1.cif.gz_A inhibitor complex of JNK3	5.100E-03	0.978	78	180	487	493	19	330	331	399	0.625	0.943
LOKIASV2_1567_ESMFold_hypothetical_protein	6emh-assembly3.cif.gz_C	6emh-assembly3.cif.gz_C Crystal structure of JNK3 in complex with a pyridinylimidazole inhibitor	4.388E-02	0.978	78	171	393	493	15	158	334	231	0.452	0.431
LOKIASV2_1567_ESMFold_hypothetical_protein	6a32-assembly1.cif.gz_A	6a32-assembly1.cif.gz_A Crystal structure of PDGFRA kinase domain mutant T674I	1.698E-03	0.978	78	167	481	493	32	316	336	360	0.639	0.848
LOKIASV2_1567_ESMFold_hypothetical_protein	6rfp-assembly1.cif.gz_A	6rfp-assembly1.cif.gz_A ERK2 MAP kinase with mutations at Helix-G	4.388E-02	0.978	78	182	403	493	15	162	337	227	0.450	0.439
LOKIASV2_1567_ESMFold_hypothetical_protein	3v6s-assembly2.cif.gz_B	3v6s-assembly2.cif.gz_B Discovery of potent and selective covalent inhibitors of JNK	3.161E-03	0.978	78	172	488	493	1	340	341	424	0.643	0.997
LOKIASV2_1567_ESMFold_hypothetical_protein	5o21-assembly2.cif.gz_B	5o21-assembly2.cif.gz_B Crystal structure of WNK3 kinase domain in a monophosphorylated state with chloride bound in the active site	1.265E-02	0.975	77	185	490	493	18	252	274	341	0.621	0.858
LOKIASV2_1567_ESMFold_hypothetical_protein	7sj3-assembly1.cif.gz_A	7sj3-assembly1.cif.gz_A Structure of CDK4-Cyclin D3 bound to abemaciclib	6.433E-02	0.975	77	175	394	493	3	145	274	228	0.446	0.522
LOKIASV2_1567_ESMFold_hypothetical_protein	7lvi-assembly1.cif.gz_A	7lvi-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 ISOFORM 1 COMPLEXED WITH LIGAND (2R)-2-AMINO-N-[3-METHOXY-4- (1,3-OXAZOL-5-YL)PHENYL]-4-METHYLPENTANAMIDE	1.150E-02	0.975	77	176	479	493	4	280	294	362	0.617	0.942
LOKIASV2_1567_ESMFold_hypothetical_protein	2oh4-assembly1.cif.gz_A	2oh4-assembly1.cif.gz_A Crystal structure of Vegfr2 with a benzimidazole-urea inhibitor	3.161E-03	0.975	77	171	485	493	14	295	299	360	0.639	0.943
LOKIASV2_1567_ESMFold_hypothetical_protein	5kz8-assembly2.cif.gz_B	5kz8-assembly2.cif.gz_B Mark2 complex with 7-[(1S)-1-(4-fluorophenyl)ethyl]-5,5-dimethyl-2-(3-pyridylamino)pyrrolo[2,3-d]pyrimidin-6-one	6.795E-03	0.975	77	171	486	493	2	222	300	345	0.641	0.737
LOKIASV2_1567_ESMFold_hypothetical_protein	6itt-assembly1.cif.gz_A	6itt-assembly1.cif.gz_A Crystal structure of unactivated c-KIT in complex with compound	3.161E-03	0.975	77	168	493	493	20	301	301	373	0.661	0.937
LOKIASV2_1567_ESMFold_hypothetical_protein	7n91-assembly2.cif.gz_B	7n91-assembly2.cif.gz_B P70 S6K1 IN COMPLEX WITH MSC2317067A-1	1.327E-02	0.975	77	169	483	493	1	268	313	354	0.639	0.856
LOKIASV2_1567_ESMFold_hypothetical_protein	6dcg-assembly1.cif.gz_A	6dcg-assembly1.cif.gz_A Discovery of MK-8353: An Orally Bioavailable Dual Mechanism ERK Inhibitor for Oncology	1.150E-02	0.975	77	180	489	493	8	324	326	403	0.629	0.972
LOKIASV2_1567_ESMFold_hypothetical_protein	4f70-assembly1.cif.gz_A	4f70-assembly1.cif.gz_A Crystal structure of human CDK8/CYCC in complex with compound 4 (1-[3-tert-butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]-3-[2-(morpholin-4-yl)ethyl]urea)	1.198E-01	0.975	77	185	300	493	27	139	327	121	0.235	0.346
LOKIASV2_1567_ESMFold_hypothetical_protein	3oy1-assembly1.cif.gz_A	3oy1-assembly1.cif.gz_A Highly Selective c-Jun N-Terminal Kinase (JNK) 2 and 3 Inhibitors with In Vitro CNS-like Pharmacokinetic Properties	2.739E-03	0.975	77	171	487	493	15	328	329	412	0.643	0.954
LOKIASV2_1567_ESMFold_hypothetical_protein	2exc-assembly1.cif.gz_X	2exc-assembly1.cif.gz_X Inhibitor complex of JNK3	2.356E-02	0.975	77	172	300	493	1	135	335	150	0.262	0.403
LOKIASV2_1567_ESMFold_hypothetical_protein	2xs0-assembly1.cif.gz_A	2xs0-assembly1.cif.gz_A Linear binding motifs for JNK and for calcineurin antagonistically control the nuclear shuttling of NFAT4	4.635E-03	0.975	77	171	487	493	17	242	346	339	0.643	0.653
LOKIASV2_1567_ESMFold_hypothetical_protein	6gl3-assembly1.cif.gz_A	6gl3-assembly1.cif.gz_A Crystal structure of human Phosphatidylinositol 4-kinase III beta (PI4KIIIbeta) in complex with ligand 44	9.564E-04	0.975	77	130	491	493	19	351	354	432	0.734	0.941
LOKIASV2_1567_ESMFold_hypothetical_protein	5i4n-assembly1.cif.gz_A	5i4n-assembly1.cif.gz_A Crystal Structure of the E596A V617F Mutant JAK2 Pseudokinase Domain Bound to Mg-ATP	2.873E-03	0.971	76	172	483	493	6	274	275	351	0.633	0.978
LOKIASV2_1567_ESMFold_hypothetical_protein	3b2t-assembly1.cif.gz_B	3b2t-assembly1.cif.gz_B Structure of phosphotransferase	4.635E-03	0.971	76	171	491	493	20	286	287	365	0.651	0.930
LOKIASV2_1567_ESMFold_hypothetical_protein	3k3j-assembly1.cif.gz_A	3k3j-assembly1.cif.gz_A P38alpha bound to novel DFG-out compound PF-00416121	1.686E-02	0.971	76	180	393	493	20	159	329	224	0.434	0.426
LOKIASV2_1567_ESMFold_hypothetical_protein	2ok1-assembly1.cif.gz_A	2ok1-assembly1.cif.gz_A Crystal structure of JNK3 bound to N-benzyl-4-(4-(3-chlorophenyl)-1H-pyrazol-3-yl)-1H-pyrrole-2-carboxamide	3.140E-02	0.971	76	174	300	493	2	135	333	148	0.258	0.402
LOKIASV2_1567_ESMFold_hypothetical_protein	6qal-assembly1.cif.gz_A	6qal-assembly1.cif.gz_A ERK2 mini-fragment binding	5.612E-03	0.971	76	166	492	493	5	332	336	417	0.663	0.976
LOKIASV2_1567_ESMFold_hypothetical_protein	4gsb-assembly1.cif.gz_A	4gsb-assembly1.cif.gz_A Monoclinic crystal form of the apo-ERK2	6.176E-03	0.971	76	171	489	493	11	341	345	419	0.647	0.959
LOKIASV2_1567_ESMFold_hypothetical_protein	5hd7-assembly1.cif.gz_A	5hd7-assembly1.cif.gz_A Dissecting Therapeutic Resistance to ERK Inhibition Rat Mutant SCH772984 in complex with (3R)-1-(2-oxo-2-{4-[4-(pyrimidin-2-yl)phenyl]piperazin-1-yl}ethyl)-N-[3-(pyridin-4-yl)-2H-indazol-5-yl]pyrrolidine-3-carboxamide	7.128E-03	0.971	76	165	492	493	2	343	347	427	0.665	0.986
LOKIASV2_1567_ESMFold_hypothetical_protein	5o2c-assembly1.cif.gz_A	5o2c-assembly1.cif.gz_A Crystal structure of WNK3 kinase and CCT1 didomain in a unphosphorylated state	5.887E-03	0.971	76	185	490	493	24	258	368	348	0.621	0.639
LOKIASV2_1567_ESMFold_hypothetical_protein	1zyc-assembly2.cif.gz_D	1zyc-assembly2.cif.gz_D Crystal Structure of eIF2alpha Protein Kinase GCN2: Wild-Type in Apo Form.	2.472E-02	0.967	75	174	491	493	7	239	256	332	0.645	0.910
LOKIASV2_1567_ESMFold_hypothetical_protein	2w5h-assembly1.cif.gz_A	2w5h-assembly1.cif.gz_A Human Nek2 kinase Apo	7.844E-03	0.967	75	180	486	493	6	238	265	341	0.623	0.879
LOKIASV2_1567_ESMFold_hypothetical_protein	7qhg-assembly1.cif.gz_A	7qhg-assembly1.cif.gz_A LIM domain kinase 2 (LIMK2) in complex with TH-470	2.720E-02	0.967	75	178	485	493	1	281	283	366	0.625	0.993
LOKIASV2_1567_ESMFold_hypothetical_protein	4f0i-assembly2.cif.gz_B	4f0i-assembly2.cif.gz_B Crystal structure of apo TrkA	3.316E-03	0.967	75	172	482	493	7	285	294	362	0.631	0.949
LOKIASV2_1567_ESMFold_hypothetical_protein	3wze-assembly1.cif.gz_A	3wze-assembly1.cif.gz_A KDR in complex with ligand sorafenib	3.316E-03	0.967	75	174	482	493	19	295	298	350	0.627	0.930
LOKIASV2_1567_ESMFold_hypothetical_protein	3vhe-assembly1.cif.gz_A	3vhe-assembly1.cif.gz_A Crystal structure of human VEGFR2 kinase domain with a novel pyrrolopyrimidine inhibitor.	2.739E-03	0.967	75	174	485	493	23	301	303	352	0.633	0.921
LOKIASV2_1567_ESMFold_hypothetical_protein	3vo3-assembly1.cif.gz_A	3vo3-assembly1.cif.gz_A Crystal Structure of the Kinase domain of Human VEGFR2 with imidazo[1,2-b]pyridazine derivative	2.611E-03	0.967	75	174	485	493	22	302	303	363	0.633	0.927
LOKIASV2_1567_ESMFold_hypothetical_protein	7ksk-assembly1.cif.gz_A	7ksk-assembly1.cif.gz_A Thiophenyl-Pyrazolourea Derivatives as Potent, Brian Penetrant, Orally Bioavailable, and Isoform-Selective JNK3 Inhibitors	7.844E-03	0.967	75	172	486	493	1	332	334	423	0.639	0.994
LOKIASV2_1567_ESMFold_hypothetical_protein	6joj-assembly1.cif.gz_A	6joj-assembly1.cif.gz_A Crystal structure of PDGFRA T674I in complex with crenolanib by soaking	1.698E-03	0.967	75	171	492	493	35	329	338	371	0.653	0.873
LOKIASV2_1567_ESMFold_hypothetical_protein	3g9n-assembly1.cif.gz_A	3g9n-assembly1.cif.gz_A JNK3 bound to (Z)-1-((6-fluoro-4H-benzo[d][1,3]dioxin-8-yl)methyl)-3-(hydroxyimino)-4-phenylindolin-2-one	3.801E-02	0.967	75	172	393	493	1	163	346	243	0.450	0.471
LOKIASV2_1567_ESMFold_hypothetical_protein	7mp8-assembly1.cif.gz_A-2	7mp8-assembly1.cif.gz_A-2 Crystal structure of the cytosolic domain of Tribolium castaneum PINK1 in the non-phosphorylated state	3.161E-03	0.967	75	129	490	493	1	377	399	461	0.734	0.945
LOKIASV2_1567_ESMFold_hypothetical_protein	2pk9-assembly3.cif.gz_C	2pk9-assembly3.cif.gz_C Structure of the Pho85-Pho80 CDK-cyclin Complex of the Phosphate-responsive Signal Transduction Pathway	1.257E-01	0.961	74	214	396	493	15	121	266	185	0.371	0.402
LOKIASV2_1567_ESMFold_hypothetical_protein	3b8r-assembly1.cif.gz_A	3b8r-assembly1.cif.gz_A Crystal structure of the VEGFR2 kinase domain in complex with a naphthamide inhibitor	7.128E-03	0.961	74	171	492	493	12	285	289	357	0.653	0.948
LOKIASV2_1567_ESMFold_hypothetical_protein	2i1m-assembly1.cif.gz_A	2i1m-assembly1.cif.gz_A cFMS tyrosine kinase (tie2 KID) in complex with an arylamide inhibitor	5.887E-03	0.961	74	165	493	493	24	311	311	369	0.667	0.926
LOKIASV2_1567_ESMFold_hypothetical_protein	6pjj-assembly1.cif.gz_D	6pjj-assembly1.cif.gz_D Human PRPF4B bound to benzothiophene inhibitor 224	2.041E-02	0.961	74	187	394	493	6	156	317	223	0.422	0.476
LOKIASV2_1567_ESMFold_hypothetical_protein	4dlj-assembly1.cif.gz_A	4dlj-assembly1.cif.gz_A Human p38 MAP kinase in complex with RL163	7.477E-03	0.961	74	180	486	493	21	327	336	395	0.623	0.914
LOKIASV2_1567_ESMFold_hypothetical_protein	7pvu-assembly2.cif.gz_B	7pvu-assembly2.cif.gz_B Crystal structure of p38alpha C162S in complex with CAS2094511-69-8, P 1 21 1	5.612E-03	0.961	74	180	486	493	20	328	336	398	0.623	0.920
LOKIASV2_1567_ESMFold_hypothetical_protein	6jok-assembly1.cif.gz_A	6jok-assembly1.cif.gz_A Crystal structure of PDGFRA in complex with sunitinib by soaking	1.960E-03	0.961	74	171	492	493	33	329	338	361	0.653	0.879
LOKIASV2_1567_ESMFold_hypothetical_protein	4qp6-assembly1.cif.gz_A	4qp6-assembly1.cif.gz_A Crystal Structure of ERK2 in complex with 5H-pyrrolo[2,3-b]pyrazine	9.963E-03	0.961	74	170	488	493	9	294	339	378	0.647	0.844
LOKIASV2_1567_ESMFold_hypothetical_protein	6sgi-assembly1.cif.gz_A	6sgi-assembly1.cif.gz_A Nek2 kinase bound to inhibitor 96	1.265E-02	0.956	73	174	486	493	5	225	252	347	0.635	0.877
LOKIASV2_1567_ESMFold_hypothetical_protein	4yr8-assembly3.cif.gz_C	4yr8-assembly3.cif.gz_C Crystal structure of JNK in complex with a regulator protein	6.133E-02	0.956	73	171	300	493	10	127	318	138	0.264	0.371
LOKIASV2_1567_ESMFold_hypothetical_protein	5ax3-assembly1.cif.gz_A	5ax3-assembly1.cif.gz_A Crystal structure of ERK2 complexed with allosteric and ATP-competitive inhibitors.	4.828E-02	0.956	73	166	396	493	6	160	329	238	0.469	0.471
LOKIASV2_1567_ESMFold_hypothetical_protein	6emh-assembly2.cif.gz_B	6emh-assembly2.cif.gz_B Crystal structure of JNK3 in complex with a pyridinylimidazole inhibitor	7.079E-02	0.956	73	180	393	493	19	157	344	222	0.434	0.404
LOKIASV2_1567_ESMFold_hypothetical_protein	6zr5-assembly1.cif.gz_A	6zr5-assembly1.cif.gz_A Crystal structure of JNK1 in complex with ATF2(19-58)	5.887E-03	0.956	73	180	486	493	24	288	348	357	0.623	0.761
LOKIASV2_1567_ESMFold_hypothetical_protein	5oat-assembly1.cif.gz_D	5oat-assembly1.cif.gz_D PINK1 structure	2.853E-02	0.956	73	170	300	493	2	145	360	160	0.266	0.400
LOKIASV2_1567_ESMFold_hypothetical_protein	7mp9-assembly1.cif.gz_A-2	7mp9-assembly1.cif.gz_A-2 Crystal structure of the cytosolic domain of Tribolium castaneum PINK1 phosphorylated at Ser205 in complex with ADP analog	1.461E-02	0.956	73	129	300	493	1	180	414	195	0.349	0.435
LOKIASV2_1567_ESMFold_hypothetical_protein	6yg4-assembly1.cif.gz_A	6yg4-assembly1.cif.gz_A Crystal structure of MKK7 (MAP2K7) in complex with K00007	3.014E-03	0.949	72	183	493	493	18	260	260	339	0.631	0.935
LOKIASV2_1567_ESMFold_hypothetical_protein	7uos-assembly1.cif.gz_A	7uos-assembly1.cif.gz_A Structure of WNK1 inhibitor complex	3.988E-02	0.949	72	174	300	493	9	130	271	135	0.258	0.450
LOKIASV2_1567_ESMFold_hypothetical_protein	7ovl-assembly1.cif.gz_A	7ovl-assembly1.cif.gz_A Protein kinase MKK7 in complex with methoxycyclohexyl-substituted indazole	9.497E-03	0.949	72	183	493	493	19	278	279	357	0.631	0.932
LOKIASV2_1567_ESMFold_hypothetical_protein	4tpt-assembly1.cif.gz_A	4tpt-assembly1.cif.gz_A Crystal Structure of the Human LIMK2 Kinase Domain In Complex With a Non-ATP Competitive Inhibitor	3.293E-02	0.949	72	181	482	493	14	253	279	347	0.613	0.860
LOKIASV2_1567_ESMFold_hypothetical_protein	6d22-assembly1.cif.gz_A	6d22-assembly1.cif.gz_A Crystal structure of Tyrosine-protein kinase receptor	3.316E-03	0.949	72	170	482	493	10	290	299	362	0.635	0.940
LOKIASV2_1567_ESMFold_hypothetical_protein	3u6j-assembly1.cif.gz_A	3u6j-assembly1.cif.gz_A Crystal structure of the VEGFR2 kinase domain in complex with a pyrazolone inhibitor	2.056E-03	0.949	72	171	488	493	15	304	308	365	0.645	0.942
LOKIASV2_1567_ESMFold_hypothetical_protein	6sgh-assembly1.cif.gz_A	6sgh-assembly1.cif.gz_A Nek2 kinase covalently bound to 2-arylamino-6-ethynylpurine inhibitor 66	1.946E-02	0.941	71	183	325	493	6	158	238	168	0.290	0.643
LOKIASV2_1567_ESMFold_hypothetical_protein	6vg3-assembly3.cif.gz_C	6vg3-assembly3.cif.gz_C Structure of unliganded, inactive PTK7 kinase domain	2.593E-02	0.941	71	171	487	493	4	264	265	362	0.643	0.985
LOKIASV2_1567_ESMFold_hypothetical_protein	4yr8-assembly1.cif.gz_E	4yr8-assembly1.cif.gz_E Crystal structure of JNK in complex with a regulator protein	6.133E-02	0.941	71	180	307	493	20	142	317	137	0.260	0.388
LOKIASV2_1567_ESMFold_hypothetical_protein	8aob-assembly1.cif.gz_A	8aob-assembly1.cif.gz_A Specific covalent inhibitor(12) of ERK2	9.432E-02	0.941	71	200	403	493	15	152	321	210	0.414	0.430
LOKIASV2_1567_ESMFold_hypothetical_protein	4hvs-assembly1.cif.gz_A	4hvs-assembly1.cif.gz_A Crystal structure of KIT kinase domain with a small molecule inhibitor, PLX647	5.100E-03	0.941	71	168	480	493	35	325	326	359	0.635	0.893
LOKIASV2_1567_ESMFold_hypothetical_protein	6fxv-assembly1.cif.gz_A	6fxv-assembly1.cif.gz_A Crystal structure of ERK2 in complex with an adenosine derivative	1.946E-02	0.941	71	171	492	493	9	334	337	417	0.653	0.967
LOKIASV2_1567_ESMFold_hypothetical_protein	1pmu-assembly1.cif.gz_A	1pmu-assembly1.cif.gz_A The crystal structure of JNK3 in complex with a phenantroline inhibitor	3.455E-02	0.941	71	172	393	493	1	164	342	243	0.450	0.480
LOKIASV2_1567_ESMFold_hypothetical_protein	8q6h-assembly1.cif.gz_A	8q6h-assembly1.cif.gz_A HUMAN PI4KIIIB IN COMPLEX WITH COVALENTLY BOUND INHIBITOR (COMPOUND 11)	8.286E-04	0.941	71	135	491	493	29	363	385	435	0.724	0.870
LOKIASV2_1567_ESMFold_hypothetical_protein	1zxe-assembly1.cif.gz_B	1zxe-assembly1.cif.gz_B Crystal Structure of eIF2alpha Protein Kinase GCN2: D835N Inactivating Mutant in Apo Form	7.789E-02	0.933	70	180	481	493	8	203	252	311	0.613	0.778
LOKIASV2_1567_ESMFold_hypothetical_protein	6qg4-assembly1.cif.gz_A	6qg4-assembly1.cif.gz_A Structure of the mitogen activated kinase kinase 7 in complex with pyrazolopyrimidine inhibitor 1h	2.873E-03	0.933	70	183	491	493	18	270	272	342	0.627	0.930
LOKIASV2_1567_ESMFold_hypothetical_protein	6rfo-assembly1.cif.gz_A	6rfo-assembly1.cif.gz_A ERK2 MAP kinase with the activation loop of p38alpha	1.686E-02	0.933	70	165	489	493	1	313	316	408	0.659	0.991
LOKIASV2_1567_ESMFold_hypothetical_protein	3rtp-assembly1.cif.gz_A	3rtp-assembly1.cif.gz_A Design and synthesis of brain penetrant selective JNK inhibitors with improved pharmacokinetic properties for the prevention of neurodegeneration	1.206E-02	0.933	70	174	488	493	2	293	331	382	0.639	0.882
LOKIASV2_1567_ESMFold_hypothetical_protein	3fl4-assembly1.cif.gz_A	3fl4-assembly1.cif.gz_A P38 kinase crystal structure in complex with RO5634	4.183E-02	0.933	70	180	393	493	21	160	339	222	0.434	0.413
LOKIASV2_1567_ESMFold_hypothetical_protein	5hnb-assembly1.cif.gz_A	5hnb-assembly1.cif.gz_A CDK8-CYCC IN COMPLEX WITH [6-Hydroxy-3-(3-methyl-benzyl)-1H-indazol-5-yl]-((S)-3-hydroxy-pyrrolidin-1-yl)-methanone	5.573E-02	0.933	70	128	300	493	1	141	342	180	0.351	0.412
LOKIASV2_1567_ESMFold_hypothetical_protein	3oz6-assembly1.cif.gz_A	3oz6-assembly1.cif.gz_A Crystal structure of MapK from Cryptosporidium Parvum, cgd2_1960	1.946E-02	0.933	70	198	489	493	15	263	343	337	0.592	0.726
LOKIASV2_1567_ESMFold_hypothetical_protein	5ew3-assembly2.cif.gz_B	5ew3-assembly2.cif.gz_B Human Vascular Endothelial Growth Factor Receptor 2 (KDR) Kinase Domain in complex with AAL993	9.497E-03	0.923	69	171	482	493	10	265	266	343	0.633	0.962
LOKIASV2_1567_ESMFold_hypothetical_protein	5di1-assembly1.cif.gz_A	5di1-assembly1.cif.gz_A MAP4K4 in complex with an inhibitor	3.624E-02	0.923	69	180	488	493	13	284	285	369	0.627	0.954
LOKIASV2_1567_ESMFold_hypothetical_protein	5uv4-assembly1.cif.gz_A	5uv4-assembly1.cif.gz_A Crystal Structure of Maize SIRK1 (sucrose-induced receptor kinase 1) kinase domain bound to AMP-PNP	5.065E-02	0.923	69	182	481	493	20	288	290	360	0.609	0.928
LOKIASV2_1567_ESMFold_hypothetical_protein	8j5w-assembly1.cif.gz_A	8j5w-assembly1.cif.gz_A The crystal structure of TrkA(F589L) kinase in complex with N-(3-cyclopropyl-5-((4-methylpiperazin-1-yl)methyl)phenyl)-4^6-methyl-14-oxo-5-oxa-13-aza-1(3,6)-imidazo[1,2-b]pyridazina-4(1,3)-benzenacyclotetradecaphan-2-yne-4^5-carboxamide	3.649E-03	0.923	69	172	487	493	14	296	298	367	0.641	0.950
LOKIASV2_1567_ESMFold_hypothetical_protein	3zsi-assembly1.cif.gz_A	3zsi-assembly1.cif.gz_A X-ray structure of p38alpha bound to VX-745	9.054E-03	0.923	69	171	486	493	15	319	326	398	0.641	0.936
LOKIASV2_1567_ESMFold_hypothetical_protein	4fv4-assembly1.cif.gz_A	4fv4-assembly1.cif.gz_A Crystal Structure of the ERK2 complexed with EK7	9.963E-03	0.923	69	180	489	493	17	280	330	373	0.629	0.800
LOKIASV2_1567_ESMFold_hypothetical_protein	4z7h-assembly2.cif.gz_B	4z7h-assembly2.cif.gz_B Crystal structure of human IRE1 cytoplasmic kinase-RNase region - complex with imidazopyridine compound 3	3.801E-02	0.923	69	176	467	493	1	245	388	343	0.592	0.631
LOKIASV2_1567_ESMFold_hypothetical_protein	4u42-assembly2.cif.gz_A	4u42-assembly2.cif.gz_A MAP4K4 T181E Mutant Bound to inhibitor compound 1	3.988E-02	0.912	68	180	488	493	10	280	282	366	0.627	0.961
LOKIASV2_1567_ESMFold_hypothetical_protein	5y90-assembly1.cif.gz_A	5y90-assembly1.cif.gz_A MAP2K7 mutant -C218S	6.478E-03	0.912	68	180	492	493	18	287	304	349	0.635	0.888
LOKIASV2_1567_ESMFold_hypothetical_protein	6pjj-assembly1.cif.gz_A	6pjj-assembly1.cif.gz_A Human PRPF4B bound to benzothiophene inhibitor 224	4.388E-02	0.912	68	164	394	493	3	157	321	242	0.469	0.483
LOKIASV2_1567_ESMFold_hypothetical_protein	1t45-assembly1.cif.gz_A	1t45-assembly1.cif.gz_A STRUCTURAL BASIS FOR THE AUTOINHIBITION AND STI-571 INHIBITION OF C-KIT TYROSINE KINASE	3.014E-03	0.912	68	168	488	493	36	330	331	367	0.651	0.891
LOKIASV2_1567_ESMFold_hypothetical_protein	4z9l-assembly1.cif.gz_A	4z9l-assembly1.cif.gz_A THE STRUCTURE OF JNK3 IN COMPLEX WITH AN IMIDAZOLE-PYRIMIDINE INHIBITOR	1.215E-03	0.912	68	172	487	493	1	332	333	396	0.641	0.997
LOKIASV2_1567_ESMFold_hypothetical_protein	4qpa-assembly2.cif.gz_B	4qpa-assembly2.cif.gz_B Crystal Structure of ERK2 in complex with 7-(1-benzyl-1H-pyrazol-4-yl)-2-(pyridin-4-yl)-5H-pyrrolo[2,3-b]pyrazine	2.853E-02	0.912	68	180	488	493	14	301	345	377	0.627	0.835
LOKIASV2_1567_ESMFold_hypothetical_protein	7ovn-assembly1.cif.gz_A	7ovn-assembly1.cif.gz_A Protein kinase MKK7 in complex with tolyl-substituted indazole	1.265E-02	0.900	67	180	493	493	19	282	283	350	0.637	0.933
LOKIASV2_1567_ESMFold_hypothetical_protein	4u43-assembly2.cif.gz_A	4u43-assembly2.cif.gz_A MAP4K4 in complex with inhibitor (compound 6)	1.769E-02	0.900	67	180	488	493	12	284	287	366	0.627	0.951
LOKIASV2_1567_ESMFold_hypothetical_protein	3c7q-assembly1.cif.gz_A	3c7q-assembly1.cif.gz_A Structure of VEGFR2 kinase domain in complex with BIBF1120	1.045E-02	0.900	67	174	485	493	15	287	291	363	0.633	0.938
LOKIASV2_1567_ESMFold_hypothetical_protein	4kkh-assembly1.cif.gz_A	4kkh-assembly1.cif.gz_A The crystal structure of inhibitor-bound JNK3	2.056E-03	0.900	67	172	487	493	1	350	351	411	0.641	0.997
LOKIASV2_1567_ESMFold_hypothetical_protein	5o1v-assembly1.cif.gz_B	5o1v-assembly1.cif.gz_B Crystal structure of WNK3 kinase domain in a monophosphorylated apo state (A-loop swapped)	8.991E-02	0.887	66	185	300	493	19	133	271	125	0.235	0.424
LOKIASV2_1567_ESMFold_hypothetical_protein	6pl3-assembly1.cif.gz_A	6pl3-assembly1.cif.gz_A TRK-A IN COMPLEX WITH LIGAND 2a	1.532E-02	0.887	66	180	482	493	11	281	291	355	0.615	0.931
LOKIASV2_1567_ESMFold_hypothetical_protein	2xir-assembly1.cif.gz_A	2xir-assembly1.cif.gz_A Crystal structure of the VEGFR2 kinase domain in complex with PF- 00337210 (N,2-dimethyl-6-(7-(2-morpholinoethoxy)quinolin-4-yloxy) benzofuran-3-carboxamide)	5.350E-03	0.887	66	171	485	493	14	295	296	359	0.639	0.953
LOKIASV2_1567_ESMFold_hypothetical_protein	6cpw-assembly1.cif.gz_A	6cpw-assembly1.cif.gz_A Discovery of 3(S)-thiomethyl pyrrolidine ERK inhibitors for oncology	2.472E-02	0.887	66	180	489	493	6	325	328	406	0.629	0.976
LOKIASV2_1567_ESMFold_hypothetical_protein	3oht-assembly1.cif.gz_B	3oht-assembly1.cif.gz_B Crystal Structure of Salmo Salar p38alpha	2.141E-02	0.887	66	180	490	493	21	269	331	357	0.631	0.752
LOKIASV2_1567_ESMFold_hypothetical_protein	6eq9-assembly2.cif.gz_B	6eq9-assembly2.cif.gz_B Crystal structure of JNK3 in complex with AMP-PCP	1.327E-02	0.887	66	171	486	493	14	280	332	365	0.641	0.804
LOKIASV2_1567_ESMFold_hypothetical_protein	1zyc-assembly1.cif.gz_B	1zyc-assembly1.cif.gz_B Crystal Structure of eIF2alpha Protein Kinase GCN2: Wild-Type in Apo Form.	2.472E-02	0.872	65	180	482	493	8	206	254	313	0.615	0.783
LOKIASV2_1567_ESMFold_hypothetical_protein	4tpt-assembly1.cif.gz_B	4tpt-assembly1.cif.gz_B Crystal Structure of the Human LIMK2 Kinase Domain In Complex With a Non-ATP Competitive Inhibitor	5.573E-02	0.855	64	198	474	493	16	201	277	292	0.562	0.671
LOKIASV2_1567_ESMFold_hypothetical_protein	6cnh-assembly1.cif.gz_A	6cnh-assembly1.cif.gz_A Human PRPF4B in complex with Rebastinib	1.265E-02	0.855	64	154	455	493	3	223	321	327	0.613	0.688
LOKIASV2_1567_ESMFold_hypothetical_protein	3hv7-assembly1.cif.gz_A	3hv7-assembly1.cif.gz_A Human p38 MAP Kinase in Complex with RL38	1.946E-02	0.855	64	180	482	493	20	214	330	316	0.615	0.591
LOKIASV2_1567_ESMFold_hypothetical_protein	2dyl-assembly1.cif.gz_A	2dyl-assembly1.cif.gz_A Crystal structure of human mitogen-activated protein kinase kinase 7 activated mutant (S287D, T291D)	4.388E-02	0.837	63	183	491	493	18	269	272	354	0.627	0.926
LOKIASV2_1567_ESMFold_hypothetical_protein	1kv1-assembly1.cif.gz_A	1kv1-assembly1.cif.gz_A p38 MAP Kinase in Complex with Inhibitor 1	1.327E-02	0.837	63	180	489	493	20	327	331	399	0.629	0.931
LOKIASV2_1567_ESMFold_hypothetical_protein	8j5x-assembly1.cif.gz_A	8j5x-assembly1.cif.gz_A The crystal structure of TrkA(G595R) kinase in complex with N-(3-cyclopropyl-5-((4-methylpiperazin-1-yl)methyl)phenyl)-4^6-methyl-14-oxo-5-oxa-13-aza-1(3,6)-imidazo[1,2-b]pyridazina-4(1,3)-benzenacyclotetradecaphan-2-yne-4^5-carboxamide	1.327E-02	0.817	62	172	482	493	8	286	296	356	0.631	0.943
LOKIASV2_1567_ESMFold_hypothetical_protein	6hkm-assembly1.cif.gz_A	6hkm-assembly1.cif.gz_A Crystal structure of Compound 1 with ERK5	3.988E-02	0.817	62	180	492	493	2	323	327	409	0.635	0.985
LOKIASV2_1567_ESMFold_hypothetical_protein	2zdu-assembly1.cif.gz_A	2zdu-assembly1.cif.gz_A Crystal Structure of human JNK3 complexed with an isoquinolone inhibitor	4.016E-03	0.817	62	174	487	493	2	329	330	390	0.637	0.994
LOKIASV2_1567_ESMFold_hypothetical_protein	6emh-assembly4.cif.gz_D	6emh-assembly4.cif.gz_D Crystal structure of JNK3 in complex with a pyridinylimidazole inhibitor	3.988E-02	0.817	62	171	487	493	15	238	331	342	0.643	0.677
LOKIASV2_1567_ESMFold_hypothetical_protein	3g9l-assembly1.cif.gz_X	3g9l-assembly1.cif.gz_X JNK3 bound to (Z)-1-((6-fluoro-4H-benzo[d][1,3]dioxin-8-yl)methyl)-3-(hydroxyimino)-4-styrylindolin-2-one	1.038E-01	0.817	62	174	300	493	2	132	336	146	0.258	0.390
LOKIASV2_1567_ESMFold_hypothetical_protein	5n68-assembly1.cif.gz_A	5n68-assembly1.cif.gz_A Crystal Structure of p38alpha in Complex with Lipid Pocket Ligand 9m	2.356E-02	0.795	61	180	486	493	21	322	328	390	0.623	0.921
LOKIASV2_1567_ESMFold_hypothetical_protein	4u79-assembly1.cif.gz_A	4u79-assembly1.cif.gz_A Crystal structure of human JNK3 in complex with a benzenesulfonamide inhibitor.	5.350E-03	0.795	61	171	487	493	1	336	337	399	0.643	0.997
LOKIASV2_1567_ESMFold_hypothetical_protein	6yg1-assembly2.cif.gz_B	6yg1-assembly2.cif.gz_B Crystal structure of MKK7 (MAP2K7) in an active state, allosterically triggered by the N-terminal helix	1.150E-02	0.772	60	183	489	493	28	300	307	365	0.623	0.889
LOKIASV2_1567_ESMFold_hypothetical_protein	6s76-assembly1.cif.gz_A	6s76-assembly1.cif.gz_A Crystal structure of human Nek7	5.065E-02	0.720	58	174	362	493	13	219	266	229	0.383	0.778
LOKIASV2_1567_ESMFold_hypothetical_protein	8bzp-assembly2.cif.gz_B	8bzp-assembly2.cif.gz_B JNK3 (Mitogen-activated protein kinase 10) in Complex with Compound 23 bearing a C(sp3)F2Br moiety	5.313E-02	0.720	58	180	486	493	16	273	326	358	0.623	0.791
LOKIASV2_1567_ESMFold_hypothetical_protein	6zwp-assembly1.cif.gz_A	6zwp-assembly1.cif.gz_A p38a bound with SR348	2.993E-02	0.720	58	171	486	493	17	320	328	401	0.641	0.927
LOKIASV2_1567_ESMFold_hypothetical_protein	6f5e-assembly1.cif.gz_B	6f5e-assembly1.cif.gz_B Crystal structure of DARPin-DARPin rigid fusion, variant DD_D12_10_47 in complex JNK1a1 and JIP1 peptide	3.801E-02	0.692	57	182	487	493	3	245	346	357	0.621	0.702
LOKIASV2_1567_ESMFold_hypothetical_protein	3soa-assembly1.cif.gz_A	3soa-assembly1.cif.gz_A Full-length human CaMKII	4.183E-02	0.692	57	173	481	493	5	285	436	375	0.627	0.644
LOKIASV2_1567_ESMFold_hypothetical_protein	6qfr-assembly1.cif.gz_A	6qfr-assembly1.cif.gz_A Structure of the mitogen activated kinase kinase 7 dfg-out conformation	1.461E-02	0.663	56	183	489	493	19	264	269	337	0.623	0.914
LOKIASV2_1567_ESMFold_hypothetical_protein	7cbx-assembly1.cif.gz_A	7cbx-assembly1.cif.gz_A Crystal structure of MAP2K7 complexed with a covalent inhibitor 12	2.141E-02	0.663	56	183	492	493	18	279	281	351	0.629	0.932
LOKIASV2_1567_ESMFold_hypothetical_protein	4yr8-assembly2.cif.gz_A	4yr8-assembly2.cif.gz_A Crystal structure of JNK in complex with a regulator protein	6.133E-02	0.663	56	171	486	493	15	318	320	399	0.641	0.950
LOKIASV2_1567_ESMFold_hypothetical_protein	4qpa-assembly1.cif.gz_A	4qpa-assembly1.cif.gz_A Crystal Structure of ERK2 in complex with 7-(1-benzyl-1H-pyrazol-4-yl)-2-(pyridin-4-yl)-5H-pyrrolo[2,3-b]pyrazine	4.357E-01	0.632	55	180	394	493	11	154	331	230	0.436	0.435
LOKIASV2_1567_ESMFold_hypothetical_protein	8ow2-assembly1.cif.gz_A	8ow2-assembly1.cif.gz_A Crystal structure of the p110alpha catalytic subunit from homo sapiens in complex with activator 1938	2.356E-02	0.632	55	177	492	493	631	886	895	339	0.641	0.286
LOKIASV2_1567_ESMFold_hypothetical_protein	3ub1-assembly2.cif.gz_B	3ub1-assembly2.cif.gz_B Ntf2 like protein involved in plasmid conjugation	4.183E-02	0.569	53	36	221	493	51	234	252	222	0.377	0.730
LOKIASV2_1567_ESMFold_hypothetical_protein	3l8x-assembly1.cif.gz_A	3l8x-assembly1.cif.gz_A P38 alpha kinase complexed with a pyrazolo-pyrimidine based inhibitor	4.603E-02	0.505	51	176	486	493	4	319	326	407	0.631	0.969
LOKIASV2_1567_ESMFold_hypothetical_protein	5hvy-assembly1.cif.gz_A	5hvy-assembly1.cif.gz_A CDK8/CYCC IN COMPLEX WITH COMPOUND 20	2.972E-01	0.505	51	128	300	493	1	136	335	181	0.351	0.406
LOKIASV2_1567_ESMFold_hypothetical_protein	8ts8-assembly1.cif.gz_A	8ts8-assembly1.cif.gz_A p85alpha/p110alpha heterodimer H1047R mutant	4.183E-02	0.505	51	177	492	493	715	983	992	346	0.641	0.271
LOKIASV2_1567_ESMFold_hypothetical_protein	3f14-assembly1.cif.gz_A-2	3f14-assembly1.cif.gz_A-2 Crystal structure of NTF2-like protein of unknown function (YP_680363.1) from CYTOPHAGA HUTCHINSONII ATCC 33406 at 1.45 A resolution	3.096E+00	0.411	48	174	221	493	58	101	112	48	0.097	0.393
LOKIASV2_1567_ESMFold_hypothetical_protein	2bo9-assembly1.cif.gz_D	2bo9-assembly1.cif.gz_D Human carboxypeptidase A4 in complex with human latexin.	1.532E-02	0.411	48	36	221	493	32	205	217	210	0.377	0.802
LOKIASV2_1567_ESMFold_hypothetical_protein	6pys-assembly1.cif.gz_A	6pys-assembly1.cif.gz_A Human PI3Kalpha in complex with Compound 2-10 ((3S)-3-benzyl-3-methyl-5-[5-(2-methylpyrimidin-5-yl)pyrazolo[1,5-a]pyrimidin-3-yl]-1,3-dihydro-2H-indol-2-one)	6.433E-02	0.382	47	132	492	493	553	877	890	407	0.732	0.365
LOKIASV2_1567_ESMFold_hypothetical_protein	5aig-assembly2.cif.gz_B	5aig-assembly2.cif.gz_B Discovery and characterization of thermophilic limonene-1,2-epoxide hydrolases from hot spring metagenomic libraries. Tomsk-sample- Valpromide complex	1.440E+00	0.353	46	38	81	493	57	101	124	46	0.089	0.363
LOKIASV2_1567_ESMFold_hypothetical_protein	5z3r-assembly4.cif.gz_E	5z3r-assembly4.cif.gz_E Crystal Structure of Delta 5-3-Ketosteroid Isomerase from Mycobacterium sp.	2.814E+00	0.353	46	36	81	493	66	111	131	47	0.093	0.351
LOKIASV2_1567_ESMFold_hypothetical_protein	8exl-assembly1.cif.gz_A	8exl-assembly1.cif.gz_A Crystal structure of PI3K-alpha in complex with taselisib	1.089E-01	0.353	46	177	492	493	617	879	892	341	0.641	0.295
LOKIASV2_1567_ESMFold_hypothetical_protein	8exu-assembly1.cif.gz_A	8exu-assembly1.cif.gz_A Crystal structure of PI3K-alpha in complex with compound 30	1.596E-01	0.301	44	177	492	493	622	885	898	346	0.641	0.294
LOKIASV2_1567_ESMFold_hypothetical_protein	8f3i-assembly1.cif.gz_A	8f3i-assembly1.cif.gz_A Crystal structure of Penicillin Binding Protein 5 (PBP5) S466 insertion variant penicillin bound form from Enterococcus faecium	4.539E+00	0.277	43	28	79	493	49	101	641	54	0.105	0.083
LOKIASV2_1567_ESMFold_hypothetical_protein	5fi4-assembly1.cif.gz_A	5fi4-assembly1.cif.gz_A Discovery of imidazo[1,2-a]-pyridine inhibitors of pan-PI3 kinases that are efficacious in a mouse xenograft model	1.142E-01	0.277	43	177	492	493	716	985	1009	347	0.641	0.268
LOKIASV2_1567_ESMFold_hypothetical_protein	8exo-assembly1.cif.gz_A	8exo-assembly1.cif.gz_A Crystal structure of PI3K-alpha in complex with compound 19	1.674E-01	0.254	42	177	492	493	622	887	900	352	0.641	0.296
LOKIASV2_1567_ESMFold_hypothetical_protein	7tz7-assembly1.cif.gz_A	7tz7-assembly1.cif.gz_A PI3K alpha in complex with an inhibitor	1.933E-01	0.254	42	179	492	493	706	974	988	345	0.637	0.272
LOKIASV2_1567_ESMFold_hypothetical_protein	2jq5-assembly1.cif.gz_A	2jq5-assembly1.cif.gz_A Solution structure of RPA3114, a SEC-C motif containing protein from Rhodopseudomonas palustris; Northeast Structural Genomics Consortium target RpT5 / Ontario Center for Structural Proteomics target RP3097	2.215E+00	0.233	41	142	221	493	40	116	128	87	0.162	0.602
LOKIASV2_1567_ESMFold_hypothetical_protein	6g0k-assembly1.cif.gz_B	6g0k-assembly1.cif.gz_B Crystal structure of Enterococcus faecium D63r Penicillin-Binding protein 5 (PBP5fm)	6.048E+00	0.233	41	26	81	493	48	104	609	57	0.114	0.094
LOKIASV2_1567_ESMFold_hypothetical_protein	8f3f-assembly1.cif.gz_A	8f3f-assembly1.cif.gz_A Crystal structure of Penicillin Binding Protein 5 (PBP5) T485M variant apo form from Enterococcus faecium	6.048E+00	0.233	41	36	81	493	59	104	641	47	0.093	0.072
LOKIASV2_1567_ESMFold_hypothetical_protein	5sw8-assembly1.cif.gz_A	5sw8-assembly1.cif.gz_A Crystal structure of PI3Kalpha in complex with fragments 7 and 11	1.596E-01	0.233	41	179	488	493	742	1016	1031	348	0.629	0.267
LOKIASV2_1567_ESMFold_hypothetical_protein	4j9a-assembly4.cif.gz_D	4j9a-assembly4.cif.gz_D Engineered Digoxigenin binder DIG10.3	6.048E+00	0.214	40	34	81	493	60	107	124	49	0.097	0.387
LOKIASV2_1567_ESMFold_hypothetical_protein	7jiu-assembly1.cif.gz_A	7jiu-assembly1.cif.gz_A HUMAN PI3KDELTA IN COMPLEX WITH COMPOUND 2F	1.089E-01	0.214	40	196	492	493	635	886	900	325	0.602	0.280
LOKIASV2_1567_ESMFold_hypothetical_protein	5xgh-assembly1.cif.gz_A	5xgh-assembly1.cif.gz_A Crystal structure of PI3K complex with an inhibitor	2.340E-01	0.214	40	133	490	493	663	974	993	396	0.726	0.314
LOKIASV2_1567_ESMFold_hypothetical_protein	1wnh-assembly1.cif.gz_A	1wnh-assembly1.cif.gz_A Crystal structure of mouse Latexin (tissue carboxypeptidase inhibitor)	6.433E-02	0.196	39	36	217	493	35	202	220	202	0.369	0.764
LOKIASV2_1567_ESMFold_hypothetical_protein	8f3m-assembly1.cif.gz_A	8f3m-assembly1.cif.gz_A Crystal structure of Penicillin Binding Protein 5 (PBP5) T485A variant with S466 insertion apo form from Enterococcus faecium	6.344E+00	0.196	39	36	81	493	59	104	642	48	0.093	0.072
LOKIASV2_1567_ESMFold_hypothetical_protein	7pg6-assembly1.cif.gz_A	7pg6-assembly1.cif.gz_A Crystal Structure of PI3Kalpha in complex with the inhibitor NVP-BYL719	2.231E-01	0.196	39	177	492	493	728	999	1026	350	0.641	0.265
LOKIASV2_1567_ESMFold_hypothetical_protein	6g0k-assembly1.cif.gz_C	6g0k-assembly1.cif.gz_C Crystal structure of Enterococcus faecium D63r Penicillin-Binding protein 5 (PBP5fm)	7.682E+00	0.179	38	26	81	493	47	103	595	57	0.114	0.096
LOKIASV2_1567_ESMFold_hypothetical_protein	6g88-assembly2.cif.gz_B	6g88-assembly2.cif.gz_B Crystal structure of Enterococcus Faecium D63r Penicillin-Binding protein 5 (PBP5fm)	8.453E+00	0.164	37	26	81	493	48	104	580	57	0.114	0.098
LOKIASV2_1567_ESMFold_hypothetical_protein	8f3z-assembly1.cif.gz_A	8f3z-assembly1.cif.gz_A Crystal structure of Penicillin Binding Protein 5 (PBP5) S422A variant apo form from Enterococcus faecium	8.867E+00	0.164	37	36	81	493	58	103	640	47	0.093	0.072
LOKIASV2_1567_ESMFold_hypothetical_protein	3ebt-assembly1.cif.gz_A-2	3ebt-assembly1.cif.gz_A-2 Crystal structure of a ntf2-like protein of unknown function (bpss0132) from burkholderia pseudomallei k96243 at 1.30 A resolution	4.995E+00	0.150	36	34	81	493	66	109	131	48	0.097	0.336
LOKIASV2_1567_ESMFold_hypothetical_protein	2rgq-assembly1.cif.gz_A	2rgq-assembly1.cif.gz_A Crystal structure of a protein of unknown function with a cystatin-like fold (npun_r3134) from nostoc punctiforme pcc 73102 at 1.80 A resolution	6.048E+00	0.150	36	174	221	493	67	114	133	50	0.097	0.361
LOKIASV2_1567_ESMFold_hypothetical_protein	3f7s-assembly1.cif.gz_A-2	3f7s-assembly1.cif.gz_A-2 CRYSTAL STRUCTURE OF A NTF2-LIKE PROTEIN OF UNKNOWN FUNCTION (PP_4556) FROM PSEUDOMONAS PUTIDA KT2440 AT 2.11 A RESOLUTION	6.344E+00	0.150	36	170	221	493	64	115	142	54	0.105	0.366
LOKIASV2_1567_ESMFold_hypothetical_protein	8f3q-assembly1.cif.gz_A	8f3q-assembly1.cif.gz_A Crystal structure of Penicillin Binding Protein 5 (PBP5) Y460A variant apo form from Enterococcus faecium	9.301E+00	0.150	36	36	79	493	58	101	640	45	0.089	0.069
LOKIASV2_1567_ESMFold_hypothetical_protein	2rd0-assembly1.cif.gz_A	2rd0-assembly1.cif.gz_A Structure of a human p110alpha/p85alpha complex	4.154E-01	0.150	36	177	482	493	718	973	997	333	0.621	0.257
LOKIASV2_1567_ESMFold_hypothetical_protein	6mkg-assembly1.cif.gz_A	6mkg-assembly1.cif.gz_A Crystal structure of penicillin binding protein 5 (PBP5) from Enterococcus faecium in the benzylpenicilin-bound form	9.301E+00	0.138	35	36	81	493	58	103	640	48	0.093	0.072
LOKIASV2_1567_ESMFold_hypothetical_protein	7rec-assembly1.cif.gz_G-2	7rec-assembly1.cif.gz_G-2 Structure of Thr354Asn, Glu355Gln, Thr412Asn, Ile414Met, Ile464His, and Phe467Met mutant human CaMKII alpha hub bound to 5-HDC	3.749E+00	0.126	34	36	79	493	62	106	126	46	0.089	0.357
LOKIASV2_1567_ESMFold_hypothetical_protein	4kz1-assembly1.cif.gz_A-2	4kz1-assembly1.cif.gz_A-2 Crystal structure of the soluble domain of VirB8 from Bartonella grahamii	3.749E+00	0.126	34	130	218	493	21	105	135	89	0.181	0.630
LOKIASV2_1567_ESMFold_hypothetical_protein	6isl-assembly1.cif.gz_B-2	6isl-assembly1.cif.gz_B-2 SnoaL-like cyclase XimE with its product xiamenmycin B	8.867E+00	0.116	33	40	81	493	61	103	120	43	0.085	0.358
LOKIASV2_1567_ESMFold_hypothetical_protein	4lso-assembly1.cif.gz_A	4lso-assembly1.cif.gz_A Crystal structure of the soluble domain of a Type IV secretion system protein VirB8 from Bartonella quintana Toulouse	3.096E+00	0.116	33	130	218	493	24	108	141	99	0.181	0.603
LOKIASV2_1567_ESMFold_hypothetical_protein	4waf-assembly1.cif.gz_A	4waf-assembly1.cif.gz_A Crystal Structure of a novel tetrahydropyrazolo[1,5-a]pyrazine in an engineered PI3K alpha	2.575E-01	0.116	33	179	492	493	723	994	1017	356	0.637	0.267
LOKIASV2_1567_ESMFold_hypothetical_protein	7pqh-assembly1.cif.gz_K	7pqh-assembly1.cif.gz_K Cryo-EM structure of Saccharomyces cerevisiae TOROID (TORC1 Organized in Inhibited Domains).	2.455E-01	0.116	33	175	482	493	815	1137	1157	387	0.625	0.279
LOKIASV2_1567_ESMFold_hypothetical_protein	4qjv-assembly1.cif.gz_B	4qjv-assembly1.cif.gz_B The X-ray crystal structure of Rpo3/Rpo11 heterodimer of euryarchaeal RNA polymerase from Thermococcus kodakarensis	3.933E+00	0.106	32	43	160	493	2	94	94	118	0.239	0.989
LOKIASV2_1567_ESMFold_hypothetical_protein	6zgn-assembly1.cif.gz_A	6zgn-assembly1.cif.gz_A Crystal structure of VirB8-like OrfG central domain of Streptococcus thermophilus ICESt3; a putative assembly factor of a gram positive conjugative Type IV secretion system.	3.248E+00	0.106	32	146	221	493	5	88	101	89	0.154	0.832
LOKIASV2_1567_ESMFold_hypothetical_protein	6wf4-assembly1.cif.gz_A	6wf4-assembly1.cif.gz_A Crystal Structure of TerC Co-crystallized with Polyporic Acid	6.655E+00	0.106	32	175	221	493	67	109	130	47	0.095	0.331
LOKIASV2_1567_ESMFold_hypothetical_protein	2z77-assembly2.cif.gz_D	2z77-assembly2.cif.gz_D X-ray crystal structure of RV0760c from Mycobacterium tuberculosis in complex with estradiol-17beta-hemisuccinate	4.762E+00	0.106	32	36	81	493	68	111	130	46	0.093	0.338
LOKIASV2_1567_ESMFold_hypothetical_protein	4nhf-assembly3.cif.gz_E	4nhf-assembly3.cif.gz_E Crystal structure of the soluble domain of TrwG Type IV secretion machinery from Bartonella grahamii	1.919E+00	0.106	32	95	218	493	7	109	142	127	0.252	0.725
LOKIASV2_1567_ESMFold_hypothetical_protein	8ecp-assembly1.cif.gz_B	8ecp-assembly1.cif.gz_B R16A PA0709 with BME modifications	8.058E+00	0.098	31	74	151	493	2	81	96	82	0.158	0.833
LOKIASV2_1567_ESMFold_hypothetical_protein	6of8-assembly1.cif.gz_G-2	6of8-assembly1.cif.gz_G-2 Structure of Thr354Asn, Glu355Gln, Thr412Asn, Ile414Met, Ile464His, and Phe467Met mutant human CamKII-alpha hub domain	3.096E+00	0.098	31	18	79	493	52	107	125	64	0.126	0.448
LOKIASV2_1567_ESMFold_hypothetical_protein	6of8-assembly1.cif.gz_D-2	6of8-assembly1.cif.gz_D-2 Structure of Thr354Asn, Glu355Gln, Thr412Asn, Ile414Met, Ile464His, and Phe467Met mutant human CamKII-alpha hub domain	5.765E+00	0.098	31	28	79	493	56	110	130	55	0.105	0.423
LOKIASV2_1567_ESMFold_hypothetical_protein	5if6-assembly2.cif.gz_B	5if6-assembly2.cif.gz_B Structure of a computationally designed 17-OHP binder	6.344E+00	0.098	31	36	81	493	68	111	133	46	0.093	0.331
LOKIASV2_1567_ESMFold_hypothetical_protein	4eoh-assembly1.cif.gz_B	4eoh-assembly1.cif.gz_B Crystal Structure of Human PL Kinase with bound Theophylline	7.323E+00	0.098	31	180	221	493	181	224	307	44	0.085	0.143
LOKIASV2_1567_ESMFold_hypothetical_protein	5ig3-assembly1.cif.gz_F	5ig3-assembly1.cif.gz_F Crystal structure of the human CaMKII-alpha hub	6.655E+00	0.090	30	36	79	493	61	105	123	46	0.089	0.366
LOKIASV2_1567_ESMFold_hypothetical_protein	5ig3-assembly1.cif.gz_B	5ig3-assembly1.cif.gz_B Crystal structure of the human CaMKII-alpha hub	4.762E+00	0.090	30	175	221	493	64	113	127	51	0.095	0.394
LOKIASV2_1567_ESMFold_hypothetical_protein	5ier-assembly3.cif.gz_C	5ier-assembly3.cif.gz_C Structure of a computationally designed 17-OHP binder	8.453E+00	0.090	30	36	81	493	66	111	131	48	0.093	0.351
LOKIASV2_1567_ESMFold_hypothetical_protein	2p9p-assembly1.cif.gz_D	2p9p-assembly1.cif.gz_D Crystal Structure of bovine Arp2/3 complex co-crystallized with ADP	6.388E-01	0.090	30	43	264	493	29	215	273	243	0.450	0.685
LOKIASV2_1567_ESMFold_hypothetical_protein	2yxu-assembly1.cif.gz_B	2yxu-assembly1.cif.gz_B Human Pyridoxal Kinase	8.058E+00	0.090	30	180	221	493	182	225	307	44	0.085	0.143
LOKIASV2_1567_ESMFold_hypothetical_protein	6w4o-assembly1.cif.gz_G	6w4o-assembly1.cif.gz_G CaMKII alpha-30 Cryo-EM reconstruction	5.240E+00	0.082	29	172	221	493	62	115	128	55	0.101	0.422
LOKIASV2_1567_ESMFold_hypothetical_protein	7rec-assembly1.cif.gz_F-2	7rec-assembly1.cif.gz_F-2 Structure of Thr354Asn, Glu355Gln, Thr412Asn, Ile414Met, Ile464His, and Phe467Met mutant human CaMKII alpha hub bound to 5-HDC	5.240E+00	0.082	29	28	79	493	57	109	130	54	0.105	0.408
LOKIASV2_1567_ESMFold_hypothetical_protein	4bqu-assembly2.cif.gz_B	4bqu-assembly2.cif.gz_B Japanin from Rhipicephalus appendiculatus bound to cholesterol: Orthorhombic crystal form	2.438E+00	0.082	29	170	282	493	20	128	149	128	0.229	0.732
LOKIASV2_1567_ESMFold_hypothetical_protein	3keu-assembly1.cif.gz_B	3keu-assembly1.cif.gz_B Crystal Structure of Human PL Kinase with bound PLP and ATP	8.867E+00	0.082	29	180	221	493	181	224	305	44	0.085	0.144
LOKIASV2_1567_ESMFold_hypothetical_protein	7urz-assembly1.cif.gz_A	7urz-assembly1.cif.gz_A Hexadecameric hub domain of CaMKII beta	5.765E+00	0.076	28	173	221	493	56	107	119	53	0.099	0.437
LOKIASV2_1567_ESMFold_hypothetical_protein	5ig3-assembly1.cif.gz_E	5ig3-assembly1.cif.gz_E Crystal structure of the human CaMKII-alpha hub	5.765E+00	0.076	28	36	81	493	62	110	125	50	0.093	0.392
LOKIASV2_1567_ESMFold_hypothetical_protein	7rec-assembly1.cif.gz_A	7rec-assembly1.cif.gz_A Structure of Thr354Asn, Glu355Gln, Thr412Asn, Ile414Met, Ile464His, and Phe467Met mutant human CaMKII alpha hub bound to 5-HDC	6.344E+00	0.076	28	36	79	493	70	112	132	46	0.089	0.326
LOKIASV2_1567_ESMFold_hypothetical_protein	4mei-assembly1.cif.gz_A-2	4mei-assembly1.cif.gz_A-2 Crystal structure of a VirB8 Type IV secretion system machinery soluble domain from Bartonella tribocorum	3.933E+00	0.076	28	132	218	493	23	105	136	99	0.176	0.610
LOKIASV2_1567_ESMFold_hypothetical_protein	7rec-assembly1.cif.gz_E-2	7rec-assembly1.cif.gz_E-2 Structure of Thr354Asn, Glu355Gln, Thr412Asn, Ile414Met, Ile464His, and Phe467Met mutant human CaMKII alpha hub bound to 5-HDC	6.981E+00	0.069	27	175	221	493	64	111	125	51	0.095	0.384
LOKIASV2_1567_ESMFold_hypothetical_protein	1hkx-assembly1.cif.gz_C	1hkx-assembly1.cif.gz_C Crystal structure of calcium/calmodulin-dependent protein kinase	1.830E+00	0.069	27	83	221	493	16	123	138	144	0.282	0.783
LOKIASV2_1567_ESMFold_hypothetical_protein	5ig3-assembly1.cif.gz_A-2	5ig3-assembly1.cif.gz_A-2 Crystal structure of the human CaMKII-alpha hub	8.867E+00	0.069	27	36	79	493	84	126	144	46	0.089	0.299
LOKIASV2_1567_ESMFold_hypothetical_protein	2lqj-assembly1.cif.gz_A	2lqj-assembly1.cif.gz_A Solution structure of the C-terminal domain of the MgtC protein from Mycobacterium tuberculosis	8.453E+00	0.063	26	47	145	493	1	78	94	102	0.201	0.830
LOKIASV2_1567_ESMFold_hypothetical_protein	6w4o-assembly1.cif.gz_C	6w4o-assembly1.cif.gz_C CaMKII alpha-30 Cryo-EM reconstruction	9.757E+00	0.063	26	36	79	493	64	108	126	46	0.089	0.357
LOKIASV2_1567_ESMFold_hypothetical_protein	7ury-assembly1.cif.gz_A	7ury-assembly1.cif.gz_A Tetradecameric hub domain of CaMKII beta	6.655E+00	0.063	26	170	221	493	58	112	131	56	0.105	0.420
LOKIASV2_1567_ESMFold_hypothetical_protein	3fhy-assembly1.cif.gz_B	3fhy-assembly1.cif.gz_B Crystal structure of D235N mutant of human pyridoxal kinase	5.496E+00	0.063	26	180	242	493	181	251	305	71	0.128	0.233
LOKIASV2_1567_ESMFold_hypothetical_protein	4en4-assembly1.cif.gz_B	4en4-assembly1.cif.gz_B Crystal Structure of the Ternary Human PL Kinase-Ginkgotoxin-MgATP Complex	5.496E+00	0.063	26	180	242	493	182	252	310	71	0.128	0.229
LOKIASV2_1567_ESMFold_hypothetical_protein	6x1k-assembly1.cif.gz_A	6x1k-assembly1.cif.gz_A Solution NMR structure of de novo designed TMB2.3	4.327E+00	0.051	24	44	126	493	57	117	124	88	0.168	0.492
LOKIASV2_1567_ESMFold_hypothetical_protein	2ux0-assembly1.cif.gz_A	2ux0-assembly1.cif.gz_A Structure of the oligomerisation domain of calcium-calmodulin dependent protein kinase II gamma	9.757E+00	0.051	24	172	221	493	71	124	137	55	0.101	0.394
LOKIASV2_1567_ESMFold_hypothetical_protein	7sjy-assembly2.cif.gz_B	7sjy-assembly2.cif.gz_B Crystal structure of Clostridium thermocellum RsgI9 S1C-NTF2 bi-domain	1.309E+00	0.051	24	44	221	493	122	301	312	221	0.361	0.577
LOKIASV2_1567_ESMFold_hypothetical_protein	5ig4-assembly1.cif.gz_F	5ig4-assembly1.cif.gz_F Crystal structure of N. vectensis CaMKII-A hub	9.757E+00	0.045	23	18	79	493	54	112	129	64	0.126	0.457
LOKIASV2_1567_ESMFold_hypothetical_protein	6qle-assembly1.cif.gz_P	6qle-assembly1.cif.gz_P Structure of inner kinetochore CCAN complex	2.324E+00	0.045	23	36	216	493	56	201	242	203	0.367	0.603
LOKIASV2_1567_ESMFold_hypothetical_protein	7urz-assembly1.cif.gz_B	7urz-assembly1.cif.gz_B Hexadecameric hub domain of CaMKII beta	6.344E+00	0.040	22	18	79	493	49	109	132	67	0.126	0.462
LOKIASV2_1567_ESMFold_hypothetical_protein	5npk-assembly1.cif.gz_D	5npk-assembly1.cif.gz_D 1.98A STRUCTURE OF THIOPHENE1 WITH S.AUREUS DNA GYRASE AND DNA	3.960E-01	0.040	22	191	493	493	420	663	674	338	0.615	0.362
LOKIASV2_1567_ESMFold_hypothetical_protein	5aii-assembly1.cif.gz_H	5aii-assembly1.cif.gz_H Discovery and characterization of thermophilic limonene-1,2-epoxide hydrolases from hot spring metagenomic libraries. CH55-sample-PEG complex	6.344E+00	0.034	21	175	219	493	60	102	129	47	0.091	0.333
LOKIASV2_1567_ESMFold_hypothetical_protein	5gyd-assembly1.cif.gz_B	5gyd-assembly1.cif.gz_B Crystal Structure of Mdm12	3.933E+00	0.029	20	144	219	493	16	117	224	116	0.154	0.455
LOKIASV2_1567_ESMFold_hypothetical_protein	7z7p-assembly3.cif.gz_C	7z7p-assembly3.cif.gz_C Structure of the fluorescent protein NeonCyan0.95 at pH 5.6	3.749E+00	0.029	20	40	137	493	137	225	226	123	0.199	0.394
LOKIASV2_1567_ESMFold_hypothetical_protein	6qlf-assembly1.cif.gz_P	6qlf-assembly1.cif.gz_P Structure of inner kinetochore CCAN complex with mask1	3.574E+00	0.029	20	36	216	493	42	187	228	196	0.367	0.640
LOKIASV2_1567_ESMFold_hypothetical_protein	2w2c-assembly1.cif.gz_L	2w2c-assembly1.cif.gz_L STRUCTURE OF THE TETRADECAMERIC OLIGOMERISATION DOMAIN OF CALCIUM- CALMODULIN DEPENDENT PROTEIN KINASE II DELTA	6.048E+00	0.024	19	81	221	493	1	118	130	155	0.286	0.908
LOKIASV2_1567_ESMFold_hypothetical_protein	7r6q-assembly1.cif.gz_N	7r6q-assembly1.cif.gz_N State E2 nucleolar 60S ribosome biogenesis intermediate - Foot region model	4.327E+00	0.024	19	48	136	493	53	121	131	90	0.181	0.527
LOKIASV2_1567_ESMFold_hypothetical_protein	3s1t-assembly1.cif.gz_B	3s1t-assembly1.cif.gz_B Structure of the regulatory domain of aspartokinase (Rv3709c; AK-beta) in complex with threonine from Mycobacterium tuberculosis	3.933E+00	0.024	19	93	265	493	30	139	156	174	0.351	0.705
LOKIASV2_1567_ESMFold_hypothetical_protein	5npp-assembly1.cif.gz_D	5npp-assembly1.cif.gz_D 2.22A STRUCTURE OF THIOPHENE2 AND GSK945237 WITH S.AUREUS DNA GYRASE AND DNA	9.825E-01	0.024	19	191	492	493	418	660	671	338	0.613	0.362
LOKIASV2_1567_ESMFold_hypothetical_protein	3cqn-assembly2.cif.gz_B	3cqn-assembly2.cif.gz_B Crystal Structure of the Lipocalin domain of Violaxanthin de-epoxidase (VDE) at pH7	5.765E+00	0.020	18	175	296	493	21	146	161	156	0.247	0.783
LOKIASV2_1567_ESMFold_hypothetical_protein	4zbl-assembly1.cif.gz_A	4zbl-assembly1.cif.gz_A Phototoxic fluorescent protein mKillerOrange	8.867E+00	0.020	18	34	131	493	134	225	225	121	0.199	0.409
LOKIASV2_1567_ESMFold_hypothetical_protein	5cdp-assembly1.cif.gz_A	5cdp-assembly1.cif.gz_A 2.45A structure of etoposide with S.aureus DNA gyrase and DNA	1.134E+00	0.020	18	191	492	493	229	471	483	339	0.613	0.503
LOKIASV2_1567_ESMFold_hypothetical_protein	2xct-assembly1.cif.gz_D	2xct-assembly1.cif.gz_D The twinned 3.35A structure of S. aureus Gyrase complex with Ciprofloxacin and DNA	1.585E+00	0.020	18	191	493	493	415	658	669	345	0.615	0.365
LOKIASV2_1567_ESMFold_hypothetical_protein	2w2c-assembly1.cif.gz_K	2w2c-assembly1.cif.gz_K STRUCTURE OF THE TETRADECAMERIC OLIGOMERISATION DOMAIN OF CALCIUM- CALMODULIN DEPENDENT PROTEIN KINASE II DELTA	8.453E+00	0.016	17	82	221	493	6	115	127	150	0.284	0.866
LOKIASV2_1567_ESMFold_hypothetical_protein	7z7o-assembly2.cif.gz_D-2	7z7o-assembly2.cif.gz_D-2 Structure of the fluorescent protein NeonCyan0.95 at pH 7.5	6.344E+00	0.016	17	44	127	493	136	206	214	104	0.170	0.332
LOKIASV2_1567_ESMFold_hypothetical_protein	2ajp-assembly3.cif.gz_B	2ajp-assembly3.cif.gz_B Crystal structure of a human pyridoxal kinase	7.682E+00	0.016	17	111	242	493	113	250	301	161	0.268	0.458
LOKIASV2_1567_ESMFold_hypothetical_protein	6fqs-assembly1.cif.gz_C	6fqs-assembly1.cif.gz_C 3.11A complex of S.Aureus gyrase with imidazopyrazinone T3 and DNA	7.030E-01	0.016	17	98	492	493	127	470	481	462	0.801	0.715
LOKIASV2_1567_ESMFold_hypothetical_protein	6z1a-assembly1.cif.gz_B	6z1a-assembly1.cif.gz_B Ternary complex of Staphylococcus aureus DNA gyrase with AMK12 and DNA	2.438E+00	0.016	17	191	492	493	417	659	671	336	0.613	0.362
LOKIASV2_1567_ESMFold_hypothetical_protein	5npk-assembly1.cif.gz_B	5npk-assembly1.cif.gz_B 1.98A STRUCTURE OF THIOPHENE1 WITH S.AUREUS DNA GYRASE AND DNA	1.744E+00	0.016	17	191	493	493	419	662	673	338	0.615	0.363
LOKIASV2_1567_ESMFold_hypothetical_protein	4bul-assembly1.cif.gz_A	4bul-assembly1.cif.gz_A Novel hydroxyl tricyclics (e.g. GSK966587) as potent inhibitors of bacterial type IIA topoisomerases	2.215E+00	0.016	17	191	492	493	420	662	674	335	0.613	0.361
LOKIASV2_1567_ESMFold_hypothetical_protein	7syf-assembly1.cif.gz_A	7syf-assembly1.cif.gz_A Reconstruction of full-length Prex-1 (PtdIns(3,4,5)P3-dependent Rac Exchanger 1)	8.512E-01	0.016	17	50	490	493	745	1036	1391	467	0.895	0.210
LOKIASV2_1567_ESMFold_hypothetical_protein	7mvs-assembly1.cif.gz_B	7mvs-assembly1.cif.gz_B DNA gyrase complexed with uncleaved DNA and Compound 7 to 2.6A resolution	2.557E+00	0.014	16	191	492	493	422	664	675	337	0.613	0.360
LOKIASV2_1567_ESMFold_hypothetical_protein	5npk-assembly2.cif.gz_b	5npk-assembly2.cif.gz_b 1.98A STRUCTURE OF THIOPHENE1 WITH S.AUREUS DNA GYRASE AND DNA	3.248E+00	0.011	15	191	493	493	422	665	675	337	0.615	0.361
LOKIASV2_1567_ESMFold_hypothetical_protein	3rfz-assembly3.cif.gz_B	3rfz-assembly3.cif.gz_B Crystal structure of the FimD usher bound to its cognate FimC:FimH substrate	4.125E+00	0.011	15	48	218	493	438	575	778	200	0.347	0.177
LOKIASV2_1567_ESMFold_hypothetical_protein	2gbx-assembly1.cif.gz_F	2gbx-assembly1.cif.gz_F Crystal Structure of Biphenyl 2,3-Dioxygenase from Sphingomonas yanoikuyae B1 Bound to Biphenyl	9.301E+00	0.010	14	86	217	493	18	138	170	147	0.268	0.712
LOKIASV2_1567_ESMFold_hypothetical_protein	2dd9-assembly2.cif.gz_C	2dd9-assembly2.cif.gz_C A mutant of GFP-like protein from Chiridius poppei	7.323E+00	0.010	14	41	131	493	126	213	213	121	0.185	0.413
LOKIASV2_1567_ESMFold_hypothetical_protein	3e8j-assembly1.cif.gz_B	3e8j-assembly1.cif.gz_B Coproporphyrinogen III oxidase from Leishmania naiffi	6.048E+00	0.009	13	11	242	493	16	145	286	244	0.471	0.455
LOKIASV2_1567_ESMFold_hypothetical_protein	6qx2-assembly1.cif.gz_A	6qx2-assembly1.cif.gz_A 3.4A structure of benzoisoxazole 3 with S.aureus DNA gyrase and DNA	4.762E+00	0.009	13	191	492	493	227	467	479	334	0.613	0.503
LOKIASV2_1567_ESMFold_hypothetical_protein	7fvt-assembly1.cif.gz_A	7fvt-assembly1.cif.gz_A Crystal Structure of S. aureus gyrase in complex with 6-[5-[2-[(4-chloro-2,3-dihydro-1H-inden-2-yl)methylamino]ethyl]-2-oxo-1,3-oxazolidin-3-yl]-4H-pyrido[3,2-b][1,4]oxazin-3-one	4.327E+00	0.009	13	192	492	493	418	659	670	341	0.611	0.361
LOKIASV2_1567_ESMFold_hypothetical_protein	5npp-assembly1.cif.gz_B	5npp-assembly1.cif.gz_B 2.22A STRUCTURE OF THIOPHENE2 AND GSK945237 WITH S.AUREUS DNA GYRASE AND DNA	5.765E+00	0.009	13	191	492	493	418	660	672	345	0.613	0.362
LOKIASV2_1567_ESMFold_hypothetical_protein	3bs0-assembly2.cif.gz_B	3bs0-assembly2.cif.gz_B Crystal structure of the P. putida toluene transporter TodX	6.981E+00	0.008	12	36	218	493	92	264	414	224	0.371	0.418
